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Abstract 
 
Gastrointestinal endoscopy is a vital tool for the detection and treatment of early neoplasia in the 
upper and lower gastrointestinal tracts. Survival from gastrointestinal cancer is largely dependent 
on the stage at diagnosis – thus detection of early lesions, or better still treatment of pre-
cancerous lesions is vital to improve outcomes. 
The world of endoscopy is changing rapidly with the development of dye-based and digital 
enhancement techniques with the aim of improving the detection and characterisation of 
neoplastic lesions. This thesis reviews the development of all the main advanced imaging 
techniques and comprehensively reviews the evidence for the use of these in the colon. 
Chapter 4 describes the development of a new classification system for characterising small 
colonic polyps using the Pentax i-Scan digital enhancement system.  
Chapter 5 describes a prospective cohort study using i-Scan for the in-vivo characterisation of 
small colonic polyps in 87 patients. No differences in the accuracy of polyp characterisation 
between high-definition white light endoscopy, i-Scan and chromoendoscopy were found when 
performed by an expert endoscopist. All 3 modalities met the ASGE criteria for management 
based on optical diagnosis. 
Chapter 6 describes a retrospective study looking at factors influencing polyp and adenoma 
detection in a large UK Bowel cancer screening cohort. Endoscope definition (standard vs high 
definition) was examined in particular. In this group of patients, endoscope definition was found 
to have no impact on any outcome measure, but endoscopist and bowel preparation were 
consistent predictors of key quality outcomes. 
Chapter 7 describes a randomised controlled clinical trial recruiting 126 patients of a pre-
endoscopy drink containing water, n-acetyl cysteine and simeticone. This was shown to 
significantly improve mucosal visibility compared to water alone, or no preparation, and also 
significantly reduced the need for procedural fluid flushes. 
Chapters 8 & 9 describes two studies examining the baseline performance and impact of training 
modules on the accuracy of colonic lesion and polyp characterisation amongst non-endoscopists 
and endoscopists with varying degrees of experience. Baseline performance of experienced 
endoscopists was found to be no different to that of inexperienced endoscopists and novices in 
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both studies, but training improved accuracy in all groups. These studies highlight the need for 
training in lesion characterisation to become part of the formal training programme for all 
endoscopists. 
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Chapter 1 - The burden of gastrointestinal cancer 
 
1.1 Gastrointestinal cancer incidence and outcomes 
There were 484,367 deaths registered in England and Wales in 20111, of which one third 
(159,178) were due to cancer2. Despite advances in diagnosis and treatment, the public 
still fears a diagnosis of cancer above any other type of disease or illness, with bowel 
cancer being the second most feared type of cancer3, 4. 
Cancers arising in the gastrointestinal tract are amongst the most common in the UK. 
Colorectal cancer is the second commonest cause of cancer related death with over 
15,000 deaths due to the condition in 20112. Upper gastrointestinal cancer, and 
specifically cancers of the oesophagus and stomach, are also common. Oesophageal 
cancer was the 6th most common cause of cancer related death in 2011, accounting for 
7603 lives, and stomach (gastric) cancer the 8th most common causing 4830 deaths2.  
Mortality rates from colorectal, oesophageal and gastric cancer have been falling over the 
past decade2 (see figures 1&2), but despite this survival rates for colorectal cancer in the 
UK lag behind those of other developed countries in the west5. The most widely accepted 
measure of survival is the 5 year survival rate which measures the percentage of patients 
still alive 5 years after diagnosis. The 5 year survival for colorectal cancer in the UK for the 
period 2004-2009 was 53.3%, in comparison to rates of 60.4% in Germany, 60.7% in 
Sweden, 61.0% in the Netherlands and 63.1% in Austria5. 
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 Figure 1  - The 20 Most Common Cancers, Percentage Change in European Age-Standardised Three Year Average 
Incidence Rates, Males, UK, 2000-2002 and 2009-2011. Reproduced with permission from Cancer Research UK6 
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 Figure 2 - The 20 Most Common Cancers, Percentage Change in European Age-Standardised Three Year Average 
Incidence Rates, Females, UK, 2000-2002 and 2009-2011. Reproduced with permission from Cancer Research UK6 
 
The UK government has identified cancer outcomes and in particular survival rates as a 
key area for improvement. In the document Improving Outcomes: A Strategy for Cancer 
published in 2011 it notes “Our record is one of delivering health outcomes which fail to 
match those achieved by the best-performing countries, or even average-performing 
countries.” and sets out the aim to “…deliver health outcomes that are among the best in 
the world”6.  
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1.2 Oesophageal Cancer 
Oesophageal cancer is the 6th commonest cause of cancer related death in the UK with 
7600 deaths due to the disease in 20112. It is also a worldwide problem being the 6th 
commonest cause of cancer related death worldwide with 482,000 cases in 20087.  
Survival rates in the UK have been gradually improving over time (see figure 3). In the 
1970’s 5 year survival was 3-6%2. However prognosis remains poor overall with the latest 
5 year survival rates being 13.4% for males and 12.6% for females for the period 2005-
20092. 
 
Figure 3 - Oesophageal Cancer, Age-Standardised Five-Year Relative Survival Rates, England and Wales 1971-1995 and 
England 1996-2009. Reproduced with permission from Cancer Research UK8 
The majority of oesophageal cancer is of two types; squamous cell cancer (SCC) and 
adenocarcinoma. Worldwide, SCC is the commonest type of oesophageal cancer8. 
However in certain western countries, including the UK and USA, the incidence of SCC has 
been overtaken by oesophageal adenocarcinoma in recent years8-10. In the UK the 
incidence of oesophageal adenocarcinoma is now nearly double that of oesophageal 
SCC11. This is due to a rapid rise in the incidence of oesophageal adenocarcinoma 
23 
 
amongst white men10, 12. The cause of this marked increase in incidence in this cohort has 
not been established. 
Established risk factors for oesophageal SCC include tobacco use, alcohol consumption, 
low socioeconomic status, previous caustic injury to the oesophagus, a history of 
squamous cell head and neck cancer, and nonepidermolytic palmoplantar keratoderma 
(tylosis)8, 13-16. 
 
Figure 4 - Oesophageal Cancer (C15), European Age-Standardised Incidence Rates, Great Britain, 1975-2011. 
Reproduced with permission from Cancer Research UK17 
 
 
The major risk factors for oesophageal adenocarcinoma are gastro-oesophageal reflux 
disease (GORD), Barrett’s oesophagus and obesity8, 11, 17-19. Barrett’s oesophagus is 
characterised by a replacement of the normal squamous lining of the distal oesophagus 
with metaplastic columnar epithelium, and is recognised as a major risk factor for 
oesophageal adenocarcinoma20. Oesophageal carcinoma arises in Barrett’s oesophagus 
through a sequential progression from metaplasia to dysplasia to carcinoma. There is 
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some evidence that Helicobacter Pylori infection may play a protective role against 
developing Barrett’s oesophagus and oesophageal adenocarcinoma21, 22.  
 
Oesophageal cancer typically presents with symptoms of dysphagia (difficulty in 
swallowing) with patients usually describing a feeling of food ‘sticking’ in their gullet. 
Other typical features are odynophagia (pain on swallowing), new onset of heartburn, 
and weight loss. 
  
Historically barium swallow studies were the initial investigation of choice for patients 
with suspected oesophageal cancer. These have now largely been replaced by endoscopy 
as the initial investigation of choice. Endoscopy offers the advantage of direct 
visualisation of the oesophagus as well as the ability to take biopsy specimens. A history 
of recent onset dysphagia should prompt an urgent referral from a patient’s general 
practitioner via the ‘2-week wait’ pathway6. This aims to provide access to urgent 
endoscopy for all patients with suspected oesophageal cancer within 2 weeks of referral. 
 
If a diagnosis of oesophageal cancer is confirmed following endoscopy and biopsy then 
further staging investigations are usually undertaken to determine the stage of the 
disease. Oeosphageal cancers are staged using the TNM (tumour, node, metastasis) 
classification which assesses the depth of local invasion (T-stage), involvement of loco-
regional lymph nodes (N-stage) and presence or absence of distant metastases (M-stage) 
– see figure 5.  
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Figure 5 - Features used to stage oesophageal carcinoma by TNM classification. Tis = intraepithelial neoplasia. HGD = 
high grade dysplasia. Reproduced with permission from Enzinger et al 13Copyright Massachusetts Medical Society. 
 
Endoscopic Ultrasound (EUS) is used to assess the depth of invasion through the wall of 
the oesophagus and spread to loco-regional lymph nodes8, 11, 20. Computerised 
tomography scanning (CT) has also traditionally been used to assess local TNM stage. 
More recently positron emission tomography CT scanning (PET-CT), using 18F-
fluorodeoxglucose to highlight foci of tumour with high metabolic activity, has been used 
to  identify involved lymph nodes and distant metastases which are either equivocal or 
not seen on standard CT scanning8, 11, 20.  
 
The outcome of oesophageal cancer depends greatly on the stage of disease at the time 
of diagnosis. Diagnosis at a pre-cancerous stage of high grade dysplasia (Tis = carcinoma 
in situ) has an excellent prognosis with 5 year survival rates in excess of 95%. Stage I 
oesophageal adenocarcinoma (T1/2 without lymph node spread or metastases) has a 5 
year survival rate of 50-80%, but in contrast stage III disease (lymph node spread or 
invasion of adjacent organs) has a 5 year survival rate of 10-15% and stage IV disease, 
characterised by distant metastases has an even more dismal prognosis with 5 year 
survival rates of less than 5%13.  
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Treatment options for oesophageal adenocarcinoma are determined by staging. High 
grade dysplasia or early T1 disease involving only the mucosa (intramucosal 
carcinoma/T1a) are suitable for endoscopic resection. More advanced T stages require 
radical surgical resection with or without pre-operative neo-adjuvant chemotherapy23. 
Oesophagectomy is a major operation and carries an in-hospital mortality rate of 4.5% 
and complication rate of 29.8% as reported in the 2010 UK wide audit24. 
Advanced disease with distant metastases is not suitable for surgical resection and should 
be treated with palliative chemotherapy, stenting of the tumour if it is causing 
obstruction or best supportive care23. 
Early Oesophageal SCC confined to the mucosa may be amenable to endoscopic 
resection, although does carry higher risk of lymph node micro metastases than 
adenocarcinoma25. Higher T stages are amenable to chemoradiotherapy followed by 
surgery for operable tumours or palliative chemoradiotherapy in advanced cases or those 
not suitable for surgery23. 
Unfortunately the majority of cases of oesophageal cancer are too advanced for potential 
curative endoscopic or surgical resection by the time they are diagnosed. Only 36% of 
cases in the UK national oesophago-gastric cancer audit were suitable for potential 
curative treatment24. Oesophageal tumours are usually bulky by the time they cause 
sufficient luminal narrowing to lead to symptoms of dysphagia. 
 
1.3 Gastric Cancer 
Gastric cancer is the 8th commonest cause of cancer related death in the UK with over 
4800 deaths due to the disease in 201126. Worldwide it accounts for 10% of cancer 
related deaths with high rates in Asia and South America27. The incidence has been 
steadily falling over the past 4 decades (see figure 6).  Overall 5 year survival rates in the 
UK have improved from 5% in the 1970’s to 17% in 2005-2009 but for the majority of 
patients diagnosed with the condition the outlook is poor (see figure 7). 
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 Figure 6 - Stomach Cancer (C16), European Age-Standardised Incidence Rates, Great Britain, 1975-2011. Reproduced 
with permission from Cancer Research UK29 
 
Figure 7 - Gastric Cancer (C16), Age-Standardised Five-Year Relative Survival Rates, England and Wales 1971-1999 and 
England 2001-2009. Reproduced with permission from Cancer Research UK30 
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The vast majority of malignant neoplasms arising in the stomach are adenocarcinomas. 
The major risk-factors for development of gastric adenocarcinoma are; infection with 
Helicobacter pylori, cigarette smoking, high alcohol intake, high dietary salt levels and 
consumption of salt based food preservatives20, 28-33. Gastric adenocarcinoma develops 
slowly over time via a progression from chronic gastritis to gastric atrophy, intestinal 
metaplasia, dysplasia and cancer20.  
Gastric cancer can present with a variety of symptoms including new onset of dyspepsia, 
weight loss, early satiety, vomiting, signs of upper gastrointestinal bleeding or anaemia20, 
28. In a similar fashion to oesophageal cancer the disease is often advanced at the time of 
diagnosis. In the UK national audit of 2010 only 36% of cases were suitable for potential 
curative treatment24. 
Diagnosis follows a similar pathway to oesophageal cancer with rapid access to upper 
gastrointestinal endoscopy plus biopsy followed by staging with CT, PET-CT and EUS 
depending on the location of the primary tumour23. Staging laparosocopy is also used to 
exclude peritoneal micrometastases23.  
Treatment options depend on the stage of disease at diagnosis with early gastric cancers 
suitable for endoscopic removal by endoscopic mucosal resection (EMR) or endoscopic 
submucosal dissection (ESD) with excellent long-term outcomes34-36. More advanced 
disease which is suitable for curative surgical resection is usually treated with pre-
operative neo-adjuvant chemotherapy followed by partial or total gastrectomy, 
depending on tumour location23. Advanced inoperable disease can be treated with 
palliative chemotherapy, stenting for obstructive tumours, and best supportive care23. 
 
1.4 Colorectal cancer and colonic polyps 
Colorectal cancer (CRC) is the third commonest malignancy in the UK and the second 
commonest cause of cancer death, with an annual incidence of approximately 40,000 
cases37. The vast majority of CRC arises from a precursor lesion, the adenomatous colonic 
polyp, via the well-established adenoma-carcinoma sequence38, 39. This process usually 
takes years, via a series of mutations in oncogenes and tumour suppressor genes. Thus 
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adenomatous polyps, with the potential to develop into cancers, are present in the colon 
for several years prior to the development of CRC, and are usually asymptomatic. The 
removal of colonic adenomas by colonoscopic polypectomy has been shown to be highly 
effective in reducing future risk of colorectal cancer40, 41. 
In addition to adenomatous colonic polyps, the other main type of polyp found in the 
colon is the hyperplastic polyp. True hyperplastic polyps have negligible malignant 
potential. Sessile serrated polyps, which are related to hyperplastic polyps, are usually 
found in the proximal colon and can progress to CRC via the alternative serrated 
pathway42. However small hyperplastic polyps in the rectum and sigmoid colon are a 
common finding at colonoscopy and have negligible malignant potential. 
The main risk factors for sporadic colorectal cancer are increasing age, male sex, obesity, 
diabetes mellitus, a history of colonic polyps, and a diet high in red meat and fat and low 
in fibre42. Certain inherited conditions can also predispose to colorectal cancer; familial 
adenomatous polyposis, Hereditary non-polyposis colorectal cancer (Lynch syndrome), 
serrated polyposis syndrome, MUTYH-associated polyposis and Peutz-Jeghers 
syndrome43, 44. However the majority of CRC cases are of the sporadic type. 
Colorectal cancer typically present with passage of blood per rectum, tenesmus, change 
in bowel habit or anaemia. However many of these ‘red-flag’ symptoms that prompt 
urgent referral have poor sensitivity and/or specificity for colorectal cancer45. Any of 
these symptoms should prompt urgent referral and the initial investigation of choice is 
usually an endoscopic examination; either a flexible sigmoidoscopy which examines the 
distal colon and rectum after preparation with an enema, or full colonoscopy following 
purgative bowel preparation. An alternative examination for patients who are unwilling 
or unable to undergo endoscopic examination is CT colonography. If colorectal cancer is 
confirmed on endoscopy and biopsy further staging is performed by CT scanning, plus 
MRI for rectal tumours42. 
The prognosis for colorectal cancer is closely linked to stage at presentation. Early disease 
carries an excellent 5 year survival of 93.2% for patients with a Duke’s A tumour, and 77% 
for those with a Duke’s B tumours. More advanced disease has a far more dismal outlook 
with rates of 47.7% for patients with a Duke’s C tumour and 6.6% for those with a Duke’s 
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D tumour (metastatic disease)46. However, only a minority of patients present with 
symptoms when they have early stage tumours. In the 2013 UK & Ireland bowel cancer 
audit only 20% of colorectal cancer treated with surgical resection was of T-stage 1 or 2, 
with the remainder being T-stage 3 or 447. Overall the survival rates for colorectal cancer 
have been steadily improving over recent decades – (see figure 8) 
 
Figure 8 - Age standardised UK colorectal cancer 5-year survival rates for adults, change over time – Reproduced with 
permission from Cancer Research UK 
 
In view of the late stage at presentation of the majority of colorectal cancer, many 
countries have introduced colorectal cancer screening programmes. The UK National 
Bowel Cancer Screening Programme (BCSP) aims to screen all adults between the ages of 
60 and 74 with the aim of reducing bowel cancer related mortality. Adults in this age 
bracket are invited to perform a guiac-based faecal occult blood test (FOBT). Those with a 
‘positive’ FOBT, indicating the presence of microscopic blood in the stool, are offered 
colonoscopy.   Reduction in CRC related mortality is achieved in two ways:- 1) Detecting 
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and removing potentially pre-malignant polyps 2) Detecting early bowel cancers which 
are amenable to curative surgery.  
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Chapter 2 - The changing role of endoscopy in the 
diagnosis and treatment of gastrointestinal cancer and 
precursor lesions 
 
2.1 The history of gastrointestinal endoscopy 
Endoscopy has come a long way since the early rigid gastroscopes of the late 19th  century 
which were introduced into the stomach in a similar fashion to a sword swallower48. The 
first flexible gastroscope, introduced by Schindler and Wolf in 1932, was a major advance 
and use of gastroscopes became more widespread48. In 1957 Basil Hirschowitz introduced 
the first fully flexible fiberoptic gastroscope, to a rather luke-warm response from his 
peers. Initial reports suggested the image quality was inferior to that obtained with a 
traditional semi-flexible gastroscope using a series of lenses. Even at this early stage of 
endoscopy comparisons were being drawn between the diagnostic accuracy of different 
endoscopic technologies.  
Instruments for examining the anus and rectum date back as far as Egypt and Pompeii48. 
Rigid sigmoidoscopes were developed in the late 19th century and permitted direct 
visualisation and biopsy of the rectum and distal sigmoid colon. By the 1960’s flexible 
sigmoidoscopes were being developed in the USA and Japan and in the late 1960’s and 
early 1970’s the first cases of total fiberoptic colonoscopy were being reported48-50. 
Alongside its diagnostic capabilities, early endoscopists were also developing the 
technique of colonoscopic polypectomy to remove adenomatous and other polyps. 
Shinya and Wolff reported a series of several hundred endoscopic polypectomies with 
good results and very low complication rates51, thus avoiding the need for laparotomy 
and colectomy. 
The 1980’s brought a further advance with the development of the photosensitive 
charged-coupled device (CCD) or ‘chip’ allowing electronic transmission of the image to a 
video monitor and the beginnings of the modern age of endoscopy52, 53. Charged-coupled 
devices, made from silicon, are divided into pixels with the resolution of the image 
produced being related to the number of pixels present on the ‘chip’.  
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 2.2 Progression from a diagnostic to therapeutic device 
As already described, colonic polypectomy was being performed even in the early days of 
fiberoptic colonoscopy54. Over the intervening years several large series of endoscopic 
removal of colonic polyps were published with this becoming a well-established 
technique and an alternative to segmental resection of the colon54-58. The advantages of 
an endoscopic approach are shorter duration of hospital stay, maintenance of bowel 
integrity and swifter recovery time. In early series the main technique involved en bloc 
electrocautery snare resection of pedunculated polyps and piecemeal snare resection of 
sessile polyps. Complication rates were low but some patients were found to have 
invasive carcinoma present in the resected specimen at rates of 3 to 24% in these early 
series54-56, 58.  The majority of these cases proceeded to surgical colonic resection. 
Recurrence rates of adenomatous tissue were also high compared to current acceptable 
standards, at up to 29%, although the majority of these could be treated by further 
endoscopic resection56. 
Refinement of the resection technique has occurred over the years. In 1973 Deyhle and 
colleagues first described the use of a submucosal fluid injection prior to snare resection 
of mucosa59. This provided a protective submucosal cushion of fluid to prevent damage to 
deeper layers of the bowel wall by diathermy. This was a particular concern in the 
proximal colon where the colon wall can be only 2-3mm thick. Deyhle described the use 
of this technique in 10 dogs, none of which suffered a perforation, and subsequent use in 
a human patient to remove 7 polyps. In 1984 Tada and colleagues described the ‘strip-off 
biopsy’ technique, using a submucosal saline injection, for resecting gastric neoplasia60. 
Following submucosal injection using a double-channelled endoscope the lesion was 
grasped with forceps and pulled through an open snare which was subsequently closed 
and resection performed. In subsequent publications by the same group the ‘strip biopsy’ 
technique was shown to be effective for removal of both gastric and colonic neoplasia up 
to 20mm in a single piece61 and for piecemeal resection of larger lesions62. These were 
the first descriptions of what is now known as endoscopic mucosal resection (EMR). 
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 Figure 9 - Strip biopsy technique. Reprinted from Karita M et al64 with permission from Elsevier. 
 
Prior to the development of EMR, endoscopic resection of very flat or slightly depressed 
gastrointestinal lesions was extremely difficult as the lesion morphology did not lend itself 
to engagement of the snare. The technique of submucosal injection also facilitated 
piecemeal snare resection of large sessile lesions. 
The EMR procedure was subsequently developed and adapted to various related 
techniques. Use of a transparent distal cap on the endoscope allowed a lesion to be 
suctioned into the cap prior to closure of a pre-mounted snare around the base of the 
lesion63. In a similar fashion rubber-band ligation devices mounted on a cap could be 
deployed around the base of the lesion sucked into the cap and subsequently removed by 
a snare placed below the rubber band64. With the development of these adaptations of 
EMR it became possible to successfully remove early oesophageal neoplasia as well as 
colonic and gastric lesions.  
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The next major advance in endoscopic resection was the development of endoscopic 
submucosal dissection (ESD). ESD was developed initially for the treatment of early gastric 
cancers but was later adapted to colonic and oesophageal lesions. Following elevation of 
a lesion by submucosal injection a circumferential mucosal incision is made using an 
electrosurgical needle-knife only a few millimetres in length. In early series resection 
following this circumferential incision was completed by snare resection57, 65. With 
development and improvement of the technique, circumferential mucosal incision was 
followed by careful submucosal dissection using the same needle-knife, allowing en bloc 
resection of lesions greater than 20 mm in size. 
The advantages of ESD over EMR are that it allows en bloc removal of larger lesions, 
enabling a precise histopathological diagnosis to be obtained including careful assessment 
of submucosal invasion. The disadvantages are that the technique is technically 
demanding, takes longer to perform, and carries higher risks of the main complications of 
bleeding and perforation. Despite these challenges, impressive results of ESD for gastric, 
oesophageal and colorectal neoplasia have been reported, with high en bloc resection 
rates and very low rates of recurrence35, 66-70. 
 
2.3 Indications for Endoscopy 
Upper and lower gastrointestinal endoscopy is performed for a number of indications: 1) 
Investigation of a patient’s symptoms which may be attributable to a gastrointestinal 
cause, for example dyspepsia, weight loss, change in bowel habit, per rectal bleeding or 
iron-deficiency anaemia; 2) Screening for cancer precursor lesions or early cancers in 
asymptomatic individuals on a population basis such as for bowel cancer screening; 3) 
Surveillance in patients with a personal history of gastrointestinal cancer, precursors 
lesions or risk factors for dysplastic lesions (eg previous colonic adenomas, colonic 
polyposis syndromes or known Barrett’s oesophagus)71. Endoscopy is also performed as 
follow-up in patients who’ve undergone previous endoscopic resection.  
In the first of these groups the main focus of the procedure is to identify any potential 
causes for the patients’ presenting symptoms. In the screening and surveillance groups, 
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patients are generally asymptomatic and the primary purpose of the examination is to 
detect neoplastic lesions such as adenomatous colonic polyps, areas of dysplasia within 
Barrett’s oesophagus or precursor lesions of gastric cancer. However, even in the 
symptomatic group, endoscopy offers a valuable opportunity to detect neoplastic lesions. 
Hence, one of the core aims of gastrointestinal endoscopy is to remove neoplastic lesions 
and therefore reduce patients’ future risk of gastrointestinal cancer or to detect cancers 
at an early stage where curative treatment is possible. For this aim to be realised several 
steps in the process need to be achieved; detection, characterisation and resection.  
 
2.4 Lesion Detection 
Detection of neoplastic lesions is dependent on several factors; those related to the 
lesion itself, the endoscopic equipment used including any additional techniques utilised, 
and the endoscopist themselves. Advanced neoplasia is likely, by its very nature, to be 
more evident during endoscopy than early neoplastic lesions. However, even invasive 
lesions can be missed at endoscopy. Miss rates of up to 7% have been reported for upper 
gastrointestinal cancers72, 73 and up to 5% for colorectal cancer74, 75. Unsurprisingly, miss 
rates for colonic adenomas are higher than for invasive cancer as adenomas are generally 
smaller and more subtle. Miss rates for colonic adenomas in tandem endoscopy studies 
range from 22% to 35%76-78. Similarly, detection of early dysplastic lesions in the 
oesophagus and stomach can be difficult as they can often be subtle and very similar in 
appearance to the background mucosa.  
Endoscopist related factors related to neoplasia detection during colonoscopy include 
success of caecal intubation (ability to perform a complete examination of the colon), 
experience and withdrawal technique. The caecal intubation rate, defined as percentage 
of colonoscopies in which the caecum is reached, is one of the key quality measures of 
colonoscopy79. If the proximal colon is not reached and visualised during the examination, 
there is potential to miss neoplastic lesions in this area of bowel. Hence there has been a 
drive in many countries, including the UK, to improve caecal intubation rates. This has 
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resulted in a significant improvement in the mean caecal intubation rate from 76.9% to 
92.3% in UK national audits80, 81.  
 
2.5 Adenoma Detection Rate 
The most widely used measure of neoplasia detection during colonoscopy is the 
Adenoma Detection Rate (ADR) which is the percentage of colonoscopies where at least 
one adenomatous polyp is detected. Recent large studies have shown that an individual 
endoscopist’s ADR is inversely correlated with the risk of interval colorectal cancer40, 82. 
Interval cancers are those that are diagnosed between a screening colonoscopy and the 
time of a subsequent planned surveillance colonoscopy. A seminal study from Poland by 
Kaminski et al., involving 186 endoscopists and 45,026 patients, divided endoscopists into 
4 groups based on their ADR (<11%, 11-14.9%, 15-19.9%, ≥20%)40. Hazard ratios for 
interval colorectal cancer occurring within 5 years of colonoscopy were greater than 10 
for each of the first 3 groups when compared to the group with an ADR of ≥20% - see 
figure 10. 
A subsequent study by Corley et al., examined the relationship between interval cancer 
rate and colonoscopist ADR following 314,872 colonoscopies performed by 136 
gastroenterologists in California, USA82. Practitioners were divided into quintiles based on 
their ADR which ranged from 7.5% to 52.5%. In comparison to the quintile with the 
lowest ADR, the adjusted hazard ratio for interval colorectal cancer in the quintile of 
colonoscopists with the highest ADR was 0.52 (95% confidence interval 0.39 – 0.69). 
Similar results were found for the risk of interval advanced stage CRC (HR 0.43, 95% CI 
0.29-0.64) or risk of death from CRC (HR 0.38, 95% CI 0.22-0.65).  
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 Figure 10 - Cumulative hazard rates for interval colorectal cancer, according to the endoscopist’s adenoma detection 
rate (ADR). Subjects underwent screening colonoscopy performed by and endoscopist with an ADR in one of the 
following categories: less than 11.0%, 11.0 to 14.9%, 15.0 to 19.9% and 20.0% or more. Reproduced with permission 
from Kaminski et al40 Copyright Massachusetts Medical Society 
 
Both these studies demonstrate significantly higher risk of interval colorectal cancer in 
patients who undergo a colonoscopy performed by an endoscopist with a low ADR in 
comparison with a colonoscopist with a high ADR. The ADR has therefore been adopted 
by national bodies as a measure of the quality of colonoscopy, with standards set for 
minimum acceptable levels of ADR83, 84. What is not known is whether lower interval CRC 
risk in colonoscopists with a high ADR is due to the detection and removal of precursor 
lesions, or whether high ADR is a surrogate marker for more thorough and detailed 
inspection of the entire colon, leading to the detection of early cancers.The true reason 
may be a combination of these two factors. 
With the identification of ADR as a key quality indicator, and predictor of future CRC risk, 
numerous studies have been performed to try and identify factors that may influence 
ADR. These include procedural, endoscopist and equipment related factors. 
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The colon is best visualised during withdrawal of the colonoscope once any excess fluid or 
liquid stool has been aspirated and a clear luminal view can be obtained. Clear 
visualisation of the mucosa is obviously dependent on adequate bowel cleansing pre-
procedure. Commonly used oral bowel cleansing preparations include polyethylene glycol 
and sodium picosulphate. It is logical to assume that detection of colonic neoplasia is 
dependent on the adequacy of bowel preparation. This has been demonstrated in several 
studies showing significantly lower rates of adenoma detection in cases with inadequate 
bowel preparation compared to cases with adequate preparation as assessed using 
validated scales such as the Boston Bowel Preparation Scale85-88. Hence adequate bowel 
preparation is a prerequisite for adequate inspection of the colon during colonoscopy. In 
the context of poor preparation, it is highly unlikely that any ancillary techniques or 
technological developments will have any impact on ADR, and rescheduling of the 
procedure should be considered. Whilst the importance of bowel preparation prior to 
colonoscopy has been well documented, at present there is no standard approach to 
‘preparing’ the upper GI tract prior to gastroscopy. 
There is evidence that increasing experience and total number of colonoscopy procedures 
performed amongst trainees improves adenoma detection89. However, a large 
prospective study amongst 21 consultants in Germany did not show any correlation 
between either lifetime colonoscopy case volume, or annual case volume, and adenoma 
detection rate90. Hence it may be the case that adenoma detection rate improves during 
the training phase of colonoscopy before plateauing. In contrast, a large study of 
adenoma detection rates in the UK bowel cancer screening programme showed a small 
but significant difference (Odds Ratio 1.2, 95% confidence interval 1.11-1.30) in the ADR 
of those endoscopists who had performed ≥300 previous screening colonoscopies versus 
those who had performed 0-299 previous screening colonoscopies91. 
Time taken for inspection during withdrawal of the colonoscope from caecum to anus has 
been shown to correlate with an individual endoscopist’s adenoma detection rate91-94. 
Barclay et al., observed a marked difference in neoplasia detection rates between 
colonoscopists, with a mean withdrawal time above and below a threshold of 6 minutes 
(≥ 6mins 28.3% vs. <6mins 11.8%, P<0.001)92. Significant differences were also observed 
in the rate of detection of advanced colonic neoplasia (≥6mins 6.4% vs. <6mins 2.6%, P = 
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0.005). More recently Lee et al., examining results from the UK BCSP, reported an 
increase in ADR with increasing mean withdrawal time up to a threshold of 10mins93. 
Multivariant analysis of data from 31,088 colonoscopies performed as part of the UK 
BCSP suggested that earlier colonoscopy start time was associated with higher ADR, 
suggesting that endoscopist fatigue may be an important factor in the quality of 
colonoscopy91. 
The use of antispasmodics such as hyoscine butylbromide is commonplace during 
colonoscopy. The antimuscarinic antispasmodic effect of these medications can be useful 
to relax colonic smooth muscle and reduce spasm during the procedure. Several studies 
have examined whether use of antispasmodics increases the ADR by relaxing the bowel 
and allowing examination of a greater proportion of the mucosa. In a randomised trial of 
hyoscine butylbromide versus placebo in 599 patients, the adjusted odds of detecting at 
least one adenoma were 1.59 (95% confidence interval 1.09-2.47 p=0.017) in the hyoscine 
groups compared to the placebo group95. However, a very similar trial in 674 patients 
conducted by de Brouwer et al., found no significant differences in polyp or adenoma 
detection rates between the hyoscine and placebo groups96. A third randomised 
controlled trial of hyoscine butylbromide versus placebo, involving 402 patients in Italy, 
again failed to show any significant differences in ADR between the two groups97. 
Changes in the patients position (eg left lateral, supine, right lateral) during colonoscopy 
are useful on insertion of the colonoscope to minimise angulation of flexures and reduce 
the formation of loops98, 99. Three studies have examined whether changes in patient 
position on withdrawal may aid ADR by positioning the colonic segment being examined 
at the highest point, allowing maximum distension with gas and draining away excess 
fluid. The studies revealed conflicting results with East et al., and Koksal et al., observing a 
positive effect on ADR of dynamic position changes on withdrawal100, 101. In contrast Ou et 
al., found no difference in ADR between groups randomised to prescribed position 
changes and ‘usual practice’102. However, it is notable that in this study baseline ADR was 
very high at approximately 40% in both groups, and that 33% of patients in the control 
group underwent at least one position change during withdrawal. 
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Other techniques to improve mucosal visualisation behind colonic folds have also been 
studied, such as the use of transparent distal attachments on the colonoscope103, and 
retroflexion of the colonoscope tip in the right colon104. However at present no definite 
conclusions about these techniques can be made. 
The impact of dye-based chromoendoscopy and more recent advances in imaging 
techniques on adenoma detection rates has been widely studied. Before discussing the 
results of these trials, the next section will describe chromoendoscopy and advanced 
imaging techniques. 
 
 
2.6 Chromoendoscopy 
Chromoendoscopy (literally colour-endoscopy) was developed in Japan in the late 1960’s 
and early 1970’s as a method of enhancing mucosal visualisation, and in particular 
identifying and characterising abnormalities in the gastrointestinal tract by applying dyes 
to the upper or lower gastrointestinal mucosa. Chromoendoscopy dyes fall into 2 broad 
categories :- Contrast agents are non-absorptive dyes which lie in the grooves, crevices 
and pits of the mucosa, highlighting raised areas and surface patterns; vital stains are 
taken up by the cells of the mucosa. The uptake of vital stains differs between normal 
mucosa and areas of inflammation or dysplasia and hence these areas are highlighted. 
2.6.1 Methylene Blue 
Several early studies examined the use of vital stains to identify areas of abnormal 
mucosa in the stomach. Suzuki et al., used methylene blue, a vital stain, to identify early 
gastric cancers and intestinal metaplasia (IM). They noted that methylene blue was taken 
up by early cancers and IM, but not by normal gastric mucosa, helping to identify and 
establish the margins of early gastric cancers which had been difficult to identify using 
standard white light endoscopy105. Ida et al., also demonstrated that methylene blue 
selectively stained areas of IM in contrast to areas of normal gastric mucosa106. Tatsuta et 
al., studied the use of a combination of two vital stains, methylene blue and Congo Red 
for identifying early gastric cancers107. They noted that when using both dyes together, 
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early cancers were bleached, in contrast to the blue-black colour of the normal 
background mucosa following the application of Congo Red. Polypoid or flat cancers 
showed a bleached appearance more often than depressed type cancers. 
In 1976 Tada et al., described their experience with the use of methylene blue and indigo 
carmine (a contrast agent) in patients with ulcerative colitis and normal colonic mucosa. 
Both dyes highlighted the surface pits and innominate grooves. Loss of this normal 
pattern was evident in areas of active inflammation, which corresponded well with 
histological assessment of biopsy specimens108. In a subsequent paper they reported the 
use of a magnifying colonoscope in combination with methylene blue dye spraying to 
examine the fine surface details in a number of colonic abnormalities. Minute capillary 
vessels were congested in areas of inflammation in ulcerative colitis. They also noted 6 
different patterns of pits of polypoid mucosal lesions and that these correlated well with 
the histology of excised lesions109. 
 
Figure 11 - Upper left, magnified colonoscopic view of normal colon mucosa stained with methylene-blue; upper right, 
the mucosal surface in active ulcerative colitis takes the stain poorly, and the magnified surface features are distorted; 
lower left, tubular surface pattern of adenomatous polyp; lower right, irregular pattern of early cancer. Reproduced 
from Tada M et al109 with permission from Elsevier. 
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More recently methylene blue has been used in patients with longstanding colitis where 
it is taken up by normal mucosa but not areas of dysplasia; therefore areas of dysplasia 
are highlighted. It has been shown to improve the detection of dysplasia in this group of 
patients110. In some studies methylene blue has been shown to improve detection of 
dysplasia in Barrett’s oesophagus111, 112, although a meta-analysis suggested no benefit 
over standard quadrantic biopsies113. Some concerns have been raised that methylene 
blue may lead to DNA damage in cells114. However this was only demonstrated in an ex 
vivo study and no adverse effects in vivo have been reported despite very widespread use 
in clinical practice. 
 
2.6.2 Lugol’s Iodine 
Lugol’s iodine is a vital stain which is used to aid the detection of squamous neoplasia in 
the oesophagus. Normal squamous mucosa stains dark brown with iodine which is taken 
up by glycogen stored within normal cells. Dysplastic cells are more metabolically active 
and therefore have lower levels of glycogen. Hence they do not stain brown and appear 
as pale yellow areas against the background of normal brown-staining squamous mucosa 
– see figure 12.  These areas are known as Lugol’s voiding lesions. 
Squamous cell dysplasia in the oesophagus (the precursor of squamous cell oesophageal 
cancer) can often be subtle and easily overlooked during gastroscopy115. Lugol’s iodine 
dye spray, used at concentrations of 1.5-2.0%, highlights areas of squamous dysplasia in 
the oesophagus116-118.  
Use of Lugol’s iodine can often lead to chest discomfort and patients should be warned 
about this before their procedure. In our unit we usually give analgesia and sedation prior 
to use of Lugol’s iodine, and ensure any excess iodine is flushed away after inspection of 
the oesophagus. 
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 Figure 12 - A subtle area of squamous cell dysplasia in the oesophagus.In the left hand picture the area of dysplasia is 
slightly pinker than the pale squamous mucosa and is located at 6 o’clock. In the right hand picture, following the 
application of Lugol’s iodine dye spray, the area of dysplasia is highlighted as an obvious yellow area on a dark brown 
background of normal mucosa. 
 
 
2.6.3 Acetic Acid 
Acetic acid works as a vital stain. When used in Barrett’s oesophagus, acetic acid stains 
the pink Barrett’s mucosa white and highlights surface patterns. Use of acetic acid 
(vinegar) dye spray has been shown to improve detection of dysplastic areas in Barrett’s 
oesophagus in high risk populations. This whitening reaction gradually fades over a few 
minutes but areas of dysplasia lose the whitening reaction much more rapidly and appear 
pink or pale red against the white background – see figure 13. The dysplastic areas also 
show loss of the normal regular surface patterns. Whilst use of acetic acid has been 
shown to improve detection of dysplasia in high risk groups, it has not yet been studied in 
the general Barrett’s surveillance population119, 120. 
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Figure 13 - Use of acetic acid chromoendoscopy in Barrett’s oesophagus.In the left hand picture the border between the 
normal pale squamous mucosa and pink Barrett’s mucosa is seen in the foreground. In the right hand picture, following 
dye spray with 2.5% acetic acid, surface patterns of the Barrett’s mucosa are highlighted. An area of dysplasia (arrow) 
shows early loss of acetowhitening. 
Acetic acid has also been shown to be of value in the diagnosis and assessment of early 
gastric cancers, where it can be used alone, or in combination with indigo carmine121, 122. 
Acetic acid has not been shown to aid detection of squamous cell dysplasia. 
 
Figure 14 - Use of acetic acid chromoendoscopy for the detection of early gastric neoplasia.Magnifying endoscopy with 
1.5% acetic acid highlighting irregular surface patterns of early gastric cancers. G – arrow highlighting irregular patterns. 
H – arrows outlining area with destructive pit patterns. Reproduced from Tanaka et al122 with permission from Elsevier. 
 
2.6.4 Cresyl Violet 
Cresyl violet is hydrocarbon based vital stain which has been used during magnifying 
colonoscopy to stain the mucosa and allow precise examination of the pit patterns of 
colonic mucosa and mucosal lesions. Large studies by Kudo et al., demonstrated the 
ability of magnifying chromoendoscopy to identify different types of pit pattern, 
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representing the openings of the Crypts of Lieberkühn123-125. Kudo noted that the shape 
of these pits differed between normal mucosa, benign hyperplastic lesions, adenomatous 
polyps and cancers. 
The method described by Kudo et al., involved cleaning any lesion with water before 
initially spraying with 0.4% indigo carmine, followed by a magnified observation. 0.2% 
cresyl violet was then applied, followed by another magnified observation – see figure 15. 
 
Figure 15 - Magnifiying endoscopy procedure.Reproduced from Kudo et al124 with permission from Elsevier. 
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Figure 16 - Kudo’s pit patterns, reproduced from Kudo et al124 with permission from Elsevier 
 
6 different types of pits were described, which correlated well with the stereomicroscopic 
appearances and the histopathological diagnosis.  
Type I pits were found in normal mucosa, hyperplastic polyps usually displayed type I or II 
pits, adenomatous lesions were found to have type IIIs, IIIL and IV pits, and Type V pit 
pattern was usually found in invasive cancers. 
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 Figure 17 - Type I pit pattern after cresyl violet staining, magnified x 100. Reproduced from Kudo et al124 with 
permission from Elsevier. 
 
 
Figure 18 - Type 2 pit pattern. A- standard endoscopy image, B– Magnified image after indigo carmine, C- Magnified 
image after cresyl violet staining.  Reproduced from Kudo et al124 with permission from Elsevier. 
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 On the basis of the studies performed by endoscopsists in the report by Kudo et al., there 
was increasing interest from endoscopists worldwide in the possibility of making a precise 
in-vivo diagnosis of colorectal lesions which could approach the accuracy of traditional 
histopathology. Were an endoscopist able to make an accurate in vivo diagnosis, this 
could help them to choose the appropriate management for the colonic lesion in 
question. Distal hyperplastic polyps have negligible malignant potential and, if confidently 
identified, could possibly be left in situ. Benign adenomas should be endoscopically 
removed, to prevent future progression to cancer, and finally invasive cancers should be 
referred for surgical resection. 
This paradigm of making an endoscopic diagnosis and basing a patient’s treatment on this 
assessment was already standard practice in the management of early gastric cancer in 
Japan. 
 
2.6.5 Indigo carmine 
Indigo carmine, a contrast agent, is a blue-coloured non-absorptive dye which when 
applied to the mucosa lies in the grooves, crevices and pits, highlighting raised areas and 
surface patterns. It is usually used at concentrations of 0.1-0.5%. Indigo carmine can be 
used to coat the entire surface of the colon to detect abnormal areas, a technique known 
as pancolonic dye spray/chromoendoscopy. It has been shown in some studies to improve 
detection of adenomatous polyps, but the benefit is mainly in detection of small flat 
adenomas in the proximal colon126-130.  
Indigo carmine has also been widely studied for the characterisation of gastric and colonic 
lesions. It is widely used in Japan to delineate the borders of early gastric cancers prior to 
endoscopic resection by EMR or ESD. Indigo carmine is also highly effective at delineating 
the borders of large flat or sessile colonic adenomas, known as laterally spreading 
tumours. These borders are often subtle in very flat polyps and precise assessment is 
essential before attempting endoscopic resection. 
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Figure 19 - Early gastric cancer in the antrum in standard white light view (A) and following indigo carmine dye spray (C). 
Reproduced from Sakai et al121with permission from Elsevier. 
 
Following on from the work by Kudo et al., examining colonic lesions with indigo carmine 
followed by cresyl violet, many groups have studied the use of indigo carmine alone with 
and without magnifying endoscopy for the characterisation of colonic lesions129, 131-134. 
The main advantage of indigo carmine over cresyl violet was the shorter time taken to 
perform an examination. Cresyl violet takes a few minutes to be absorbed into cellular 
structures whereas indigo carmine produces an instant contrast effect. The application of 
indigo carmine for in vivo diagnosis in the colon will be discussed in greater detail in the 
next chapter. 
Pancolonic dye spray using indigo carmine has also been shown to improve detection of 
areas of dysplasia (pre-cancerous change) in patients with longstanding ulcerative colitis 
or Crohn’s colitis135-137. The borders of a subtle flat dysplastic area can be highlighted by 
the blue indigo carmine dye – see Figure 20. Therefore, the use of pancolonic dye spray 
can avoid the need for multiple non-targeted biopsies, and is now recommended by the 
British Society of Gastroenterology (BSG) as the preferred method of screening for 
dysplasia in patients with colitis43.    
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Figure 20 - Confirmed T2 rectal cancer in a patient with longstanding ulcerative colitis highlighted with 0.2%  indigo 
carmine pancolonic dye spray. Arrows show the edge of a central area with loss of pit patterns (type V) indicative of 
invasive disease. 
 
2.7 Advanced Endoscopic Imaging Techniques 
Advanced endoscopic techniques or virtual chromoendoscopy include a number of 
different technologies that alter the endoscope image either optically or digitally, with 
the aim of highlighting mucosal surface details.  
Most advanced imaging techniques were developed as alternatives to traditional 
chromoendoscopy, to be available at the push of a button. This may potentially save time 
and avoid the inconvenience associated with chromoendoscopy where dye must be 
either applied via a spray catheter or flushed down the suction channel of the endoscope. 
They also avoid the problem of pooling of dye which then needs to be suctioned away to 
enable clear visualisation of the mucosa. Advanced imaging systems have been designed 
with the aim of improving detection of abnormal areas/neoplasia and allowing accurate 
characterisation. They have been studied widely throughout the gastrointestinal tract and 
have multiple applications.  
 
2.7.1 Narrow-Band Imaging 
Narrow-band imaging (NBI) was developed in the last decade by the Olympus corporation 
as a feature on their endoscope systems. It had been noted that with magnifying 
endoscopy minute changes in capillary vessels in the mucosa could be observed, and that 
these could be used to identify abnormalities such as early squamous cell dysplasia of the 
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oeosphagus138 or the presence of Helicobacter pylori in the stomach139. The usual 
spectrum of visible light is in the range 400 nm to 700 nm. Gono et al., experimented with 
optical filters to narrow the bandwidth of light emitted from an endoscopic light source. 
Preliminary experiments, examining the capillary patterns of the human tongue, 
demonstrated that different bandwidths had different levels of penetration of the 
mucosa. By relative filtering of yellow and red light and allowing passage of narrow bands 
of blue light (415nm) and green light (540nm) which fell within the absorption band of 
haemoglobin, minute capillaries and sub-epithelial vessels were highlighted. These effects 
were also subsequently noted to enhance minute vascular patterns in Barrett’s 
oesophagus and in colonic polyps140.  
 
Figure 21 - Explanation of the theory behind narrow NBI. Reproduced with permission from Haidry & Lovat141 
 
Hence, NBI was developed as an alternative method of examining colonic lesions in detail, 
to enable an endoscopist to predict histopathology and provide possible evidence of 
invasion in neoplastic lesions. The theoretical benefit of NBI was that it could be available 
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at the touch of a button, rather than having to apply dye to the mucosa via the suction 
channel or through a spray catheter. This had potential advantages in terms of time 
savings and ease of use. 
NBI has been widely studied and has multiple clinical applications. It has been shown to 
be more accurate than standard white light endoscopy in diagnosing and delineating early 
gastric cancers142-144. When used for the examination of Barrett’s oesophagus, NBI can 
improve detection of areas of dysplasia145-147. 
In contrast, when used during colonoscopy, NBI does not improve detection of 
adenomas148, nor does it improve detection of dysplastic areas in patients with 
longstanding colitis149-151. However NBI has been shown to be highly accurate at 
characterising colonic lesions, and in particular distinguishing small adenomatous and 
hyperplastic polyps152-154. This will be discussed in more detail in the next chapter. 
 
2.7.2 Flexible Spectral Imaging Colour Enhancement (FICE) 
FICE is a feature of Fujinon endoscopes. It differs from NBI in that no physical colour filter 
is used. Rather, spectral estimation technology is applied to the full spectrum image and 
post-processor technology digitally alters the bandwidths of light in the displayed image. 
In a similar fashion to NBI, red light is relatively reduced and blue light enhanced, with the 
aim of enhancing surface patterns and vascular structures. Therefore it works on similar 
principles to NBI but differs in that the FICE system allows 10 different wavelength 
settings to be selected. 
Table 1 - FICE pre-set bandwidths. Numbers in the upper row represent the 10 possible FICE settings. R, G & B are the 
wavelengths of red, green and blue light used in nm. 
 0 1 2 3 4 5 6 7 8 9 
R 500 500 550 540 520 500 580 520 540 550 
G 445 470 500 490 500 480 520 450 415 500 
B 415 420 470 420 405 420 460 400 415 400 
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FICE has been widely studied in clinical practice. Similar to NBI, FICE does not appear to 
improve detection of adenomas during colonoscopy but is accurate in distinguishing 
adenomatous and hyperplastic polyps155, 156. The ability of FICE to distinguish hyperplastic 
and adenomatous polyps also appears to be improved with higher definition 
endoscopes157.  
 
 
Figure 22 - Colonic adenoma viewed with standard white light (A) and FICE (B). Reproduced from Togashi et al158 with 
permission from Elsevier. 
 
2.7.3 i-Scan 
i-Scan is the advanced imaging feature supplied with Pentax endoscopes. It is a digital 
contrast method with 3 modes of enhancing mucosal appearances:- 
• Surface Enhancement (SE) enhances dark light borders by increasing the 
luminance of light pixels at a dark-light border and decreasing the luminance of 
dark pixels at the dark-light border. SE can be adjusted in intensity from +1 to +6 
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 Figure 23 - Pictorial explanation of i-Scan. SE showing digital enhancement of dark-light borders. Luminance of bright 
pixels at the border is increased and of dark pixels is decreased.  Reproduced from Kodashima & Fujishiro159 with 
permission from Baishideng Publishing. 
 
• Contrast Enhancement (CE) identifies pixels with low luminance identified and 
relatively enhances the blue component while suppressing the red and green 
components of light in these pixels. CE can also be adjusted in intensity from +1 to 
+6 
 
Figure 24 - Pictorial explanation of i-Scan CE showing digital manipulation of the red, blue and green light components 
in pixels with low luminence, with relative suppression of red light in these pixels.  Reproduced from Kodashima & 
Fujishiro159 with permission from Baishideng Publishing. 
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• Tone enhancement (TE) works along similar principles to NBI and FICE. Post 
processor technology separates out the red, blue and green components of light 
and relatively suppressed the red component whilst enhancing or not altering the 
blue and green components. Several different settings can be chosen with the aim 
of highlighting different regions of the GI tract. 
 
Figure 25 - Pictorial explanation of i-Scan TEshowing digital manipulation of red, blue and green components of the 
white light spectrum. Three different TE settings are shown; TE-e for esophagus, TE-g for gastric and TE-c for colon. In 
TE-c setting red light is suppressed whilst blue and green light are enhanced.  Reproduced from Kodashima & 
Fujishiro159 with permission from Baishideng Publishing. 
 
 
i-Scan has features similar to the NBI and FICE systems in that blue and green light 
wavelengths are selected, and red light reduced by post-processor technology. 
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In addition, any borders of contrast in the mucosa are digitally enhanced. The aim is to 
highlight surface patterns and vascular structures.  Several studies have shown i-Scan to 
be accurate in distinguishing small adenomatous and hyperplastic colonic polyps160-162. In 
the oesophagus i-Scan can help identify subtle mucosal breaks due to reflux 
oesophagitis163. 
i-Scan have 3 pre-defined settings of combinations of SE, CE and TE:- 
• i-Scan 1 – Surface & Contrast enhancement  
• i-Scan 2 – Tone enhancement ‘colon’ 
• i-Scan 3 – Surface, Contrast and Tone enhancement ‘colon’ 
SE and CE are complimentary, enhancing dark-light borders, whilst TE alters the colour 
spectrum. All 3 components are combined in the i-Scan 3 setting. Example images are 
displayed in Figures 26-29. 
  
Figure 26 - Adenomatous polyp viewed with HDWL. 
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Figure 27 - Adenomatous polyp viewed with i-Scan 1 (SE & CE). 
 
 
Figure 28 - Adenomatous polyp viewed with i-Scan 2 (TE-colon) 
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 Figure 29 - Adenomatous polyp viewed with i-Scan 3 (SE, CE & TE-colon) 
 
2.7.4 Autofluorescence imaging 
Autofluorescence imaging (AFI) utilises the natural fluorescence of tissues when they are 
exposed to short wavelengths of light, which then emit longer wavelengths of light. This 
phenomenon occurs due to naturally occurring fluorophores such as collagen, porphyrins 
and NADH. Differences in the proportion of these molecules between neoplastic and non-
neoplastic tissues lead to differences in the intensity or colour of autofluorescence light 
emitted164. In Barrett’s oesophagus non-dysplastic mucosa emits green fluorescence 
whereas dysplastic areas emit pink fluorescence. AFI improves detection of dysplasia in 
Barrett’s but non-dysplastic areas are also highlighted so there is a high false positive 
rate165. In the colon under AFI adenomatous polyps appear purple, whilst hyperplastic 
polyps appear green, similar to normal mucosa – see figure 30166-168. 
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Figure 30 - 20mm flat colonic adenoma viewed with standard white light  (a) and AFI (c). Reproduced from Rotondano 
et al166  with permission from Springer. 
 
2.7.5 Confocal Laser Endomicroscopy 
Confocal laser endomicroscopy (CLE) uses a scanning laser and fluorescence to illuminate 
tissue and measure reflected light. The reflected light passes through a pinhole so that 
only a very narrow depth of field is visualised in the image produced. The laser constantly 
scans across the field of view, effectively building up the image one pixel at a time. CLE 
therefore provides highly magnified images, approaching that of white light microscopy. 
Two CLE systems are available for use in endoscopy; an integrated system built into the 
endoscope (eCLE, Pentax – now discontinued) and a probe-based CLE system where the 
confocal probe is fed down the endoscope working channel (pCLE, Cellvizio, Mauna Kea 
Technologies). The field of view for CLE is very small (240-600µm for pCLE, 500µm for 
eCLE). eCLE uses topical acriflavin as the fluorophore and pCLE uses intravenous 
fluorescein. Some concerns have been raised about the potential carcinogenicity of 
topical acriflavin169. 
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 Figure 31 - integrated CLE system (now discontinued). Reproduced with permission from Keisslich et al170 with 
permission from Elsevier 
 
Figure 32 - probe-based CLE system. Reproduced with permission from Wallace & Fockens 171 with permission from 
Elsevier. 
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 Figure 33 –– CLE image of normal colonic mucosa. B – standard endoscopic image of hyperplastic polyp. C- H&E stain 
white light microscopy of hyperplastic polyp. D – CLE image of hyperplastic polyp. Reproduced from Buchner et al172 
with permission from Elsevier. 
 
CLE gives a highly magnified image of a small field of view. Hence its main application in 
terms of endoscopic imaging is in the characterisation of lesions and abnormalities. An 
area for closer inspection must first be identified by a wider field technique such as 
standard white light endoscopy, chromoendoscopy or advanced imaging such as NBI or 
AFI. CLE has been shown to be effective in the detection of dysplasia in Barrett’s 
oesophagus with a meta-analysis showing a pooled sensitivity of 68% and specificity of 
88% for detection of high grade dysplasia or early Barrett’s cancer173. Individual studies 
have shown varying results, and this may reflect varying experience and training in the 
interpretation of CLE images, which will be very unfamiliar to most endoscopists174, 175. In 
patients with longstanding colitis, CLE in combination with methylene blue colonoscopy 
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has been shown to be an effective tool for characterising lesions detected during 
colonoscopy176. CLE for the characterisation of colorectal polyps has also been the subject 
of a number of studies, which will be reviewed in the next chapter. 
 
2.7.6 High definition endoscopy 
Alongside the development of novel techniques and technologies to help detect and 
characterise gastrointestinal neoplasia, there has been a continuous improvement in the 
definition of white light video-endoscopy. The earliest video-endoscopes had a resolution 
of around 50,000-100,000 pixels, producing images which at the time were felt to be 
comparable to fiberoptic endoscopes53, 177, 178. In the intervening decades the resolution 
of endoscopes has improved, firstly with the introduction of ‘high resolution endoscopy’ 
with over 400,000 pixels and more recently high-definition endoscopy with up to 
1.3 million pixels. Whether improved endoscope resolution leads to improved detection 
or characterisation of gastrointestinal lesions has been the focus of many studies which 
will be reviewed in later chapters of this thesis. 
 
  
64 
 
Chapter 3 -  In-vivo optical characterisation in the colon 
 
3.1 Types of Colonic Mucosal lesions 
Colonic mucosal lesions can be divided into 3 groups:- 
Non-neoplastic lesions – these have negligible malignant potential. By far the most 
common are hyperplastic polyps, but these also include inflammatory polyps and 
lymphoid aggregates. 
Non-malignant neoplastic lesions – this includes polyps which are benign but with 
malignant potential, the commonest being adenomatous polyps, with others such as 
traditional serrated adenomas and sessile serrated lesions being found less often.  
Cancers - invasive colorectal adenocarcinomas. It is felt that the vast majority of these 
arise from adenomatous or serrated polyps as precursor lesions38, 39, 42. There is a wide 
spectrum of endoscopic appearances from very early submucosally invasive cancers to 
large advanced lesions with deep invasion into the bowel wall or adjacent structures.  
 
3.2 The concept of in-vivo characterisation 
Since the early years of endoscopy, endoscopists have posed the question of whether an 
accurate diagnosis of colorectal lesions could be made on the basis of the endoscopic 
characteristics. Advanced cancers are clearly abnormal in appearance, even to the 
untrained eye of a novice endoscopist or assistant who has minimal experience in 
endoscopy. They will stand out from the normal background mucosa and will often cause 
significant stricturing of the colonic lumen – see figure 34. In this situation additional 
imaging techniques may not add much to the endoscopic diagnosis. 
Where subtle endoscopic characteristics have more of a role is in distinguishing between 
i) non-invasive neoplastic polyps and early invasive lesions and ii) non-neoplastic and 
neoplastic polyps. This is useful because the management of colorectal lesions is 
dependent on their histology. Non-neoplastic lesions with negligible or no malignant 
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potential can be safely left in situ, without need for endoscopic removal. In contrast 
neoplastic polyps should be removed to reduce potential future progression to colorectal 
cancer, and in the vast majority of cases this can be achieved endoscopically. Invasive 
adenocarcinomas are not suitable for endoscopic resection and should be removed by 
surgical resection of the involved segment of the colon, assuming appropriate fitness of 
the patient to undergo surgery. Hence it is an important skill of an endoscopist to be able 
to make an accurate real-time assessment of colorectal lesions encountered during 
colonoscopy to guide appropriate management. The majority of lesions encountered will 
be small and benign with series reporting rates of 0.4%-4.4% of all lesions encountered 
during colonoscopy as being malignant179, 180. Even in the UK BCSP, where an enriched 
population of patients with positive faecal occult blood testing undergo colonoscopy, 90% 
of neoplastic lesions are benign181.  
 
 
Figure 34 - Advanced stricturing rectal cancer with the borders of the lesion marked by arrows. 
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3.3 Early attempts at colonic in-vivo characterisation 
In the early days of fiberoptic endoscopy it was felt that accurate distinction between 
non-neoplastic and neoplastic polyps could not be made on the basis of the endoscopic 
appearances. In a paper from 1976 on the incidence and clinical significance of rectal 
polyps, Payne commented that “The gross appearances, including size, do not therefore 
give any indication of the microscopic character, and excision of all rectal polyps is 
mandatory”.182 
 
In 1982 Chapuis et al., examined 120 polyps ranging from 3 mm to 3.5 cm in size found 
during 78 fiberoptic flexible sigmoidoscopy procedures183. They attempted to predict 
whether lesions were adenomatous or hyperplastic based on endoscopic appearances 
and were correct in 83% of cases. In a similar study, published in 1987 by Neale et al., 81 
polyps were assessed with an accuracy of predicted histology of 80%184. Norfleet et al., in 
1988 reported a 75% accuracy of optical diagnosis when compared to confirmed 
histopathology of 611 polyps185. All of these early studies concluded that standard white 
light endoscopy was not able to distinguish between neoplastic and non-neoplastic polyps 
with sufficient accuracy to forego formal histopathological assessment182-185. Therefore, 
endoscopic removal or biopsy was recommended to guide management and this has 
been the paradigm for the vast majority of colonoscopists since the invention of 
endoscopy. 
 
Many subsequent studies, as described throughout the rest of this chapter have 
compared to accuracy of optical diagnosis with histopathology as the gold standard. Most 
of these studies use the following terms to describe the results of various optical 
techniques 
 
• Accuracy = number of correctly characterised lesions using optical diagnosis 
                                Total number of lesions 
• Sensitivity (for neoplasia) = number of correctly characterised neoplastic lesions 
     Total number of neoplastic lesions 
• Specificity = number of correctly characterised non-neoplastic lesions 
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    Total number of non-neoplastic lesions 
• Negative Predictive value = no. of correctly characterised non-neoplastic lesions 
     Total number of non-neoplastic calls 
 
3.4 Chromoendoscopy for the in-vivo characterisation of colonic lesions 
The forerunners of improvements in colonic in vivo characterisation were Japanese 
endoscopists. In 1994 Professor Kudo et al., described 7 different types of pit which could 
be identified in either normal colonic mucosa, or colonic mucosal lesions, when examined 
by magnifying colonoscopy123. The pits observed represented the opening of the mucosal 
crypts of Lieberkühn and were predictive of the underlying histology. 
 
 
 
The pits Kudo described were: 
• Normal round pit – found in normal colonic mucosa 
• Small round pit – found in borderline malignant lesions or adenocarcinoma 
• Small asteroid pit – found in hyperplastic polyps 
• Large asteroid pit – found in hyperplastic polyps or serrated adenomas 
• Oval pits – found in adenomatous polyps 
• Gyrus-like pits – found in tubulovillous adenomas 
• Non-pit – found in adenocarcinomas 
 
These 7 different types of pits were classified into 6 groups: 
• Type I – normal round pits 
• Type II – small and large asteroid pits 
• Type IIIs – small round pits 
• Type IIIL – oval pits 
• Type IV – gyrus-like pit 
• Type V – non-pit pattern 
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Figure 35 - Kudo’s pit patterns. Reproduced from Kudo et al124 with permission from Elsevier. 
 
In a subsequent study in 1996, Kudo et al., examined 2050 colonic lesions by magnifying 
chromoendoscopy using indigo carmine and cresyl violet vital staining. Comparison was 
made between the pit pattern observed and the histopathological diagnosis for 1613 
neoplastic lesions, showing good correlation. However there were exceptions to the 
expected findings (see table 2); a small percentage of neoplastic lesions had pit patterns 
associated with normal mucosa or non-neoplastic lesions, and some lesions with type IIIL 
or IV pit pattern were found to contain cancer. Type V pit pattern was strongly predictive 
of cancer with 22 of 33 lesions demonstrating this pattern containing cancer. The main 
focus of this study was predicting the histology of neoplastic lesions, rather than 
differentiating neoplastic and non-neoplastic lesions. However this landmark study 
demonstrated the possibility that magnifying chromoendoscopy could be used to predict 
the histology of colonic neoplasia and thus guide treatment. 
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Table 2 - Relationship between pit patterns and histopathological diagnosis in 1613 colorectal lesions. Reproduced 
from Kudo et al124 with permission from Elsevier.  
 Pit pattern with magnifying electric videoscope 
Total 
 I, II IIIs IIIL IV V 
Histopathological diagnosis 
Adenoma 
Villous adenoma 
Cancer 
 
46 
0 
0 
 
29 
0 
3 
 
1145 
17 
71 
 
150 
47 
72 
 
11 
0 
22 
 
1381 
64 
168 
Total 46 32 1233 269 33 1613 
 
 
3.5 Magnifying Chromoendoscopy  
Following Kudo’s work a number of groups conducted studies using magnifying 
chromoendoscopy to differentiate between neoplastic and non-neoplastic colonic polyps 
– see table 3. Togashi et al., examined 923 lesions found in 1280 patients, the majority of 
which were <10mm in diameter132. They used magnifying chromoendoscopy with indigo 
carmine, plus crystal violet in some cases and assessed polyps using Kudo’s classification. 
Assessments initially took around 10 minutes per polyp but reduced with experience to 
‘the same time as to take a biopsy’. 741 of the 923 lesions were neoplastic and 180 non-
neoplastic. The sensitivity for correctly predicting neoplasia was 92% with a specificity of 
73.3% and overall accuracy of 88.4%. The authors report that ‘obvious’ non-neoplastic 
polyps were not included and hence without this policy the reported specificity may have 
been higher. They noted that accuracy of optical diagnosis was related to polyp size, 
being 94.8% for polyps 6-10mm in diameter but 88.4% for those ≤5mm in diameter 
(P<0.001 for difference between the groups). This suggested that it may be more difficult 
to make an accurate assessment of smaller polyps. Togashi and colleagues also raised the 
possibility that obvious non-neoplastic polyps could be left in situ, thus saving time and 
money and reducing risk by avoiding unnecessary polypectomy. They also noted that 
appropriate training in chromoendoscopy techniques and interpretation was vital. 
 
A second retrospective study from Japan conducted by Kato et al used indigo carmine 
chromoendoscopy and Kudo’s classification to examine 3438 colonic lesions in 4445 
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patients between 1993 and 1998. Similarly to Togashi et al., obvious diminutive (≤5mm) 
hyperplastic polyps were excluded. Therefore, the vast majority of lesions were 
neoplastic (3159, 92%). Kato et al., emphasised the importance of cleaning mucus off the 
surface of a polyp, using a mucolytic such as Pronase, prior to assessment with 
chromoendoscopy. They reported a sensitivity for neoplasia of 98.7%, specificity of 41.9% 
and overall accuracy of 94.1%.  
 
Both of these very large studies confirmed the potential of magnifying chromoendoscopy 
to accurately differentiate between neoplastic and non-neoplastic polyps. Several 
subsequent studies conducted in the Far East reported similar results with high sensitivity 
rates for predicting neoplasia of 93–96%, but lower specificity rates of 64-93%134, 186-188. 
Overall accuracy ranged from 80.6-95.6%. Hence, using magnifying chromoendoscopy, a 
very small percentage of neoplastic polyps were characterised as non-neoplastic (false 
negatives) whereas a greater percentage of non-neoplastic polyps were characterised as 
being neoplastic (false positives). Tung et al., also emphasised the importance of using a 
mucolytic agent to remove mucus prior to dye spray assessment186. A large single study 
from the UK examined 1008 colonic lesions using indigo carmine plus crystal violet in 
some cases. Results were comparable to Japanese studies with diagnostic sensitivity, 
specificity and accuracy in excess of 90%189 for differentiating neoplastic and non-
neoplastic polyps. However, differentiating lesions with low grade dysplasia and high 
grade dysplasia/cancer proved more difficult with a sensitivity for HGD/cancer of only 
50% and specificity of 98%.  
 
 
 
 
 
 
 
 
 
71 
 
Table 3 - Studies of magnifying chromoendoscopy for the characterisation of colonic polyps. NR = not reported. RT = 
real time, P = picture 
 Author Year Country Real-
time/ 
Picture 
Size Neoplasti
c lesions 
Non-
neoplastic 
lesions 
Sensitivity 
% 
Specificity 
% 
Accuracy 
% 
Togashi132 1999 Japan RT NR 741 180 92.0 73.3 88.4 
Kato133 2001 Japan RT All sizes 3159 279 98.7 41.9 94.1 
Tung186 2001 Taiwan RT All sizes 118 57 93.8 64.6 80.6 
Konishi134 2003 Japan RT Max 10mm 330 75 93.0 85.0 92.0 
Hurlstone189 2004 UK RT All sizes 627 381 97.7 91.6 95.4 
Fu187 2004 Japan RT Max 10mm 160 46 96.3 93.5 95.6 
Su188 2004 Taiwan RT Mean 
6.3mm 
164 106 95.1 86.7 91.8 
De Palma190 2006 Italy RT Max 5mm 82 158 97.5 94.3 95.4 
Chiu191 2007 Taiwan P Max 20mm 
mean 
5.3mm 
141 39 94.3 82.9 91.6 
Tischendorf19
2 
2007 Germany P Max 50mm 
Mean10.6m
m 
60 40 91.7 90.0 91.0 
Pohl193 2008 Germany P Max 20mm 
Mean 
7.7mm 
89 61 95.5 73.8 87.7 
Chang194 2009 Taiwan P Max 10mm 82 81 93.9 66.7 80.1 
Parra-
Blanco195 
2009 Spain P Max 5mm 14 5   76.8 
 
Dos Santos196 2012 Brazil RT Max 4mm 86 34 96.5 88.2 94.2 
  
 
3.6 Non-magnifying Chromoendoscopy 
Use of magnifying chromoendoscopy outside of the Far East (mainly Japan) was rare. 
Western endoscopists were not familiar with the technique and it was viewed as time-
consuming. Vital stains such as cresyl violet need a few minutes to take effect once they 
have been applied to the mucosa. As an alternative to traditional magnifying 
chromoendoscopy the use of non-magnifying chromoendoscopy with indigo carmine was 
explored. 
Axelrad and colleagues used a high resolution endoscope to perform chromoendoscopy 
with only minimal magnification (1.5x) to examine 55 small colonic polyps <10mm in 
diameter during screening colonoscopy131. Sensitivity for predicting neoplastic histology 
72 
 
was 93%, specificity95% and overall accuracy 95%. These were impressive results for a 
non-magnification technique but based on a very small series.  
Kiesslich et al., from Mainz, Germany examined 283 polyps (73 neoplastic, 210 non-
neoplastic) using mostly non-magnifying chromoendoscopy with indigo carmine129. 
Kudo’s pit patterns were used for characterisation of polyps. In their protocol, if no polyps 
were found on initial white light examination, the distal 30cm of sigmoid colon and 
rectum were sprayed with indigo carmine to aid lesion detection. This would explain the 
high numbers of non-neoplastic polyps found in this study as diminutive hyperplastic 
polyps are very common in the distal colon and rectum and become more evident after 
dye-spraying. The results for sensitivity and accuracy in this study were very similar to the 
Japanese studies using a magnifying technique – see table 3. In addition specificity was 
92.4%, higher than that found in most studies using magnifying chromoendoscopy. 
In a multicentre study conducted in the US using high-resolution non-magnifying 
chromoendoscopy with ingido carmine, Eisen and colleagues characterised 520 colonic 
polyps197. Hyperplastic polyps were classified as those displaying circular surface ‘dots’, 
similar to the normal mucosa, whereas adenomatous polyps had surface ‘grooves’ or a 
sulcus-like appearance. In essence this was a very simplified representation of Kudo’s pit 
pattern classification. Only polyps 10 mm or less in diameter were included in the study. 
In the reported results they found a sensitivity of 82% for prediction of adenomatous 
histology, specificity of 82% and overall accuracy of 82%. However, 40 polyps were 
excluded at the time of endoscopy “because of inadequate staining or inability to see the 
pits or grooves.” If these polyps are included in the results as false calls on an intention-
to-characterise basis then sensitivity, specificity and accuracy fall to 79%, 74% and 76% 
respectively.  
In an attempt to determine whether magnification added further diagnostic accuracy 
over and above non-magnifying chromoendoscopy, Fu et al., examined 206 polyps 
<10mm in diameter sequentially using white light, non-magnifying chromoendoscopy and 
finally magnifying chromoendoscopy187. A prediction of histology was made after 
assessment with each modality. 160 polyps were neoplastic and 46 non-neoplastic, with 
180 of the 206 polyps being 5mm or less in size. The results are displayed in table 4.. 
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Magnifying chromoendoscopy was found to have significantly higher accuracy than white 
light colonoscopy (P=0.0001) and non-magnifying chromoendoscopy (p=0.0152). 
However, there was no statistically significant difference in accuracy between white light 
endoscopy and non-magnifying chromoendoscopy (p=0.111). These results suggested 
that non-magnifying chromoendoscopy offered no diagnostic advantage over white light 
endoscopy, or that the study was insufficiently powered to demonstrate a significant 
difference between these two modalities. One potential explanation for this lack of 
difference was the high accuracy (84%) achieved with standard white light endoscopy. 
The main gain of magnifying chromoendoscopy was found to be an increase in specificity 
from 67.4% with white light endoscopy to 76.1% with non-magnifying chromoendoscopy 
to 93.5% with magnifying chromoendoscopy.  
Table 4 - Results of  In-vivo characterisation of 206 colonic polyps reproduced from Fu et al187. 
Method Diagnostic Accuracy, % Sensitivity, % Specificity, % 
White light 84.0 88.8 67.4 
Chromoendoscopy 89.3 93.1 76.1 
Chromoendoscopy 
with magnification 
95.6 96.3 93.5 
 
A German study by Apel et al., examined 273 polyps <5 mm in size limited to the rectum 
and sigmoid colon using standard white light endoscopy followed by high resolution non-
magnifying chromoendoscopy with indigo carmine198. Of the included lesions 82% were 
hyperplastic polyps. This study found no significant difference in accuracy between white 
light and non-magnifying chromoendoscopy (81% & 83% respectively, p = NS).  
 
Table 5 - Studies of non-magnifying indigo carmine chromoendoscopy for the characterisation of colonic polyps.* - 
Sensitivity, specificity and accuracy 79%, 74% and 76% on intention-to-characterise analysis. ** - rectosigmoid polyps 
only. NR = not reported, RT = real-time, P = picture 
74 
 
Author Year Country Real-time/ 
Picture 
study 
Size Neoplastic 
lesions 
Non-
neoplastic 
lesions 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Axelrad131 1996 USA RT Max 10mm 14 41 93 95 95 
Kiesslich129 2001 Germany RT Mean 14mm 73 210 91.8 92.4 92.6 
Eisen197 2002 USA RT Max 10mm 186 294 82*  82* 82* 
Fu187 2004 Japan RT Max 10mm 160 46 93.1 76.1 89.3 
Su199 2006 Taiwan P Max >20mm 70 40 95.7 87.5 92.7 
Apel198 2006 Germany RT Max 5mm 48** 225** 64.6 94.7 89.3 
Sonwalkar2
00 
2006 UK RT Max 30mm 
Mean 7mm 
467 187 91 82 88.1 
Chiu191 2007 Taiwan P Max 20mm 
Mean 5.3mm 
141 39 81.9 82 81.9 
Ince201 2007 Turkey RT NR 55 163 80 89 86.7 
Pohl193 2008 Germany P Max 20mm 
Mean 7.7mm 
89 61 91 67.2 81.3 
Pohl155 2009 Germany RT Max 65mm 
Mean 7.5mm 
271 94 90.4 60 82.5 
Parra-
Blanco195 
2009 Spain P Max 5mm 14 5   70.5 
Longcroft-
Wheaton 
156 
2011 UK RT Max 10mm 155 77 94 84 91 
Yoshida202 2012 Japan P Max 20mm 95 56 96.8 89.2 94.7 
 
Sonwalkar et al., reported sensitivity of 91%, specificity of 82% and accuracy of 86.1% in a 
retrospective analysis of non-magnifying indigo carmine chromoendoscopy to assess 654 
colonic lesions200. In a subanalysis of polyps <10mm in size, overall accuracy of 
chromoendoscopic assessment was higher than the whole cohort at 90.1%, suggesting 
that larger lesions are not necessarily easier to characterise. 
3.7 Narrow-band imaging (NBI) with magnification 
NBI was developed as an alternative to traditional chromoendoscopy as an aid to in vivo 
characterisation of gastrointestinal lesions. Machida et al., performed a pilot study, using 
conventional white light endoscopy, NBI with magnification and indigo carmine 
chromoendoscopy with magnification, to examine 43 colorectal lesions in 34 patients203. 
They examined how well features of the surface of polyps were visualised with NBI 
compared to the other two modalities. NBI enabled better visualisation of pit patterns 
than conventional colonoscopy. Chromoendoscopy was found to be superior to NBI in 
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this regard. NBI was found to be the best modality for examining the fine vascular 
network of lesions. Accuracy of endoscopic diagnosis was the same for NBI and 
chromoendoscopy (93.4%), both higher than for conventional white-light endoscopy 
(79.1%), although this small study had very limited power to compare NBI and 
chromoendoscopy. 
In another Japanese study, Tanaka et al., examined 90 colonic lesions (9 hyperplastic 
polyps, 60 adenomas and 21 early cancers) using Kudo’s pit patterns visualised with NBI 
and compared these with the pit patterns observed with a stereomicroscope204. Overall 
there was 93% agreement in pit pattern classification between the two modalities, with 
discordant results mainly found in those lesions with a type V pit pattern under 
stereomicroscopy. 
Tischendorf et al., from Aachen, Germany performed a picture study of 200 colonic 
lesions examined by 2 endoscopists, divided equally between magnifying 
chromoendoscopy and magnifying NBI192. Lesions were characterised by both Kudo’s pit 
patterns and by vascular patterns, firstly by white light endoscopy and then by 
chromoendoscopy/NBI. Based on pit pattern assessment there were no significant 
differences in performance between chromoendoscopy and NBI. However, NBI was 
superior to chromoendoscopy for assessing vascular patterns when compared in terms of 
sensitivity, accuracy and negative predictive value. The authors commented that 
chromoendoscopy may obscure the view of blood vessels, making assessment of vascular 
patterns more difficult. However, they also noted that in reality, it was extremely difficult 
for an endoscopist to focus on pit patterns and ‘ignore’ vascular patterns, or vice versa.  
In a UK based study, East et al., examined 116 polyps <10 mm in size in real-time using 
magnifying NBI. Polyps were characterised according to Kudo’s pit patterns and then by 
‘Vascular pattern intensity’ (VPI)152. VPI was defined as “a subjective assessment of the 
darkness of the lines that outline each colonic crypt or pit compared with adjacent normal 
mucosa”. Darker lines represented increased microvascular density and were classified as 
‘Strong’ VPI and indicated a dysplastic polyp. Pale lines were classified as ‘weak’ VPI and 
those that were the same as the background mucosa ‘normal’ VPI. Weak and normal VPI 
were suggestive of non-neoplastic polyps.  
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Table 6 - In-vivo characterisation of 116 small polyps using magnifying NBI, reproduced from East et al152 
Method Diagnostic Accuracy, % Sensitivity, % Specificity, % 
Pit Patterns 89.6 88.0 90.9% 
Vascular Pattern Intensity 91.4 94.0 89.4% 
Combined PP & VPI 92.2   98.0 87.9% 
 
No statistically significant differences in sensitivity, specificity and accuracy were found 
between pit pattern and VPI assessments, although there was a trend toward better 
performance using the VPI assessment – see table 6. This study demonstrated that high 
accuracy using NBI could be achieved even when assessments were limited to small 
polyps (<10mm) with a mean size of 3.4mm which were generally felt to be more difficult 
to characterise than larger lesions. In contrast the mean size of lesions in the studies by 
Machida203 and Tischendorf192 were 7.5 mm and 10 mm respectively. East et al., 
commented that for polyps ≤5mm in size, if sufficiently accurate, endoscopic assessment 
could potentially replace formal histopathological assessment. Even though there was no 
demonstrated difference in performance between pit pattern and VPI assessment it was 
noted that Kudo’s pit patterns were not developed for use with NBI. The authors 
suggested that NBI may replace chromoendoscopy for Western endoscopists, being 
easier to use and with a potentially shorter learning curve. 
In a key study Sano et al., examined 150 polyps <10 mm in size in real-time using 
magnifying NBI205. Polyps were characterised according to the presence of ‘meshed 
capillary’ vessels which were green-brown in colour, in contrast to the yellowish colour of 
the normal colonic mucosa. Polyps with invisible or faintly visible meshed capillary vessels 
were classified as non-neoplastic and those with clearly visible meshed capillary vessels as 
neoplastic – see figure 36. 
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 Figure 36 - Magnifying endoscopic assessment with NBI. A – invisible/faint meshed capillary vessels in a hyperplastic 
polyp. B – clearly visible meshed capillary vessels in a an adenomatous polyp. Reproduced from Sano et al205 with 
permission from Elsevier. 
NBI assessment using Sano’s classification of meshed capillary vessels was found to have 
sensitivity for neoplasia of 96.4%, specificity of 92.3% and accuracy of 95.3% when 
compared to histopathology, results that were comparable to those achieved with 
magnifying chromoendoscopy. The authors felt that meshed capillary vessel assessment 
is “easier to reproduce, simpler, and faster than conventional chromocolonoscopy” and 
may offer a shorter learning curve for western endoscopists. Similar levels of accuracy 
were found using magnifying NBI in a large Japanese study by Wada et al., that included 
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all colonic lesions including large polyps and cancers – see table 7206, although this study 
only included 33 non-neoplastic polyps out of 617 lesions. 
 
Table 7- Studies of magnifying narrow-band imaging for the characterisation of colonic polyps. RT = real-time, P = 
picture 
Author Year Country Real-
time/ 
Picture 
study 
Size Neoplastic 
lesions 
Non-
neoplastic 
lesions 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Machida203 2004 Japan RT Max 25mm 
Mean 7.5mm 
34 9 100 75 93.4 
Tischendorf19
2 
2007 Germany P Max 50mm 
Mean ~10mm 
63 37 93.7 89.2 92 
Chiu191 2007 Taiwan P Max 20mm 
Mean 5.3mm 
141 39 94.3 82.9 91.6 
East152 2008 UK RT Max 9mm 50 66 98 88 92.2 
Sano205 2009 Japan RT Max 10mm 111 39 96.4 92.3 95.3 
Chang194 2009 Taiwan P Max 10mm 82 81 93.3 66 79.8 
Wada206 2009 Japan RT Max 60mm 
Mean 14.5mm 
584 33 97.1 90.1 96.8 
Tischendorf20
7 
2010 Germany P Max 20mm 
Mean 7.2mm 
63 37 92.1 89.2 91.0 
 
Zhou208 2011 China RT Max 40mm 
Mean 10mm 
43 total 
  93 
Singh209 2011 Australia RT Max 30mm Mean 
8.4mm 
30 20 98 89 90 
Gross210 2011 Germany P Max 10mm 258 176 89.7 89.8 89.7 
Ignjatovic211 2011 UK P Max 10mm 40 40 91.1 44.4 67.8 
Sato212 2011 Japan P Mean 6.5mm 339 85   88.2 
 
3.8 Narrow-band imaging without magnification 
Although NBI was initially developed with magnifying endoscopes, in some areas of the 
world (in particular the USA) it was marketed for use with high-definition non-magnifying 
endoscopes. 
Su et al., compared white light endoscopy, NBI and chromoendoscopy without use of 
magnification in a picture study of 110 colonic lesions including larger polyps and cancers 
(65 adenomas, 50 hyperplastic, 5 cancers)199. Lesions were characterised by 2 
experienced endoscopists using Kudo’s pit pattern classification. The results showed no 
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difference in performance between chromoendoscopy and NBI (see tables 5 and 9) but 
that both performed better than white light endoscopy. 
Sikka et al examined 80 polyps <10 mm in size in a picture study, demonstrating high 
levels of accuracy, sensitivity and specificity – see table 9213. 
Rogart et al from Connecticut, USA conducted a real-time study assessing 265 polyps, 
94% of which were <10 mm in size214. High definition NBI was used, with some electronic 
magnification, but no true optical magnification. Four  endoscopists participated and 
received training on NBI assessment prior to commencement of the study. Polyps 
assessment was based on a combination of a modified Kudo’s pit pattern and ‘vascular 
colour intensity’ (VCI) which assessed the mucosal hue of the polyp under NBI and 
compared this to the surrounding mucosa. ‘Light’ VCI (same colour as the surrounding 
mucosa) was indicative of non-neoplastic histology, whereas ‘medium’ or ‘dark’ VCI 
(darker than the surrounding mucosa to varying degrees) were indicative of neoplastic 
histology – see table 8 .  
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Table 8 - Modified Kudo’s classification and Vascular colour intensity with NBI.Reproduced from Rogart et al214 with 
permission from Elsevier. 
 
 
This study also examined endoscopists’ confidence levels in their optical diagnosis and  
the effect of any learning curve. 76% of predictions with NBI could be made with high 
confidence compared to 48% with white light. Overall there was no significant difference 
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in accuracy of optical characterisation between white light (77%) and NBI (80%). 
However, there was an improvement in sensitivity with NBI over white light (80% vs 69%, 
P<0.05). It is notable that there was considerable overlap in vascular colour intensity 
between neoplastic and non-neoplastic polyps with approximately 30% of neoplastic 
polyps demonstrating light VCI, and approximately 30% of non-neoplastic polyps 
demonstrating medium VCI.  
NBI accuracy improved from 74% to 87% between the first and second halves of the study 
but accuracy with white light did not change (78% & 79% respectively), suggesting a 
potential learning curve effect with NBI, and emphasising the importance of training in 
any new technique used for lesion/polyp assessment. 
In contrast to the study by Rogart et al, Rastogi et al did not demonstrate a significant 
learning effect between the first and second halves of a study involving real-time 
assessment of 236 polyps215. Assessments were performed by a single experienced 
endoscopist and found a marked difference in diagnostic accuracy between high 
definition white light (61%) and NBI (93%). Sensitivity for neoplasia was also dramatically 
different with a rate of 96% for NBI and a surprisingly low rate of 38% with high definition 
white light assessment. However there was no significant difference between the two 
modalities in specificity (HDWL 97%, NBI 89%). 
Several other studies from academic centres using non-magnifying NBI achieved high 
rates of sensitivity (77% – 96%), specificity (68%-92%) and accuracy (78.6%-94%)154, 160, 167, 
172, 207, 208, 216-218. Tischendorf performed a picture study comparing magnifying and non-
magnifying NBI207. Although vessel clarity was rated as higher with magnifying NBI, there 
was no actual significant difference in diagnostic accuracy between the two modalities.  
What this large number of studies demonstrated was that NBI, with or without 
magnification, was a viable alternative to chromoendoscopy for the accurate in vivo 
assessment of colonic lesions, at least in the hands of experienced endoscopists in 
academic centres. They also demonstrated that assessment of vascular patterns using NBI 
could prove just as accurate as assessment of pit patterns using chromoendoscopy. 
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Table 9 - Studies of non-magnifying narrow-band imaging for the characterisation of colonic polyps.*- only high 
confidence predictions included in results. RT = real-time, P = picture, Retro = retrospective. 
Author Year Country Real-
time/ 
Picture 
study 
Size Neoplastic 
lesions 
Non-neoplastic 
lesions 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Su199 2006 Taiwan P Max >20mm 70 40 95.7 87.5 92.7 
Chiu191 2007 Taiwan P Max 20mm 
Mean 5.3mm 
141 39 81.9 82 81.9 
Sikka213 2008 USA P Max 10mm 49 31 95 90 93 
Rastogi153 2008 USA P Max 20mm 
Mean 4.4mm 
29 22 96.5 86.4 92 
Rogart214 2008 USA RT Max >10mm 131 134 80 81 80 
Rastogi215 2009 USA RT Mean 4.9mm 143 93 96 89 93 
Ignjatovic216 2009 UK RT Max 10mm 198 80 94* 89* 93* 
Rex217 2009 USA 
RT 
95% <10mm 230 221 
92 87 89 
96* 92* 94* 
van den 
Broek167 
2009 Netherla
nds 
RT Median 3mm 88 118 89.8 70.3 78.6 
Buchner172 2010 USA RT Max 60mm 
Median 
10mm 
31 10 77 90 80.5 
Henry154 2010 USA RT Max 30mm 
Median 3mm 
67 59 92.5 88.1 90.5 
Tischendorf20
7 
2010 Germany P Max 20mm 
Mean7.4mm 
58 42 87.9 90.5 89 
Rastogi218 2011 USA RT Mean 5.9m 933 total 89.9 68.1 81.6 
Zhou208 2011 China RT Mean 10mm 70 total   90 
Lee160 2011 Korea RT Max 5mm 80 76 88.8 86.8 87.8 
Kuiper168 2011 Netherla
nds 
RT Max 10mm 116 112 87.7 63.1 75 
Ignjatovic211 2011 UK P Max 10mm 40 40 66.6 42.5 54.5 
Kuiper219 2012 
Netherla
nds 
RT Max 9mm 141 140 
69.7 74.5 72 
75.2* 76* 75.6* 
Gupta220 2012 USA Retro Mean 5.3mm 801 453 93.7 72.4 86 
Paggi221 2012 Italy RT Max 9mm 351 161 94.9 65.8 85.7 
Hewett222 2012 USA 
RT Median 3mm, 
98% ≤5mm 
38 197 89.5 94.4 93.6 
  93.9* 98.4* 97.7* 
Hewett223 2012 USA RT Max 10mm 149 87 98 69 89 
Sakamoto224 2012 Japan RT Median 5mm 239 31 94.1 74.2 91.9 
Repici225 2013 Italy RT Max 9mm 346 228 90 81 87 
Vu226 2014 USA RT Max 5mm 580 total 80 83 77.1 
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 3.9 Flexible Spectral Imaging Colour Enhancement (FICE) 
As described in the previous chapter, the FICE system of Fujinon endoscopes utilises post-
processor technology to digitally alter the bandwidths of light in the displayed image, 
with 10 different settings available. Several studies have used FICE for the in vivo 
assessment of colonic lesions.  
Pohl et al examined 150 lesions with a mean size of 7.7 mm using white light, FICE and 
indigo carmine, all with and without magnification193. Images captured during 
colonoscopy were characterised by an expert endoscopist blinded to the 
histopathological diagnosis. In this study the FICE setting used had wavelengths of 420 nm 
(blue), 480 nm (green) and 500 nm (red). FICE and chromoendoscopy, with or without 
magnification achieved higher sensitivity for neoplasia than white light endoscopy. 
However there were no significant differences between FICE/chromoendoscopy and 
white light endoscopy in specificity. Accuracy was greater with FICE than white light 
endoscopy either with or without magnification. Chromoendoscopy accuracy was only 
significantly higher than white light with when used with magnification.  
A real-time study performed by the same group compared in vivo characterisation of 676 
colonic lesions assessed by 15 colonoscopists155. Subjects underwent assessment with 
FICE or indigo carmine chromoendoscopy. This was primarily a study examining detection 
of adenomas with FICE compared to white light endoscopy and did not show any 
significant difference in this regard. However, it also examined in vivo characterisation, 
showing no significant difference between FICE and indigo carmine assessment in terms 
of sensitivity (93.2% vs 90.4%, p0.44) or specificity (61.2% vs 60%, p=0.91). Analysis 
restricted to polyps <10mm in size revealed very similar results.  
Togashi and colleagues examined 107 polyps ≤5mm in size sequentially using white light 
endoscopy, FICE and finally chromoendoscopy with indigo carmine plus acetic acid in 
some cases if the pit patterns were not clearly seen with indigo carmine alone158. Optical 
magnification was used with all 3 modalities. A simple classification system was used for 
FICE assessments, where lesions with a visible capillary network were classified as 
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neoplastic and those without a visible capillary network as non-neoplastic. Both FICE and 
chromoendoscopy were found to have greater accuracy and sensitivity than white light 
endoscopy. There was no significant difference found in specificity, although this was 
limited to the assessment of only 27 non-neoplastic polyps. No significant differences in 
accuracy or sensitivity were found between FICE and chromoendoscopy. The authors 
noted that inflamed non-neoplastic polyps could be misinterpreted as adenomatous 
polyps due to their vascular appearance. 
The findings of these three studies by Pohl et al., and Togashi suggested that, similar to 
NBI, FICE was very similar in performance to chromoendoscopy when applied to the in-
vivo characterisation of colonic polyps.  
A later study by Longcroft-Wheaton et al from Portsmouth used sequential assessments 
with white light, FICE and indigo carmine, and showed superior accuracy, sensitivity and 
specificity of FICE and chromoendoscopy compared to white light endoscopy156. No 
significant differences were found between FICE and chromoendoscopy. Similarly, dos 
Santos et al found no differences between FICE and chromoendoscopy in the same 
outcome measures when assessing 95 diminutive polyps in real-time196. 
In a further study Longcroft-Wheaton et al also noted that FICE performance was 
dependent on the resolution of endoscope used157. Sensitivity was found to be 
significantly higher when FICE was used with HD endoscopes compared to SD, whereas 
endoscope definition did not affect specificity.  
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Table 10 - Studies of FICE for the in-vivo characterisation of colonic polyps. 
Author Year Country 
Real-
time/ 
Picture 
study 
Size Optical Magnification 
N
eoplastic lesions 
N
on-neoplastic 
lesions 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Pohl193 2008 Germany P 
Max 20mm 
Mean 7.7mm 
No Mag 
89 61 
89.9 73.8 83.3 
Mag 96.6 80.3 90 
Pohl155 2009 Germany 
 
RT 
 
Max 65mm 
Mean 7.5mm 
No Mag 236 85 93.2 61.2 84.7 
Teixeira227 2009 Brazil RT 
Max 50mm 
Median 5mm 
Mag 250 59 99.2 94.9 98.3 
Togashi158 2009 Japan RT Max 5mm Mag 80 27 92.5 70.4 86.9 
Parra-
Blanco195 
2009 Spain P Max 5mm 
No Mag 
14 5 
  58.9 
Mag   70.5 
Buchner17
2 
2010 USA RT 
Max 60mm 
Mean 10mm 
No Mag 60 18 75 83 76.9 
Longcroft-
Wheaton1
56 
2011 UK RT Max 10mm No Mag 155 77 88 82 86 
Kim228 2011 Korea RT Max 10mm No Mag 315 210 77.1 85.2 80.4 
Yoshida202 2012 Japan P Max 20mm No Mag 95 56 89.4 89.2 89.4 
dos 
Santos196 
2012 Brazil RT Max 4mm Mag 67 28 91.7 95.7 92.6 
 
 
 
 
86 
 
3.10 i-Scan 
The i-Scan system, a feature of Pentax endoscopes, also features post-processor 
technology to manipulate the endoscopic image with the aim of improving the 
visualisation of minute surface and vascular patterns.  
As described in chapter 2, i-Scan consists of 3 features:- 
• Surface Enhancement  
• Contrast Enhancement  
• Tone enhancement  
 
i-Scan has been examined in several studies as a tool for the in vivo characterisation of 
colonic lesions. Hoffman et al examined the distal 30 cm of colon, firstly with high 
definition white light, followed by a second endoscope withdrawal with i-Scan229. This 
study used tone enhancement p-mode (pattern) and v-mode (vessels). A third withdrawal 
was then performed after dye-spraying with methylene blue. This study was primarily 
examining lesion detection and the vast majority of lesions found in this study were small 
hyperplastic polyps. In vivo characterisation was also examined and was restricted to 
polyps ≤5 mm in size. i-Scan was found to have a sensitivity of 82% and specificity of 96% 
for neoplastic lesions, although it should be noted that only 11 neoplastic polyps were 
included in these results.  
A second larger study, by the same group from Germany, was also primarily a study 
examining polyp detection, but also examined in vivo characterisation using i-Scan tone 
enhancement (p or v mode) and surface enhancement162. A total of 82 neoplastic and 63 
non-neoplastic lesions were included with a mean size of 5.6 mm. Impressive outcomes 
with sensitivity of 98%, specificity of 100% and overall accuracy of 98.6% were 
demonstrated. This study does not report if any lesions were excluded or whether only 
high confidence predictions are included in these results. 
Lee et al., from Korea, compared high definition white light (HDWL) and NBI on Olympus 
endoscopes and HDWL and i-Scan using Pentax endoscopes for the in-vivo 
characterisation of diminutive (≤5mm) colonic polyps160. Tone enhancement (colon 
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mode) was used for i-Scan assessments. A unified classification system for the two 
advanced imaging technologies was developed prior to commencement of the study – 
see table11. 
Table 11 - Unified endoscopic classification of diminutive colonic polyps under digital chromoendoscopy– adapted from 
Lee et al160 
 Adenomas Hyperplastic polyps 
Mucosal pattern Oval, tubular, or elongated pits No definite pits or circular or 
dotted pits 
Vascular density Increased vascular density: short, 
thick vessels; distinct vascular 
density surrounding pits; or 
overall 
increased vascular contrast to 
surrounding normal mucosa. 
Scarce vascular density: no 
visualized vessels or only minute, 
thin superficial vessels. 
 
Lee et al found that both NBI and i-Scan achieved significantly higher sensitivity and 
accuracy than their respective HDWL assessments. In a similar finding to other studies, 
they found no difference in specificity between NBI/i-Scan and HDWL, suggesting that 
advanced imaging techniques may improve characterisation of adenomatous polyps, 
avoiding false negative predictions, but do not necessarily lower the false positive rate 
(hyperplastic polyps being incorrectly characterised as adenomas).  
Hong et al compared in vivo diagnostic accuracy of HDWL with i-Scan 1 (Surface and 
contrast enhancement) and i-Scan 2 (surface, contrast and tone enhancement) in 352 
patients randomised to the 3 modalities161. A total of 323 polyps were assessed. No 
significant differences in sensitivity, specificity and accuracy were found between HDWL 
and i-Scan 1. However i-Scan 2 performed significantly better in all 3 measures in 
comparison to HDWL. These results suggested that the component of i-Scan which 
improved diagnostic performance beyond that of HDWL endoscopy was tone 
enhancement, which used colour filtering characteristics similar to NBI and FICE. 
In contrast, a study by Chan et al from the USA examined 146 lesions <10 mm in size in 
real-time using HDWL and i-Scan230. All i-Scan modes could be used during the i-Scan 
assessments. No significant differences were found between HDWL and i-Scan in 
sensitivity (74.1% vs 72.2%), specificity (69.4% vs 71.4%) or accuracy (71.8% vs 71.8%) 
although it is notable that the levels achieved in this study are considerably lower than in 
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most other real-time studies performed with i-Scan. For example Pigo et al reported 
sensitivity of 93.2%, specificity of 87.5% and accuracy of 92%231. 
Han et al compared surface enhancement, tone enhancement (colon) and tone 
enhancement (pit pattern) images of 45 polyps <10 mm in size in a picture study232. 
Histology was predicted by 4 experienced endoscopists. No significant differences in 
sensitivity, specificity or accuracy were found between the 3 modalities and kappa values 
for all 3 modalities suggested good inter-observer agreement. 
Table 12 - Studies of in-vivo characterisation of colonic polyps using i-Scan. * = i-Scan 1,  **=i-Scan 2, ***=TE colon, 
****=TE pit pattern, NR = not reported, RT = real-time, P = picture 
Author Year Country Real-time/ 
Picture 
study 
Size Neoplastic 
lesions 
N
on-
neoplastic 
 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Hoffman229 2010 Germany RT Max 5mm 11 58 82 96  
Hoffman162 2010 Germany RT Mean 5.6mm 82 63 98 100 98.6 
Lee160 2011 Korea RT Max 5mm 74 66 94.6 86.4 90.7 
Hong161 2012 Korea RT NR 
71 45 80.3* 77.8* 79.3* 
74 35 86.5** 91.4** 88.1** 
Chan230 2012 USA RT Max 10mm 54 49 72.2 71.4 71.8 
Han232 2012 Taiwan P Max 9mm 45 total 
75* 82.7* 77.2* 
71.1*** 78.8*** 73.3*** 
75**** 80.8**** 76.7**** 
Pigo231 2013 Italy RT 
Max 30mm 
Mean 6.8mm 
119 31 93.2 87.5 92 
Neumann233 2013 Germany/USA P 
Max 20mm 
Mean 4mm 
77 33   83.9 
Bouwens234 2013 Netherlands P NR 36 14 79.3 85.7 81.1 
Schachschal2
35 
2014 Germany RT 
NR 461 214 78.1 73.4 76.6 
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3.11 Autofluorescence Imaging 
Autofluorescence imaging has been studied as an in vivo diagnostic technique for the 
assessment of colonic lesions. Van den Broek et al used AFI and NBI to assess 208 colonic 
lesions in vivo167. Lesions appearing purple or ambiguous in colour were classified as 
neoplastic and those appearing green as non-neoplastic.  AFI was found to have very high 
sensitivity for predicting neoplastic histology (98.9%), which was significantly greater than 
NBI (89.8%). However the specificity of AFI was very low (35.3%), significantly lower than 
NBI (70.3%) which also resulted in significantly lower overall accuracy (AFI 62.5%, NBI 
78.6%, P<0.001). 
In view of these results the authors combined the techniques into a diagnostic algorithm; 
“all AFI purple lesions as well as AFI ambiguous lesions with Kudo III to V (NBI) were 
regarded as adenomas, whereas AFI green lesions and AFI ambiguous polyps with Kudo I 
to II were considered non-neoplastic”167 resulting in sensitivity of 97.7%, specificity of 
73.7% and accuracy of 84%. The results obtained with this AFI/NBI algorithm trended 
towards greater accuracy than NBI alone but did not reach statistical significance. The 
combination of NBI/AFI coupled with high resolution white light endoscopy was termed 
‘trimodal imaging’.  
A subsequent picture study by the same group produced similar results, with high AFI 
sensitivity (98%) but low specificity (49%), and the same AFI/NBI algorithm having 
significantly higher accuracy than NBI or AFI alone. 
In contrast, Kuiper et al found that the AFI/NBI algorithm had higher accuracy than AFI 
alone but was no better than NBI alone168. These studies showed that AFI, although 
having excellent sensitivity for predicting neoplastic lesions, was not suitable as a stand-
alone in-vivo diagnostic technique in the colon due to the very high false positive rate. 
A subsequent large picture study of white light, NBI and AFI by Sato et al showed higher 
accuracy rates of AFI amongst specialists (89.2%) and residents (86.1%)212. However in 
this study only the best quality images were selected for inclusion, potentially excluding 
more difficult lesions. Of note 80% of the lesions were neoplastic, mitigating against the 
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low specificity rate and not reflecting the usual spectrum of lesions found in clinical 
practice. 
 
Table 13 - Studies of Autofluorescence imaging (AFI) for the in-vivo characterisation of colonic lesions. 
Author Year Country 
Real-
time/ 
Picture 
Modality/ 
Subjects Size 
N
eoplastic 
lesions 
N
on-
neoplastic 
lesions 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Wang236 1999 USA   AFI   12 6 83 100   
McCallum237 2008 UK Real-time 
AFI 
Max 
10.5mm 
3-4mm 
median 54 21 85 81 84 
van den 
Broek167 
 
2009 
 
Netherlands 
 
Real-
time 
 
AFI 
Max 
50mm 
median 
3mm 
 
88 
 
118 98.9 35.3 62.5 
NBI/AFI Alg 97.7 73.7 84 
van den 
Broek238 2009 Netherlands Picture 
AFI Experts 
mean 
5.5mm 22 28 97 56 74 
AFI/NBI Alg 
Experts 
mean 
5.5mm 22 28 86 83 85 
AFI non-
experts 
mean 
5.5mm 22 28 92 65 77 
AFI/NBI Alg  
non-
experts 
mean 
5.5mm 22 28 85 85 85 
Kuiper168 2011 Netherlands Real-time 
AFI 
 
116 113 89.7 36.6 62 
AFI/NBI alg   115 112 88 58 73 
Ignjatovic211 2011 UK Picture 
AFI Experts 
4.5mm 
mean 40 40 63 43 53 
AFI Non-
experts 
4.5mm 
mean 40 40 57 7 32 
Sato212 2011 Japan Picture 
AFI Single 
expert 
6-7mm 
mean 339 85 88.8 67.1 84.9 
AFI 3 
specialist 
6-7mm 
mean 339 85 
  
89.2 
AFI 
residents 
6-7mm 
mean 339 85 
  
86.1 
Rotondano166 2012 Italy Real-time AFI 
 
66 7 
  
63 
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3.12 Confocal Laser Endomicroscopy 
Confocal laser endomicroscopy produces highly magnified images where individual cells 
can be distinguished. It can therefore in theory enable an endoscopist to make a highly 
accurate assessment of likely histology of colonic lesions. The image obtained is likely to 
be an unfamiliar one to many endoscopists and therefore adequate training is 
paramount. 
Several studies have assessed CLE for the in-vivo characterisation of colonic lesions, either 
in isolation or in comparison to other modalities such as NBI and FICE. 
Buchner et al compared pCLE with FICE and NBI and found pCLE to have significantly 
greater sensitivity than NBI/FICE combined but with no significant difference in 
specificity172. Overall accuracy with CLE was 88.2% - see table 14. However the sensitivity 
recorded with NBI/FICE was lower than in most other studies using these modalities – see 
tables 7, 9 & 10. 
Gomez et al reported a lower accuracy of pCLE of 75% for assessing 75 colonic lesions239. 
Accuracy rose to 88% when only those lesions from which acceptable quality videos had 
been captured were included in the analysis. However only 1/3 of the captured videos in 
this study were of acceptable quality. 
High accuracy rates around 95% were reported with integrated CLE used in real-time in 
studies by Sanduleanu and Xie240, 241.  
Shahid et al compared pCLE with NBI242. They found CLE to have higher sensitivity (CLE 
86% vs NBI 64%, P=0.008) but the reverse to be true for specificity (CLE 78% vs NBI 92%, 
P=0.027). Overall accuracy did not differ significantly between the two modalities. A 
second study by Shahid et al showed no significant difference between real-time and 
offline assessments with pCLE243. 
Whilst the accuracy achieved with CLE in characterising colonic lesions is similar to that 
with chromoendoscopy or advanced imaging techniques, doubts remain as to whether 
this is a viable real-world tool for endoscopists. For any new technique to be widely 
accepted it must be relatively easy to learn, reliable, not add significantly to the time of a 
procedure and be cost-effective. 
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CLE is time-consuming, as demonstrated in the Sanduleanu study where the mean 
withdrawal time during colonoscopy was 60 mins240. This is simply not feasible in a busy 
endoscopy list. Although other colonic CLE studies do not specify the withdrawal time or 
the time taken to make CLE assessments, it is likely to be considerable given the nature of 
the technique and the need to capture high quality images which are very prone to 
movement artefact. For example, in the Gomez study, only 1/3 of videos captured were 
deemed acceptable for analysis239. Many CLE studies used assessment of captured CLE 
images ‘offline’ thereby requiring a further time to be allocated for image assessment 
after the endoscopy list had been completed. Hence, although CLE is a novel and 
interesting tool, it is likely to be one that is best used in very specialist centres rather than 
for the vast majority of endoscopists. In addition the Pentax eCLE system has now been 
discontinued. 
 
Table 14 - Studies of in-vivo characterisation of colonic lesions by confocal laser endomicroscopy. 
Author Year Country 
pCLE/eCLE 
Real-
time/Offline 
Size 
N
eoplastic 
lesions 
N
on-neoplastic 
lesions 
Sensitivity %
 
Specificity %
 
Accuracy %
 
Buchner 2010 USA pCLE, offline Mean 10mm 
Max 60mm 
81 39 88 89 88.2 
De Palma 2010 Italy pCLE, offline Mean 13mm 
Max 25mm 
21 11 100 84.6 92.3 
Gomez 2010 USA pCLE, offline NR 50 25 76 72 75 
Sanduleanu 2010 Netherlands 
eCLE, real-
time 
Median 6-
8mm 
Max 32mm 
74 42 97.3 92.8 95.7 
Xie 2011 China 
eCLE, real-
time 
Max 20mm 
Mean 7.5mm 
66 49 93.9 95.9 94.8 
Shahid 2012 USA pCLE, offline 
Max 10mm 
Mean 4.6mm 
58 72 86 78 82 
Shahid 2012 USA 
pCLE, real-
time 
Max 60mm 
Mean 10mm 
80 74 
81 76 79 
pCLE, offline 88 77 83 
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3.13 The clinical significance of small and diminutive colonic polyps 
Small colonic polyps are those defined as 6-9 mm in size and diminutive those ≤5 mm – 
see table 15. The proportion of polyps found during colonoscopy that are either 
diminutive or small has changed over the years.  
   Table 15 - Classification of polyp size 
Classification Size 
Diminutive ≤5mm 
Small 6-9mm 
Large ≥10mm 
    
In the National Polyp Study published in 1990, 37.6% of 5066 polyps were diminutive and 
36.5% small – see table 16244. Kulling et al published a series of 1681 polyps in 2001 of 
which 64.3% were diminutive and 26.8% small245. Subsequent large series by Church and 
Lawrance showed an increasing proportion of the polyps found during colonoscopy to be 
in the diminutive bracket179, 246. 
In 2009, Rex et al published a series of 10,780 polyps of which 81.6% were diminutive and 
11.9% small247.  
Table 16 - Proportion of polyps found during colonoscopy that are small or diminutive. 
Author Year No. Polyps Diminutive 
(≤5mm) 
Small (6-9/10mm) 
O’Brien et al244 1990 5066 37.6% 36.5% 
Kulling et al245 2001 1681 64.3% 26.8% 
Church et al246 2004 5722 76.6% 11.6% 
Lawrance et al179 2006 1988 74.2% 13.4% 
Rex et al247 2009 10780 81.6% 11.9% 
 
This rise in the percentage of diminutive polyps as a proportion of all polyps found during 
colonoscopy over the past 2 decades is unlikely to be due to a change in biology of the 
subjects included in these studies. Rather, advances in the resolution of endoscopes are 
likely to be leading to diminutive polyps being found in greater and greater numbers. In 
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addition, the recognition of adenoma detection and withdrawal time as key quality 
indicators is now well recognised amongst endoscopists and hence practice may have 
changed, leading to improved detection of diminutive adenomas. Indeed, the polyp 
detection rate in large UK colonoscopy audits increased from 22.5% reported in 2004 to 
32.1% in the nationwide audit performed in 2011. 
This poses the question of how best to deal with the increasing numbers of diminutive 
polyps found during colonoscopy. Removing polyps and submitting these for 
histopathology incurs a cost of approximately £58 per polyp in the UK156. Removal of 
increasing numbers of polyps also adds time to the procedure. Traditionally all small and 
diminutive polyps have been removed and submitted for histopathological assessment as 
endoscopists could not reliably distinguish between adenomatous and hyperplastic 
polyps.  
Several studies have examined the risk of finding advanced histology or invasive cancer in 
polyps of various sizes – see table 17. Most studies define advanced histology as the 
presence of high grade dysplasia +/- the presence of >25% villous elements. The size 
brackets used vary slightly eg 6-9 mm or 6-10 mm but do not differ greatly.  Table 17 
shows the pooled results of 8 studies reporting the histology of over 25,000 diminutive 
and small polyps. Two of these studies only included adenomas, whereas the other 6 
studies included polyps of all types. The pooled risk of advanced histology in diminutive 
polyps is 1.97%, or approximately 1 in 50, and the risk of a diminutive polyp containing 
cancer is 0.04% or 1 in 2,500. For small polyps the risk of advanced histology is 9%, or 
approximately 1 in 11, and the risk of cancer 0.38% or approximately 1 in 260 polyps. The 
actual risks are likely to be slightly lower given that two studies excluded non-
adenomatous polyps from their figures244, 248. 
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Table 17 - Risk of advanced neoplasia or cancer in small and diminutive colonic polyps. NR = not reported. Adv 
Histo= advanced histology. 
Study No Polyps 
≤5mm 6-9mm 
Adv Histo Cancer Adv Histo Cancer 
Waye  
Am J Gastro 
1988249 
Total = 1046 all up 
to 6mm 
44 (4.2%) 1 
(0.1%) 
  
O,Brien 
Gastroenterology 
1990244 
Total = 5044 
1270 Ad ≤5mm 
1230 Ad 6-10mm 
858 Ad >10mm 
2.0% (of 
adenomas) 
NR 12.6% (of 
adenomas 
6-10mm) 
NR 
Kulling 
Endoscopy  
2001245 
Total =1681 
1081 ≤5mm 
451 6-10mm 
149 >10mm 
8.5% NR NR NR 
Church 
Dis Col Rectum 
2004246 
Total = 5722 
4381 ≤5mm 
666 6-10mm 
675 >10mm 
91 (4.4%) 2 
(0.1%) 
66 
(15.8%) 
1 
(0.2%) 
Butterly  
CGH  
2006248 
Total = 1933 
adenomas 
1012 <5mm 
921 5-10mm 
17 (1.7%) 
of 
adenomas 
0 (0%) 93 (10.1%) 
of 
adenomas 
8 
(0.9%) 
Lawrance  
J Gas Hep  
2006179 
Total = 1988 
1434≤5mm 
266 6-9mm 
49 (3.5%)  0 (0%) 53 (19.9%) 3 
(1.1%) 
Rex  
Am J Gas  
2009247 
Total = 10,780 
8,798 ≤5mm 
1,282 6-9mm 
79 (0.87%) 4 
(0.05%) 
68 (5.3%) 0 (0%) 
Gupta GIE 
2012250 
1620≤5mm 9 (0.5%) 0 (0%)   
Total 20,642 ≤5mm 
4,816 6-10mm 
 
406 
(1.97%) 
7 
 
(0.04%) 
435  
(9.03%) 
12  
(0.38%) 
. 
 
3.14 Effect of polyp size on in-vivo characterisation outcomes 
This changing spectrum of polyps found during colonoscopy over time may also have an 
impact on the ability to make an accurate in-vivo diagnosis. Many studies have examined 
the effect of polyp size on the accuracy of in-vivo diagnosis. From the results published in 
these studies it is possible to compare the in vivo performance of various techniques 
based on polyp size. 
Two studies have recorded results of white light in vivo diagnosis broken down by polyp 
size. Both Longcroft-Wheaton and Kim found that white light endoscopy had significantly 
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lower sensitivity for diminutive polyps compared to those ≥6 mm in size – see table 18156, 
228. However specificity was actually lower for larger polyps, reaching statistical 
significance in the Longcroft-Wheaton study. It should be noted that this was not a 
primary outcome measure so these results should be viewed as hypothesis-generating. 
These results would suggest that the main areas where white light endoscopy falls down 
are in mis-classifying small adenomas as non-neoplastic polyps and also over-calling larger 
non-neoplastic polyps as adenomas. In general 80-90% of polyps larger than 5 mm are 
neoplastic so it is understandable that endoscopists would tend to classify these as 
neoplastic. 
Table 18 - Effect of polyp size on in-vivo diagnosis outcomes with white light endoscopy. 
Study Modality Size comparison P value for comparison 
Longcroft-
Wheaton156 
White light 
Accuracy, ≤5mm vs 6-9mm 66.5% vs 79.2%, P=0.078 
Sensitivity, ≤5mm vs 6-9mm 65.6% vs 87.7%, P=0.003 
Specificity, ≤5mm vs 6-9mm 69.2% vs 33.3%, P=0.041 
Kim228 White light 
Accuracy, ≤5mm vs 6-9mm 70.1% vs 74.8%, P=0.333 
Sensitivity, ≤5mm vs 6-9mm 56.7% vs 75.0%, P=0.002 
Specificity, ≤5mm vs 6-9mm 85.7% vs 74.3%, P=0.154 
 
Interestingly very similar results were reported in a study using fiberoptic endoscopes 
published in 1987184 – see table 19. So despite major advances in endoscope resolution in 
appears that endoscopists still tend to mis-diagnose small adenomas and larger 
hyperplastic polyps. 
Table 19 - Cases with incorrect prediction of histology by polyp size reproduced from Neale et al187.Numbers are 
absolute numbers of polyps. 
 Polyp size 
 <5 mm 5mm >5mm 
False negatives 6 2 - 
False positives - 3 5 
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Tung et al compared the accuracy of indigo carmine chromoendoscopy in polyps ≤5mm 
with those >5mm. Accuracy was 84.5% in the >5mm group and 78.6% in the ≤5mm group 
but this difference did not reach statistical significance (P = 0.649)186. However there was 
a significant difference in sensitivity based on size, with higher sensitivity in the subset of 
polyps >5mm. Similar to the results reported by Longcroft-Wheaton and Kim using white 
light endoscopy, specificity was actually significantly lower for polyps >5mm156, 228. Su et 
al found significantly higher sensitivity, and also accuracy, of chromoendoscopy in polyps 
>5mm – see table 20188. Numbers of non-neoplastic lesions >5mm were very small in this 
study, so it is difficult to draw any meaningful conclusions. 
Pohl et al again found significantly higher sensitivity with chromoendoscopy in larger 
polyps (≥10mm) compared to those <10mm, but no difference in specificity between 
these two groups. In contrast, Longcroft-Wheaton found no difference in accuracy, 
sensitivity or specificity between diminutive polyps and those >5mm. Overall these results 
suggest that whilst chromoendoscopy improves sensitivity overall compared to white 
light endoscopy, diminutive adenomas remain more difficult to assess than larger ones. 
Table 20 - Effect of polyp size on in-vivo diagnosis outcomes with chromoendoscopy. 
Study Modality Size comparison P value for comparison 
Tung186 
Chromoendoscopy with 
magnification 
Accuracy, ≤5mm vs >5mm  78.6% vs 84.5%, P=0.649 
Sensitivity, ≤5mm vs >5mm 88.5% vs 100%, P=0.042 
Specificity, ≤5mm vs >5mm 70.8% vs 35.7%, P=0.029 
Su188 
Chromoendoscopy 
without magnification 
Accuracy, ≤5mm vs >5mm  88.2% vs 96.9%, P=0.021 
Sensitivity, ≤5mm vs >5mm 88.4% vs 100%, P<0.001 
Specificity, ≤5mm vs >5mm 88.0% vs 75.0%, P=1.000 
Pohl155 
Chromoendoscopy 
without magnification 
Sensitivity, <10mm vs 
≥10mm 
87.6% vs 98.6%, P=0.014 
Specificity, <10mm vs 
≥10mm 
62.0% vs 46.7%, P=0.410 
Longcroft-
Wheaton156 
Chromoendoscopy 
without magnification 
Accuracy, ≤5mm vs 6-9mm 89.7% vs 93.5%, P=0.475 
Sensitivity, ≤5mm vs 6-9mm 93.3% vs 95.4%, P=0.849 
Specificity, ≤5mm vs 6-9mm 84.6%, vs 83.3%, 
P=1.000 
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Several studies using advanced imaging techniques (FICE, NBI) have reported results 
broken down by polyp size. 
Pohl compared results using FICE without magnification between polyps <10mm and 
those ≥10mm and demonstrated a significant difference in sensitivity, but no difference in 
specificity – see table 21155. Similar results were reported by Longcroft-Wheaton156. 
Ignjatovic et al found no differences in accuracy, sensitivity or specificity between 
diminutive and small polyps when examined with NBI +/- chromoendoscopy216. 
Kim et al compared accuracy of FICE with magnification in subgroups of polyps ≤5mm and 
6-9mm and found no significant difference in accuracy (85.4% vs 91.2%, P = 0.109)228. The 
same was true of FICE without magnification (79.1% vs 83.7%, P = 0.288). No significant 
difference in sensitivity was found although there was a trend towards higher sensitivity 
in the group of polyps 6-9mm with both FICE and FICE with magnification.  
Rastogi et al examined 993 polyps using NBI and presented  results according to polyp 
size. Accuracy was 81.1% for polyps <10mm and 79.4% for polyps ≤5mm. Although 
absolute figures are not provided to allow statistical calculation, due to the small 
percentage difference and large sample size, it is likely there is no significant difference in 
accuracy. 
Yoshida found significantly higher accuracy and sensitivity using FICE in polyps ≥6mm 
compared to those ≤5mm. No difference in specificity was found between the two 
groups. 
Repici et al examined 574 polyps using NBI. Subgroup analysis of polyps ≤5mm and those 
6-9mm showed no significant difference in NBI accuracy (85% vs 91%, P = 0.093). 
However sensitivity was significantly lower in the group of smaller polyps and specificity 
was significantly lower in the group of larger polyps. 
Schachschal examined 675 polyps using i-Scan235. Both accuracy and sensitivity were 
significantly lower in polyps ≤5mm than those 6-10mm in size. There was no statistically 
significant difference found in specificity. 
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The results of these studies of advanced imaging techniques broken down by polyp size 
show very similar results to those performed with chromoendoscopy, namely that even 
with advanced imaging small adenomas are more difficult to accurately characterise than 
larger ones. 
 
Table 21 - Effect of polyp size on in-vivo diagnosis outcomes with advanced endoscopic imaging techniques. 
Study Modality Size comparison P value for comparison 
Pohl155 
FICE without 
magnification 
Sensitivity, <10mm vs 
≥10mm 
90.1% vs 97.9%, P=0.037 
Specificity, <10mm vs 
≥10mm 
61.3% vs 60.0%, P=1.000 
Ignjatovic216 
NBI without magnification 
+/- chromoendoscopy 
Accuracy, ≤5mm vs 6-9mm 92% vs 98%, P=0.21 
Sensitivity, ≤5mm vs 6-9mm 93% vs 98%, P=0.46 
Specificity, ≤5mm vs 6-9mm 88% vs 100%, P=1.00 
Longcroft-
Wheaton156 
FICE without 
magnification 
Accuracy, ≤5mm vs 6-9mm 83.2% vs 92.2%, P=0.096 
Sensitivity, ≤5mm vs 6-9mm 83.3% vs 95.4%, P=0.040 
Specificity, ≤5mm vs 6-9mm 83.1% vs 75.0%, P=0.795 
Kim228 
FICE without 
magnification 
Accuracy, ≤5mm vs 6-9mm 79.1% vs 83.7%, P=0.288 
Sensitivity, ≤5mm vs 6-9mm 73.9% vs 83.0%, P=0.087 
Specificity, ≤5mm vs 6-9mm 85.1% vs 85.7%, P=1.000 
FICE with magnification 
Accuracy, ≤5mm vs 6-9mm 85.4% vs 91.2%, P=0.109 
Sensitivity, ≤5mm vs 6-9mm 84.7% vs 92.0%, P=0.095 
Specificity, ≤5mm vs 6-9mm 86.3% vs 88.6%, P=0.928 
Yoshida202 FICE without 
magnification 
Accuracy, ≤5mm vs ≥6mm 82.7% vs 97.1%, P=0.009 
Sensitivity, ≤5mm vs ≥6mm 78.0% vs 95.2%, P=0.005 
Specificity, ≤5mm vs ≥6mm 87.5% vs 90.0%, P=0.838 
Repici225 NBI without magnification 
Accuracy, ≤5mm vs ≥6mm 85% vs 91%, P=0.093 
Sensitivity, ≤5mm vs ≥6mm 86% vs 99%, P<0.001 
Specificity, ≤5mm vs ≥6mm 84% vs 65%, P=0.016 
Schachschal235 i-Scan 
Accuracy, ≤5mm vs 6-10mm 71.1% vs 87.1%, P<0.05 
Sensitivity, ≤5mm vs 6-
10mm 
68.6% vs 93.7%, P<0.05 
Specificity, ≤5mm vs 6-
10mm 
75.3% vs 61.3%, P=NS 
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3.15 Clinical applications of in-vivo characterisation of small colonic polyps 
Methods of in-vivo characterisation were initially developed to assess gastric and colonic 
lesions to predict whether they were suitable for endoscopic resection, or had features 
suggesting deep submucosal invasion and therefore were best treated by surgery. 
As chromoendoscopy and advanced imaging techniques developed, many studies began 
to examine their usefulness for assessing small and diminutive colonic polyps. 
Clinical applications of being able to make an accurate in vivo assessment have been 
suggested for some time. In 1996 Axelrad suggested that use of a diagnostic method such 
as chromoendoscopy could avoid the need for histopathology and could have large cost 
savings131. Togashi suggested that confidently identified non-neoplastic polyps could be 
left in situ, saving time and money and reducing risk from unnecessary polypectomy132. 
Eisen and colleagues stated that high resolution chromoendoscopy “…has the potential to 
realize large savings in time, resources and cost” but that training of endoscopists was 
required to reach adequate levels of accuracy and further studies would need to examine 
cost-effectiveness197. They proposed a threshold value of 90% for negative predictive 
value of adenomatous histology.  Konishi et al wrote that an optical non-biopsy technique 
could reduce costs but would need to be “perfect”134. In 2006 Apel noted that precise 
endoscopic diagnosis with chromoendoscopy could avoid overtreatment of diminutive 
rectosigmoid hyperplastic polyps and reduce costs198. 
Two important papers published in 2009, both using narrow-band imaging, suggested a 
future way forward in the management of small colonic polyps. Rex identified features, 
visible using NBI without magnification, that were predictive of adenomatous or 
hyperplastic histology217. These were used to prospectively characterise 451 colonic 
polyps in vivo. A confidence level was assigned to in vivo predictions – high confidence if a 
polyp displayed features predictive of one type of histology and no features of the 
alternative histology, and low confidence if features of both types of histology were 
visible. Overall in vivo accuracy for the entire cohort of polyps was 89%, but rose to 94% 
in those polyps with a high confidence prediction. High confidence predictions were 
possible in 80% of adenomas and 83% of hyperplastic polyps. For diminutive polyps high 
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confidence predictions yielded an accuracy of 93% overall and for diminutive hyperplastic 
polyps a 95% accuracy rate was reported. 
Rex also examined the effectiveness of using the in vivo characterisation of diminutive 
polyps, with a high confidence prediction, on setting post-polypectomy surveillance 
intervals. Patients who are found to have adenomas at colonoscopy are scheduled to 
undergo a future surveillance colonoscopy, with the time interval determined by the 
number, size and histology of adenomas found at baseline colonoscopy. The 
recommended intervals vary slightly between the UK, USA and Europe but are broadly 
similar. The British Society of Gastroenterology surveillance recommendations are shown 
in figure 37. 
 
Figure 37 - British Society of Gastroenterology colonoscopic surveillance interval following adenoma removal. 
Reproduced from Cairns et al43 with permission from BMJ publishing. 
In the study by Rex et al, surveillance intervals based on the US guidelines were 
recommended based on the in vivo assessment of diminutive polyps with a high 
confidence assessment combined with histopathology of polyps larger than 5 mm. These 
were compared to the recommended surveillance based on the histopathology results of 
all polyps. The recommended surveillance interval was the same as that determined by 
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histopathology alone in 94% to 98.5% of patients depending on interpretation of the US 
guidelines. 
Based on these results the paper suggests that using high confidence NBI predictions 1) 
DCPs could be resected and discarded, without the need for submitting tissue for 
histopathological assessment and 2) distal hyperplastic polyps with a high confidence 
assessment could be left in situ. 
A second study published in 2009 by Ignjatovic et al from St Mark’s Hospital, London 
examined 278 polyps ≤10 mm using HDWL, +/- NBI +/- chromoendoscopy if required216. 
Based on the confidence of their endoscopic assessment, the endoscopists decided how 
each polyp would be managed were a policy of optical diagnosis in place. For polyps with 
a high confidence assessment management would be based on the optical diagnosis, and 
for those with a low confidence assessment it would be based on histopathology. This 
was termed a ‘Resect and Discard’ policy in which small polyps with high confidence 
assessments would be resected and discarded, rather than sent for histopathology. 
Surveillance intervals, based on optical diagnosis, could be made in 82 patients and in 80 
of these were in concordance with the interval based on histopathology. Adopting this 
approach was predicted to save £13,343 in reduced pathology and clinic costs. 
Following the publication of these studies the American Society of Gastrointestinal 
Endoscopy (ASGE) published guidelines for the use of real-time endoscopic assessment of 
the histology of diminutive colonic polyps251. These Preservation and Incorporation of 
Valuable Endoscopic Innovations (PIVI) guidelines aim to direct both developers of 
technology and researchers towards finding solutions and answering important clinical 
questions in the field of endoscopy. As a consequence, real-time endoscopic prediction of 
DCP histology was identified as a key area for research and development. 
The ASGE proposed that new paradigms could be adopted for the management of DCPs, 
along very similar lines to those proposed in the Rex and Ignjatovic studies216, 217. These 
also included clear diagnostic thresholds that any new technique should meet before 
adoption into usual clinical practice. 
The two paradigms were set out as follows:- 
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1) ‘Resect and Discard’ Paradigm 
“In order for colorectal polyps ≤5 mm in size to be resected and discarded without 
pathologic assessment, endoscopic technology (when used with high confidence) used to 
determine histology of polyps ≤5 mm in size, when combined with the histopathologic 
assessment of polyps >5 mm in size, should provide a ≥90% agreement in assignment of 
post-polypectomy surveillance intervals when compared to decisions based on pathology 
assessment of all identified polyps.” 
 
 
2) ‘Do not Resect’ paradigm 
“In order for a technology to be used to guide the decision to leave suspected 
rectosigmoid hyperplastic polyps ≤5 mm in size in place (without resection), the 
technology should provide ≥90% negative predictive value (when used with high 
confidence) for adenomatous histology.” 
 
The main proposed benefits of these paradigms for managing DCPs were reduction in 
pathology costs, avoiding the risk of unnecessary polypectomy, and the ability to set a 
surveillance interval at the time of procedure, rather than needing to wait for histology 
results. 
This ASGE PIVI statement gave direction and clear goals for researchers studying 
advanced imaging techniques and chromoendoscopy. 
Longcroft-Wheaton et al examined the performance of white light endoscopy, FICE and 
indigo carmine chromoendoscopy used sequentially against the ASGE ‘Resect and 
Discard’ paradigm156. A total of 232 polyps were examined by a single expert endoscopist. 
White light endoscopy led to agreement with BSG surveillance intervals, based on 
histopathology, in 83% of patients, not meeting the PIVI threshold. However both FICE 
and chromoendoscopy assessments had 97% agreement with histopathology based 
surveillance intervals, exceeding the PIVI threshold. 
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Gupta et al performed a retrospective analysis of 3 trials of NBI without magnification to 
assess performance against the PIVI thresholds220. These included 410 patients in total. 
When comparing surveillance intervals, including optical diagnosis of DCPs against the US 
national surveillance guidelines, they used two different histopathology-based 
surveillance interval regimes for comparison (A&B). This stems from the US guidelines 
which give two surveillance interval options of either 5 years (Regime A) or 10 years 
(Regime B) following the removal of 1-2 small low risk adenomas252.  Surveillance interval 
determined by optical diagnosis of DCPs, combined with histopathology of polyps >5mm 
was in agreement with regime A in 86.1% of cases and regime B in 94.1%. Hence the PIVI 
threshold for ‘Resect and Discard’ was met for regime B but not regime A. The negative 
predictive value for adenomatous histology of diminutive rectosigmoid polyps in this 
study was 95.4%, meeting the PIVI threshold for a ‘Do not Resect’ policy. Adoption of 
both the ‘Resect and Discard’ and ‘Do not Resect’ policies for DCPs in this cohort of 410 
patients was estimated to generate potential cost savings of $93,712, or $228 per patient. 
In an Italian study by Pigo et al., 150 polyps were examined by a single experienced 
endoscopist using i-Scan and reported a NPV of 93% for adenomatous histology of 
diminutive rectosigmoid polyps. 
 
3.16 Effect of Endoscopist experience and training 
As has been discussed, large numbers of studies using a variety of techniques have 
demonstrated high levels of accuracy in distinguishing between neoplastic and non-
neoplastic small and diminutive colonic polyps.  
The ASGE PIVI statement set performance thresholds for new technologies which should 
be met before a strategy of optical diagnosis for the management of SCPs/DCPs is 
adopted into widespread clinical practice. Concerns have been raised that while the levels 
of accuracy achieved in many studies are impressive, the vast majority of these have been 
performed in tertiary academic centres by endoscopists with experience in in vivo 
diagnostic techniques and special interest in this field134, 152, 155, 156, 160, 161, 187, 190, 195, 198, 205, 
216, 217, 228, 253.  
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Concerns about the generalisability of this approach to the management of DCPs has led 
to several recent studies examining the performance of optical diagnosis in ‘community’ 
settings.  
Ladabaum and colleagues enrolled 13 community endoscopists into a study using NBI for 
the optical diagnosis of DCPs254. Prior to the in vivo part of the study, all participating 
endoscopists underwent a computer based training module on the principles of in vivo 
characterisation using NBI. Accuracy in a test set of images improved from a mean of 79% 
to 94% following training. However only 6 of the 12 endoscopists who completed the 
in vivo part of the study achieved the 90% NPV threshold for leaving distal hyperplastic 
polyps in situ. Surveillance intervals, based on high confidence NBI characterisation of 
DCPs, were in agreement with histopathology based intervals in only 79% of patients, 
falling short of the PIVI threshold. 
In a Dutch study (the DISCOUNT trial) Kuiper studied the performance of 3 community 
endoscopists who used HDWL and NBI for in vivo characterisation of polyps up to 10 mm 
in size219. Prior to the study the 3 endoscopists had not used NBI in their practice on a 
regular basis, but had participated in previous studies using NBI and received a further 
short training session prior to the starts of this study. Agreement with histopathology 
based surveillance recommendations was only achieved in 81% of patients using high 
confidence NBI assessments of DCPs.  
A third study was performed in Italy with 6 community based endoscopists, all with 
experience of using NBI. Before starting the study all 6 endoscopists received further 
training on NBI polyp assessment, with a pre- and post-training test.  Surveillance interval, 
based on high confidence NBI assessments of DCPs, matched those of histopathology 
based intervals in 85.3% of cases221. Negative predictive value for adenomatous histology 
of left sided polyps (although not specifically rectosigmoid polyps) was 88.4%. Hence in 
this study NBI in the hands of community endoscopists once again failed to achieve the 
targets for performance set by the ASGE. 
A recently published German study enrolled 10 experienced community based 
endoscopists who had each performed >10,000 colonoscopies235. They used the i-Scan 
surface enhancement feature to assess Kudo’s pit patterns for in vivo characterisation of 
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polyps <10 mm in size. Prior to study commencement, the participating endoscopists 
were provided with schematic drawings and example images of pit patterns which they 
could also refer to during the study. Before the in vivo characterisation part of the study, 
between 20-25 colonoscopies were performed by each endoscopist using i-Scan. 
Surveillance intervals, based on in vivo assessment of DCPs were correct in only 69.5% of 
cases, although it should be noted that this study did not include a confidence assessment 
of endoscopists’ predictions of polyp histology. 
A further recently published American study using HDWL and NBI compared the 
performance of 6 experienced (>5000 colonoscopies) community based and academic 
endoscopists using HDWL +/- NBI226 to assess DCPs. Formal teaching and a validated 
image set were provided prior to study commencement. The image set was also available 
for reference during study procedures. Histology was predicted using HDWL +/- NBI at 
each endoscopist’s discretion and confidence in the in vivo prediction was rated on a 
visual analogue scale. Concordance with US surveillance intervals, based on a ‘Resect and 
Discard’ approach, was 87.8% for the community endoscopists and 83.2% for academic 
endoscopists. Interestingly, the community endoscopists only used NBI in 13% of polyp 
assessments, compared to 76% of assessments made by academic endoscopists. 
As has been described above, to date the 5 published studies of optical diagnosis of DCPs 
performed in ‘community’ settings have all failed to show performance that meets the 
requirements for adoption of the ‘Resect and Discard’ and ‘Do not Resect’ paradigms set 
out in the ASGE PIVI statement. Hence there is concern about the generalisability of the 
findings from studies performed in academic centres by endoscopists with an interest in 
in vivo diagnosis. Clearly a process of training and accreditation in in vivo diagnosis would 
be required before either ‘resect and discard’ or ‘do not resect’ paradigms could be 
adopted into widespread practice, and prior to this further studies are required that can 
demonstrate adequate performance thresholds can be met by non-expert endoscopists. 
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Chapter 4 – Use of i-Scan for the in-vivo characterisation 
of small colonic polyps – developing and validating a 
system for characterising small colonic polyps with i-Scan 
and determining the performance of individual 
components of i-Scan 
 
 
4.1 Introduction – Systems for characterising small colonic polyps 
All advanced in vivo diagnostic techniques require well-defined classification systems that 
are transferable and reproducible. The most widely used system for the characterisation 
of colonic mucosal lesions is chromoendoscopy in conjunction with Kudo’s pit patterns, as 
previously described123-125.  
4.1.1 NBI 
Several classification systems using NBI for the characterisation of colonic lesions have 
been described. Tanaka used Kudo’s pit patterns as the assessment system with NBI204, 
whereas Tischendorf et al used a combination of Kudo’s pit patterns and vascular 
patterns192. It became clear during further studies that the main effect of NBI was to 
enhance visibility of vascular patterns, which tended to be more prominent in 
adenomatous polyps in comparison to hyperplastic polyps. East et al described this as 
‘vascular pattern intensity’ (VPI) with adenomas having high VPI and hyperplastic polyps 
low VPI152. A very similar classification system using ‘vascular colour intensity’ (VCI) was 
described by Rogart214. Sano et al described ‘meshed capillary vessels’ with adenomas, 
demonstrating clearly visible meshed capillary vessels and hyperplastic polyps having 
invisible or faintly visible meshed capillary vessels205. 
More recently a system for colonic polyp classification for use with magnifying and non-
magnifying NBI endoscopes has been described223. This is termed the NBI International 
Colorectal Endoscopic (NICE) classification system. The NICE classification combines 
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assessments of overall lesion colour, vascular patterns and surface patterns to predict 
likely histology as detailed in table 22.  
These criteria were validated by groups of medical students and fellows (gastroenterology 
trainees) without prior knowledge of NBI, who applied them to a large set of polyp 
images. Amongst medical students, colour yielded significantly lower accuracy, sensitivity 
and specificity than vessel or surface pattern assessment, but amongst fellows all three 
criteria performed well. 
Table 22- NICE classification for classification of diminutive colorectal polyps using NBI.Reproduced from Hewett et 
al223. 
NICE Criterion Type 1 Type 2 
Colour Same or lighter than background Browner relative to background (verify 
colour arises from vessels) 
Vessels None, or isolated lacy vessels 
coursing across the lesion 
Brown vessels surrounding white 
structures 
Surface Pattern Dark or white spots of uniform size, 
or homogeneous absence of pattern 
Oval, tubular, or branched white 
structures surrounded by brown vessels 
Most likely pathology Hyperplastic Adenoma 
 
4.1.2 FICE 
Similar to studies using NBI, several systems for characterising colonic polyps using FICE 
have been described. Pohl used Kudo’s pit patterns and vascular pattern intensity with 
similar descriptions of what constituted high and low intensity as that described in studies 
using NBI155. Togashi et al used magnifying FICE and characterised polyps as adenomas or 
hyperplastic based on the presence or absence of a visible capillary network158. Teixeira et 
al described a more complex characterisation system using magnifying FICE for all 
colorectal lesions227. This was divided into 5 different vascular patterns as shown in figure 
38. Longcroft-Wheaton et al described a novel classification system named ‘NAC’ which 
described endoscopic features visible with FICE of Non-neoplastic polyps, Adenomas and 
Cancers255.  
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 Figure 38 - Endoscopic capillary vessel classification using FICE. Figures A-E show vessel types I-V respectively. Figures 
A/B – hyperplastic, Figures C/D – adenomas, Figure E – carcinoma. Reproduced from Teixeira et al227 with permission 
from Elsevier.  
 
4.1.3 i-Scan 
Studies of small colonic polyp characterisation using the Pentax i-Scan system have used a 
variety of classification systems. Hoffman et al used Kudo’s pit patterns as well as 
assessment of ‘vessel architecture’, although the precise system for classifying vessel 
patterns is not described in their study162.  
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Lee at al developed a new classification system for use with both NBI and i-Scan which 
combined assessment of mucosal pattern and vascular density – see table 23. 
Table 23 - Endoscopic classification of diminutive colonic polyps using digital chromoendoscopy. Reproduced from Lee 
et al160 with permission from Elsevier. 
 Adenoma Hyperplastic 
Mucosal pattern Oval, tubular or elongated pits No definite pits or circular or 
dotted pits 
Vascular density Increased vascular density: short, 
thick vessels; distinct vascular 
density surrounding pits; or 
overall increased vascular 
contrast to surrounding normal 
mucosa 
Scarce vascular density: no 
visualised vessels or only minute, 
thin superficial vessels. 
 
Hong et al characterised polyps with i-Scan using a combination of modified Kudo’s pit 
patterns and vascular colour intensity, as demonstrated in table 24. 
Table 24 - Histology prediction with HDWL and i-Scan using modified Kudo’s pit pattern and vascular colour intensity. 
Reproduced from Hong et al161 with permission from Elsevier. 
  
 
Pigo et al used the NICE classification, developed using NBI, for polyp characterisation 
with i-Scan231, whereas Schachschal et al used Kudo Pit patterns. 
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As can be seen a number of different classification systems for use with advanced 
endoscopic imaging techniques have been described. When the individual components 
and descriptors are broken down there are three main aspects of the assessment; 
i) vascularity, ii) vascular patterns and iii) surface patterns. The different classification 
systems use slightly different phrases to describe the typical vascular and surface patterns 
suggestive of non-neoplastic polyps and adenomas, but they are essentially describing the 
same features. 
 
 
4.2 Development of a system for characterising small colonic polyps with i-
Scan 
4.2.1 Aims 
The aim of this study was to describe and validate the features of small colonic polyps 
which are predictive of neoplastic or non-neoplastic histology and are visible with i-Scan.  
4.2.2 Methods 
Digital images of 100 small (1-9mm) colonic polyps (50 adenomatous and 50 hyperplastic) 
were captured from patients attending for BCSP colonoscopy. Images of consecutive 
polyps were captured until 50 high quality images of polyps of each histological type were 
obtained.  All patients gave informed consent for anonymised use of images for study and 
training purposes.  
Polyps were cleansed prior to image capture using a flush solution of water, n-
acetylcysteine and simeticone delivered via the endoscope working channel. This ensured 
minimal residual stool debris or mucus was present on the mucosal surface prior to image 
capture. Pentax EC-3890Li 1.2 Megapixel HD+ colonoscopes were used linked to a EPKi 
processor (Pentax Medical, UK). The endoscope image was transmitted between 
processor and screen via an HD connection, and displayed on a high definition monitor 
capable of displaying 1080 horizontal lines. Images were captured in i-Scan 3 mode, which 
incorporates all 3 features of i-Scan (SE+3, CE+2, TE colon) onto a USB storage device. 
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Several images of each polyp were captured and the one deemed to have the best clarity 
was selected for analysis. 
Images were collated into a Microsoft Powerpoint presentation and randomised using a 
computer generated shuffled number sequence (GraphPad, SanDiego, USA). Randomised 
images were then viewed by a single expert endoscopist (PZB) with extensive experience 
of in vivo diagnosis. The expert endoscopist was blinded to the histopathological diagnosis 
for each lesion.  
Visible features of polyps viewed with i-Scan were assessed and divided into 3 categories 
adapted from the previously developed NAC classification system used with FICE and 
indigo carmine chromoendoscopy255-257 – vascularity, vascular patterns and surface 
patterns. All polyps were assessed for any visible features which may be predictive of 
histology, which were categorised as follows:- 
 
Vascularity 
• Hypovascular- polyp paler than the surrounding mucosa 
• Isovascular – polyp of the same vascularity as the surrounding mucosa 
• Hypervascular – polyp darker and more vascular than the surrounding mucosa  
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Figure 39- Example of a polyp graded as hypovascular with i-Scan. 
 
Figure 40 - Example of a polyp graded as isovascular with i-Scan. 
 
Figure 41 - Example of a polyp graded as hypervascular with i-Scan. 
 
Vascular patterns 
• No visible vessels – no vessels visible on the surface of the polyp 
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• Fine vessels not following the edges of crypts  - thin, fine or thread vessels coursing 
across the surface of the polyp and not related to the crypts/pits 
• Dense regular pericryptal vessels – thicker vessels, densely packed and following 
the edges of crypts/pits 
 
Figure 42 - Example of a polyp with no visible vessels 
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Figure 43 - Example of a polyp demonstrating a fine vessel not following the edges of crypts (marked by arrow) 
 
 
Figure 44 - Example of a polyp with dense regular pericryptal vessels 
 
 
Surface patterns 
• No surface patterns – no surface patterns visible 
• Large non-compact pits  - Large dark circles or star-shaped pits 
• Small compact regular, tubular or branched pits – Densely packed circles, ovals or 
branched pits with a gyrus-like pattern 
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 Figure 45 - Example of a polyp with no visible surface patterns 
 
 
Figure 46 - Example of a polyp with large non-compact pits 
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 Figure 47 - Example of a polyp with compact regular tubular pits 
 
The visible features for each individual polyp were also noted and then collated for 
comparison to the final histopathological diagnosis as determined by an accredited BCSP 
consultant histopathologist. 
 
4.2.3 Results 
The results of frequency of each predictive diagnostic feature in adenomatous and 
hyperplastic polyps are detailed in table 25 
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Table 25 - Features of the modified NAC classification system for i-Scan found in adenomatous and hyperplastic polyps 
viewed with i-Scan 3. 
 Adenomatous Polyps Hyperplastic Polyps 
Vascularity 
• Hypovascular 
• Isovascular 
• Hypervascular 
 
2/50 (4%) 
18/50 (36%) 
30/50 (60%) 
 
17/50 (34%) 
22/50 (44%) 
11/50 (22%) 
Vascular Patterns 
• No visible vessels 
• Fine vessels not following                                  
the edges of crypts   
• Dense regular pericryptal    
vessels 
• Unable to assess 
 
13/50 (26%) 
5/50 (10%) 
 
30/50 (60%) 
 
2/50 (4%) 
 
38/50 (76%) 
10/50 (20%) 
 
2/50 (4%) 
 
0/50 (0%) 
Surface patterns 
• No surface patterns 
• Large non-compact pits 
• Small compact regular, 
tubular or branched pits 
• Unable to assess 
 
11/50 (22%) 
5/50 (10%) 
32/50 (64%) 
 
2/50 (4%) 
 
32/50 (64%) 
18/50 (36%) 
0/50 (0%) 
 
0/50 (0%) 
 
As can be seen from the above table, vascularity is of some use in characterising small 
polyps. Adenomatous polyps are more likely to be hypervascular, however a significant 
minority of hyperplastic polyps were also graded as hypervascular, so there is 
considerable overlap. If polyps were characterised on vascularity alone, with 
hypervascular polyps predicted to be adenomatous and iso/hypovascular polyps 
predicted to be hyperplastic, then predictions would be correct in 69.5% of cases overall.  
The presence of dense regular pericryptal vessels was highly suggestive of adenomatous 
histology. Furthermore, virtually all hyperplastic polyps had either no visible vessels or 
fine vessels not following the edges of crypts. Interestingly, 1 in 10 adenomas were 
judged to also have fine vessels not following crypts.  
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In terms of surface patterns all hyperplastic polyps had no visible surface patterns or large 
non-compact pits. Again there was some overlap with some adenomas having no visible 
surface pattern or large non-compact pits. However the majority of adenomas  
demonstrated small compact regular, tubular or branched pits. 
In a small number of images one or more features could not be adequately assessed. 
 
4.2.4 Discussion 
The features that were found to be visible in this series are broadly similar to those 
described in previous similar studies using i-Scan, as well those using FICE and NBI  
described in the introduction to this chapter. It appears that i-Scan therefore highlights 
similar characteristics of small colonic polyps to FICE/NBI. 
In general adenomatous polyps viewed with i-Scan 3 tend to demonstrate the following 
features:- 
• Hypervascularity 
• Dense regular pericryptal vessels 
• Small compact regular tubular/branched pits 
And hyperplastic polyps demonstrate the following features:- 
• Isovascularity or Hypovascularity 
• No visible vessels or occasionally fine vessels not following the edge of crypts 
• No visible surface pattern or large non-compact pits 
When vascularity alone is used as a discriminator, accuracy is approximately 70%, and is 
similar to that reported when white light endoscopy is used in isolation for polyp 
characterisation156, 160, 161, 218. It is likely that the usefulness of vascularity, as a 
discriminator between adenomatous and hyperplastic polyps, is dependent on polyp size. 
As demonstrated by these results, small and diminutive adenomatous polyps are often 
isovascular or even hypovascular and hence can easily be mistaken as hyperplastic polyps. 
The grading of vascularity in the NAC classification system is akin to VPI and VCI  
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described by East and Rogart respectively152, 214 and the grading of colour in the NICE 
classification system223. Rogart et al also noted in their study using NBI that 19% of 
adenomatous polyps had light VCI and 29% of non-adenomatous polyps had medium VCI. 
Hence to make a more accurate diagnosis, inspection of other features, namely vascular 
and surface patterns is required. 
The presence of dense regular pericryptal vessels and/or small compact regular, tubular 
or branched pits, is highly suggestive of adenomatous histology. In this series these 
features were found in approximately two-thirds of adenomas, but almost never in 
hyperplastic polyps. Hence it appears that these features have a high positive predictive 
value for adenomatous histology. 
In our adapted NAC classification system the finding described as dense regular 
pericryptal vessels is likely to equate to the “brown vessels surrounding white structures” 
described in the NICE classification223 using non-magnifying NBI. Similarly the 
classification of surface patterns in the NAC classification system is similar to that 
described in the NICE classification for NBI223, the NBI/i-Scan combined classification160 
and Kudo’s pit patterns. 
What the results of this study also demonstrate is that there is some overlap of features 
suggestive of neoplastic and non-neoplastic histology. Some of this may be accounted for 
by interpretation of the observer and may vary between different endoscopists. Polyps 
which display features not typically associated with their histological type will pose a 
greater challenge to an endoscopist attempting to make an optical diagnosis. In some 
cases the vascular patterns and surface patterns may be discordant, being suggestive of 
opposing histological diagnoses. This is the rationale behind the inclusion of confidence 
ratings in the ASGE PIVI statement regarding diminutive colon polyps – polyps not 
displaying diagnostic features, or conflicting features, should be assigned low confidence 
assessments and managed according to formal histopathology, rather than optical 
diagnosis251. 
Given that many of the diagnostic features of SCPs/DCPs described in studies using NBI, 
FICE and i-Scan are very similar, there is potential for adoption of a universal classification 
system, such as the NAC or NICE classification systems, for use with all 3 advanced 
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imaging modalities. Agreement on a universal classification system would help 
standardise assessment of polyps in vivo and aid teaching and training in optical 
diagnostic techniques. 
Following this initial study to develop a system for small colonic polyp characterisation 
with i-Scan, we proceeded to validate this characterisation system and also analyse the 
separate components of i-Scan. 
 
 
4.3 Validating the system for characterising small colonic polyps with i-Scan 
and analysing separate i-Scan components 
 
4.3.1 Aims 
The aim of this study was to validate the criteria developed for characterising small 
colonic polyps with i-Scan and to determine the effectiveness of the separate 
components of the i-Scan system in visualising polyp features and predicting histology. 
 
4.3.2 Methods 
A separate series of digital images of 100 small colonic polyps (50 adenomatous and 50 
hyperplastic) were captured from patients attending for BCSP colonoscopy.  All patients 
gave informed consent for anonymised use of images for study and training purposes.  
As this was a pilot study and following advice from a clinical statistician, no formal power 
calculations were considered appropriate. A probability value of P<0.05 was considered 
to be statistically significant and as this was a hypothesis generating study, no corrections 
were made for multiple comparisons. 
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Methods for polyp cleansing prior to image capture, the Pentax endoscopy equipment 
and image capture techniques, were identical to those described in the earlier part of this 
chapter. In this study images of each polyp were captured in 3 different i-Scan modes:- 
• i-Scan 1 – Surface & Contrast enhancement – SE+3/CE+4 
• i-Scan 2 – Tone enhancement ‘colon’ 
• i-Scan 3 – Surface, Contrast and Tone enhancement – SE+3/CE+4/TE ‘colon’ 
 
As described in chapter 2, surface and contrast enhancement are designed to highlight or 
sharpen dark-light borders and are designed to work in conjunction. Tone enhancement is 
more akin to NBI or FICE in that it is a digital colour filter, reducing red wavelengths of 
light and accentuating blue and green wavelengths. The i-Scan system allows 
manipulation of each setting with a range of settings from +1 to +6 for SE and CE. Six 
different tone enhancement modes are available, including those designed for the 
diagnosis of ‘Barrett’s oesophagus’ and ‘Gastric pathologies’. Red, green and blue light 
manipulation varies between the 6 different modes. Following a period of familiarisation 
with the i-Scan system, experimentation with all settings when viewing normal colonic 
mucosa and colonic polyps was undertaken. The above settings were chosen as the 
optimal settings for each of the three i-Scan components by the study endoscopist who 
has extensive experience in colonic in-vivo diagnostic techniques (>5,000 colonoscopies). 
Ideally one would wish to analyse the performance of all possible combinations of i-Scan 
settings, but with 216 possible combinations, this was not feasible. 
In total 300 images were captured, with 3 images taken of each polyp, one with each i-
Scan mode. 
 
Images were then collated into a Microsoft Powerpoint presentation, randomised using a 
computer generated shuffled number sequence (GraphPad, SanDiego, USA). Images were 
then viewed separately and independently by two endoscopists with experience of in vivo 
diagnostic techniques (>200 colonoscopies performed using advanced imaging 
techniques) who had not participated in the first part of the study and were blinded to 
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the definitive histopathological diagnosis for each lesion. All lesions were assessed for 
vascularity, vascular patterns and surface patterns using the features described in the first 
study. Both endoscopists also made a prediction of histological diagnosis based on the 
assessment of all three factors. 
 
4.3.3 Results  
Table 26 - Features of adenomatous polyps visible with i-Scan 1, 2 and 3 rated by two endoscopists.Scores are the 
combined scores of the two endoscopists. 
Adenomatous Polyps i-Scan 1 (SE+CE) i-Scan 2 (TE) i-Scan 3 (SE+CE+TE) 
Vascularity 
• Hypovascular 
• Isovascular 
• Hypervascular 
 
24/100 (24%) 
34/100 (34%) 
42/100 (42%) 
 
12/100 (12%) 
8/100 (8%) 
80/100 (80%) 
 
8/100 (8%) 
18/100 (18%) 
74/100 (74%) 
Vascular Patterns 
• No visible vessels 
• Fine vessels not 
following                       
the edges of crypts 
• Dense regular 
pericryptal    vessels 
• Unable to assess 
 
26/100 (36%) 
11/100 (11%) 
 
 
59/100 (59%) 
 
4/100 (4%) 
 
15/100 (15%) 
4/100 (4%) 
 
 
81/100 (81%) 
 
0/100 (0%) 
 
13/100 (13%) 
5/100 (5%) 
 
 
82/100 (82%) 
 
0/100 (0%) 
Surface patterns 
• No surface patterns 
• Large non-compact 
pits 
• Small compact regular, 
tubular or branched 
pits 
• Unable to assess 
 
26/100 (26%) 
11/100 (11%) 
 
61/100 (61%) 
 
 
2/100 (2%) 
 
8/100 (8%) 
7/100 (7%) 
 
83/100 (83%) 
 
 
2/100 (2%) 
 
9/100 (9%) 
7/100 (7%) 
 
81/100 (81%) 
 
 
3/100 (3%) 
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Table 27 - Features of hyperplastic polyps visible with i-Scan 1, 2 and 3 rated by two endoscopists. Scores are the 
combined scores of the two endoscopists. 
Hyperplastic Polyps i-Scan 1 (SE+CE) i-Scan 2 (TE) i-Scan 3 (SE+CE+TE) 
Vascularity 
• Hypovascular 
• Isovascular 
• Hypervascular 
 
59/100 (59%) 
31/100 (31%) 
10/100 (10%) 
 
52/100 (52%) 
26/100 (26%) 
22/100 (22%) 
 
51/100 (51%) 
27/100 (27%) 
22/100 (22%) 
Vascular Patterns 
• No visible vessels 
• Fine vessels not 
following                       
the edges of crypts 
• Dense regular 
pericryptal    vessels 
• Unable to assess 
 
54/100 (54%) 
32/100 (32%) 
 
 
12/100 (12%) 
 
2/100 (2%) 
 
44/100 (44%) 
39/100 (39%) 
 
 
14/100 (14%) 
 
3/100 (3%) 
 
34/100 (34%) 
53/100 (53%) 
 
 
11/100 (11%) 
 
2/100 (2%) 
Surface patterns 
• No surface patterns 
• Large non-compact 
pits 
• Small compact regular, 
tubular or branched 
pits 
• Unable to assess 
 
62/100 (62%) 
25/100 (25%) 
 
10/100 (10%) 
 
 
3/100 (3%) 
 
46/100 (46%) 
41/100 (41%) 
 
11/100 (11%) 
 
 
2/100 (2%) 
 
49/100 (49%) 
36/100 (36%) 
 
12/100 (12%) 
 
 
3/100 (3%) 
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Table 28 - Sensitivity (for adenomatous histology), specificity and overall accuracy of 100 polyps viewed with i-Scan 1, 2 
and 3 rated by two endoscopists. 
Diagnostic Accuracy i-Scan 1 (SE+CE) i-Scan 2 (TE) i-Scan 3 (SE+CE+TE) 
Sensitivity 
Endoscopist A 
Endoscopist B 
Total, % (95%CI) 
 
28/50 (56%) 
41/50 (82%) 
69/100,69% (59-77%) 
 
44/50 (88%) 
42/50 (84%) 
86/100,86% (78-92%) 
 
41/50 (82%) 
46/50 (92%) 
87/100, 87% (79-92%) 
Specificity 
Endoscopist A 
Endoscopist B 
Total, % (95%CI) 
 
43/50 (86%) 
46/50 (92%) 
89/100, 89% (81-94%) 
 
41/50 (82%) 
46/50 (92%) 
87/100, 87% (79-92% 
 
41/50 (82%) 
47/50 (94%) 
88/100,88% (80-93%) 
Accuracy 
Endoscopist A 
Endoscopist B 
Total, % (95%CI) 
 
71/100 (71%) 
87/100 (87%) 
158/200, 79%(73-84%) 
 
85/100 (85%) 
88/100 (88%) 
173/200, 86.5%(81-
91%) 
 
82/100 (82%) 
93/100 (93%) 
175/200,87.5%(82-91%) 
 
The majority of adenomatous polyps in this series were rated as hypervascular by the two 
endoscopists when viewed with i-Scan 2 or 3 which are the two i-Scan modes which 
include tone enhancement. However when viewed with i-Scan 1 only 42% of polyps were 
rated as hypervascular. Comparison using Fisher’s exact test demonstrates that there is a 
statistically significant difference in the proportion of adenomas rated as hypervascular 
between i-Scan 1 and 2 (P<0.001) and between i-Scan 1 and 3 (P<0.001). No significant 
difference was found between i-Scan 2 and 3 (P=0.401). 
In this series 74% of adenomatous polyps viewed with i-Scan 3 were rated as 
hypervascular compared to 60% rated by the endoscopist in the first study.  
i-Scan mode also influenced the ratings of vascular patterns in adenomatous polyps. Of 
the adenomas viewed with i-Scan 1, 36% were rated as having no visible vessels, but this 
fell to 15% and 13% with i-Scan 2 and 3 respectively. There was a corresponding increase 
in the proportion of adenomas rated as having dense regular pericryptal vessels (59%, 
81% and 82% for i-Scan 1, 2 & 3 respectively). The differences between i-Scan 1 and 2 
(P=0.001) and i-Scan 1 and 3 (P<0.001) were statistically significant. 
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Rating of surface patterns in adenomas also differed depending on i-Scan mode used. 
More adenomas viewed with i-Scan 1 were rated as having no visible surface patterns, 
compared to those viewed with i-Scan 2 or i-Scan 3. There was a corresponding increase 
in the proportion of polyps rated as having ‘Small compact regular, tubular or branched 
pits’. The difference in proportion of adenomas with no visible surface pattern between i-
Scan 1 and 2 was statistically significant (P=0.001), as was the difference between i-Scan 1 
and 3 (P=0.003). There was no significant difference between i-Scan 2 and 3 (P=1.00). 
In the assessment of hyperplastic polyps use of i-Scan 2 or 3 led to a greater proportion of 
polyps being classified as hypervascular. The difference between i-Scan 1 and i-Scan 2/3 
were statistically significant (P=0.03). 
The proportion of hyperplastic polyps with no visible vessels did not differ significantly 
between i-Scan 1 and 2 (P=0.203) or i-Scan 2 and 3 (P=0.192), but did between i-Scan 1 
and 3 (P=0.006). Correspondingly the proportion of hyperplastic polyps with ‘fine vessels 
not following the edges of crypts’ was greatest with i-Scan 3.  
When surface patterns in hyperplastic polyps were assessed more polyps viewed with i-
Scan 1 were rated as having no visible surface patterns, compared to i-Scan 2 or i-Scan 3. 
The difference in this proportion between i-Scan 1 and 2 was statistically significant 
(P=0.033), but not between i-Scan 1 and i-Scan 3 (P=0.088) or between i-Scan 2 and i-Scan 
3 (P=0.777). There was a corresponding increase in the proportion of hyperplastic polyps 
rated as having large non-compact pits. Interestingly 10-12% of hyperplastic polyps were 
judged to have small compact regular, tubular or branched pits which are typically 
associated with adenomatous histology. 
Compared to i-Scan 1 assessments mean sensitivity for adenomatous histology was 
significantly higher with i-Scan 2 (P=0.006), and with i-Scan 3 (P=0.003). There was no 
significant difference in sensitivity between i-Scan 2 and i-Scan 3 assessments (P=1.000). 
No significant differences in specificity were found between the 3 i-Scan modes (i-Scan 1 
vs i-Scan 2 P=0.828, i-Scan 1 vs i-Scan 3 P=1.000, i-Scan 1 vs i-Scan 3 P=1.000). 
Overall accuracy increased from 79% with i-Scan 1 to 86.5% with i-Scan 2 and 87.5% with 
i-Scan 3. There was no significant difference in overall accuracy between i-Scan 1 and i-
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Scan 2 (P=0.063) or i-Scan 2 and i-Scan 3 (P=0.882). However there was a significant 
difference between i-Scan 1 and i-Scan 3 assessments (P=0.032).  
 
4.3.4 Discussion 
The results of this study validate the criteria developed for assessment of small colonic 
polyps with i-Scan. The adapted NAC criteria for characterising small colonic polyps using 
i-Scan, developed in the first study described in this chapter, were applied to a different 
image library by two different endoscopists. The results were very similar in terms of the 
frequency with which each diagnostic feature was found in adenomatous and 
hyperplastic polyps. They also enabled the endoscopists to make an accurate prediction 
of histopathology based on the overall assessment. 
 
In general, data from this study suggests that adenomatous polyps tend to demonstrate 
the following features:- 
• Hypervascularity 
• Dense regular pericryptal vessels 
• Small compact regular tubular/branched pits 
And hyperplastic polyps demonstrate the following features:- 
• Isovascularity or Hypovascularity 
• No visible vessels or occasionally fine vessels not following the edge of crypts 
• No visible surface pattern or large non-compact pits 
 
More adenomatous polyps were rated as hypervascular in this series compared to the 
first study (74% vs 60%). This may represent a different spectrum of adenomatous polyps, 
or differences between endoscopists in their assessment of vascularity. Where the line 
between isovascular and hypervascular is drawn involves a certain degree of subjectivity. 
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The proportion of adenomas rated as being hypervascular was significantly higher when 
viewed with i-Scan 2/3 compared to i-Scan 1. This suggests that the tone enhancement 
feature of i-Scan accentuates differences in vascularity between adenomas and the 
surrounding normal mucosa. 
It is notable that, as was found in the first study, 22% of hyperplastic polyps viewed with i-
Scan 3 were rated as being hypervascular. Hypervascularity is a feature strongly 
associated with adenomatous polyps but clearly can also be found in hyperplastic polyps. 
Therefore, relying on vascularity alone to make an in-vivo characterisation is not 
sufficient, and other visible features also need to be assessed. 
The application of tone enhancement also appears to improve the visibility of surface and 
vascular patterns in adenomas in comparison to SE/CE alone.  
In the assessment of hyperplastic polyps, application of combined SE, CE and TE (i-Scan 3) 
appeared to accentuate the visibility of fine vessels not following the edges of crypts. TE 
alone (i-Scan 2) did not make a significant difference compared to SE/CE (i-Scan 1).  
In terms of overall assessment of polyp histology in this study it appears that TE improves 
recognition of adenomas in comparison to SE/CE. However TE does not appear to 
improve recognition of hyperplastic polyps. When overall accuracy was assessed, the 
combination of SE/CE/TE was significantly more accurate than SE/CE but did not differ 
from TE alone. In similar findings Hong et al found that use of all 3 i-Scan components 
(SE/CE/TE) together resulted in significantly higher accuracy for assessing SCPs than 
HDWL, but no significant difference was found between SE+CE and HDWL accuracy161. 
Thus it appears that the feature of i-Scan that offers the main gains in terms of improving 
visibility of diagnostic features and overall prediction of histology is tone enhancement. 
The main gains in prediction of histology are in recognition of adenomas, whereas TE 
does not appear to have an influence on recognition of hyperplastic polyps. 
These findings are in keeping with several other studies that found a significant 
improvement in sensitivity over white light when advanced spectral filter based imaging 
techniques were applied, but no significant change in specificity. This phenomenon does 
not seem to be limited to studies with i-Scan160, 161, but has also been reported in several 
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studies using FICE158, 193, 228 and NBI191, 207, 214. Longcroft-Wheaton et al found that both 
sensitivity and specificity were significantly higher with FICE compared to white light 
when all polyps <10 mm were analysed, but that only sensitivity was significantly higher 
in the subgroup of polyps <5 mm in size156.  
Therefore the main benefit of optical or digital filter technologies, such as i-Scan TE, FICE 
or NBI, may be an ability to accentuate the appearance of small pericryptal capillary 
vessels found in many adenomatous polyps, and hence improve recognition of 
adenomatous polyps, thus avoiding ‘false negative’ calls. 
The limitations of this study were that pictures were assessed ‘off-line’ rather than in real 
time. A still image may not demonstrate all the features that can be assessed in vivo. Care 
was taken to produce and select high quality images, and this is reflected in the fact that 
in only a very small percentage of cases, vascular and surface patterns could not be 
assessed. This study was performed with two endoscopists both of whom had experience 
of in vivo diagnostic techniques, and hence it is not clear whether the findings would 
apply to all endoscopists. 
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Chapter 5 – Invivo study of high definition white light 
endoscopy, i-Scan and Indigo carmine for the in-vivo 
characterisation of small colonic polyps 
 
5.1 Introduction 
Colonoscopy and removal of adenomatous polyps is effective at reducing future risk of 
colorectal cancer40. The majority of polyps found at colonoscopy are small (<10 mm) or 
diminutive (≤5 mm)244, 250. The traditional paradigm is that white light endoscopy cannot 
reliably distinguish between small adenomatous and hyperplastic polyps, so at present, 
standard practice is to remove all such polyps and submit them for histopathological 
analysis.  
If a sufficiently accurate in vivo assessment of polyps can be made this may allow 1) 
adoption of a ‘resect and discard’ policy for diminutive (≤5 mm) colonic polyps, (DCPs), 
thus reducing pathology costs, and 2) the endoscopist to leave in situ diminutive 
rectosigmoid hyperplastic polyps, which have negligible malignant potential. The ASGE 
has identified this as a key area for new endoscopic technologies and has set 
performance thresholds which technologies should aim to meet 251. 
Dye based chromoendoscopy and digital ‘virtual chromoendoscopy’ techniques such as 
Narrow-Band Imaging (NBI) and Fujinon Intelligent Colour Enhancement (FICE) have all 
been shown to improve the accuracy of distinguishing between neoplastic and non-
neoplastic SCPs152, 155, 156, 158, 160, 161, 187, 190, 215, 216. 
In studies limited to the assessment of SCPs (i.e. those excluding lesions >10 mm) overall 
diagnostic accuracies of 61-84% have been reported with white light endoscopy alone 156, 
158, 160, 161, 185, 187, 190, 215. The use of indigo carmine chromoendoscopy improves accuracy to 
80-95% 156, 158, 187, 190, with similar results reported with NBI (88-94%)152, 160, 215, 216 and FICE 
(80-87%)155, 156, 158. 
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Pentax i-Scan is a novel virtual chromoendoscopy system designed to enhance surface 
and vascular patterns to improve in-vivo assessment. It combines use of high-definition 
white light (HDWL) endoscopy with enhancement of dark-light borders and manipulation 
of the red, blue and green components of light. Examples of polyps viewed in HDWL and 
i-Scan modes are shown in figures 48 & 49. 
Preliminary studies with i-Scan have shown it to be effective in the in vivo 
characterisation of colonic lesions162, 231 and small colonic polyps specifically160, 161. 
 
  
Figure 48 - Adenomatous polyp viewed with HDWL (left image) and i-Scan (SE+3, CE+2, TE colon – right image) 
 
 
Figure 49 - Hyperplastic polyp viewed with HDWL (left image) and i-Scan (SE+3, CE+2, TE colon – right image) 
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5.2 Aims 
The aim of this study was to compare the performance of HDWL endoscopy, HDWL plus i-
Scan and indigo carmine chromoendoscopy for the assessment of SCPs in vivo, and to 
determine whether i-Scan assessment can fulfil the ASGE criteria for assessment of DCPs. 
 
5.3 Methods 
The study was approved by the local research and ethics committee and registered at 
ClincalTrials.gov (NCT 01761279). Endoscopy equipment used was on loan to the 
department from Pentax Medical UK for evaluation. 
This was a prospective single centre cohort study. Patients attending for colonoscopy 
through the UK Bowel Cancer Screening Programme (BCSP) from May 2011 to May 2012 
were prospectively recruited and informed consent was obtained. The UK BCSP offers 
Guaiac-based faecal occult blood test (FOBt) to adults aged 60-74, with colonoscopy 
offered to those with a positive FOBt. 
The primary outcome was overall diagnostic accuracy of in-vivo assessment of SCPs. 
Secondary outcomes were the specificity and sensitivity for adenomatous histology, and 
the negative predictive value for adenomatous histology of diminutive rectosigmoid 
polyps. The accuracy of prediction of polyp surveillance intervals based on in-vivo 
assessment of all DCPs combined with histology of polyps >5 mm was also assessed. 
Prior to commencement of the study, the endoscopist underwent a period of 
familiarisation with the endoscope and imaging technology, including development of a 
novel classification system for assessment of colonic polyps using i-Scan. This 
classification system was adapted from a previously described classification system 
“N.A.C.” which was developed for assessment of all colonic mucosal lesions as described 
in the previous chapter255-257. A total 100 polyps were assessed by the study endoscopist, 
documenting features predictive of neoplastic or non-neoplastic histology as described in 
chapter 4 and set out in table 29 and figure 50. This was validated on a further 100 polyps 
by two other investigators who recorded vascular and surface patterns, which were 
compared to the final histopathology.  
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Table 29 - NAC classification system adapted for i-Scan 
 Neoplastic Non-neoplastic 
Vascular patterns Dense regular 
pericryptal vessels 
No vessels, or fine 
vessels not following 
edges of pits 
Surface Patterns Small compact regular 
round / 
tubular/branched pits 
No surface patterns, 
or large non-compact 
pits 
 
 
 
Figure 50  - Adapted NAC Classification SystemExamples: a – dense regular pericryptal vessels, b – several fine thread 
vessels not following the edges of pits, c – small compact regular round pits, d – large non-compact pits, e – tubular and 
branched pits, f – no visible surface patterns 
 
Prospective sample size calculations were performed with an expected HDWL accuracy of 
75% and i-Scan and chromoendoscopy accuracies of 85%. Using power (1−β) of 80% and a 
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two−sided significance level (α) of 0.05, 198 polyps were required to demonstrate a 
significant difference between HDWL and i-Scan. A 5% increase was made to allow for lost 
or non-retrieved specimens giving a final target of 208 polyps. 
 
Statistical analysis was performed using SPSS v20 (IBM, Portsmouth, UK). McNemar’s test 
for repeated measures was used to compare accuracy, sensitivity and specificity between 
HDWL, iScan and chromoendoscopy.  
All procedures were performed by a single endoscopist (PZB) with extensive experience in 
in vivo characterisation of colonic polyps. Pentax EC-3890Li 1.2 Megapixel HD+ 
colonoscopes were used linked to an EPKi processor (Pentax Medical, UK). The endoscope 
image was transmitted between processor and screen by an HD connection, and 
displayed on a high definition monitor capable of displaying 1080 horizontal lines. 
Colonoscopy was performed either without sedation or under conscious sedation with 
midazolam (0.5-2.5mg and pethidine (25-50mg).  The endoscope was first inserted to the 
caecum in HDWL mode. Polyps <10 mm in size found on withdrawal of the colonoscope 
were assessed.  Firstly the polyp was flushed with a solution of water, simethicone and n-
acetylcysteine to remove any excess stool, mucus and bubbles. Each polyp was then 
assessed sequentially using HDWL endoscopy followed by i-Scan surface, contrast and 
tone enhancement modes (i-Scan 1 = SE+3 CE +4, i-Scan 2 = SE+1, TE colon, i-Scan 3 = 
SE+3, CE+2, TE colon) and finally chromoendoscopy using 0.5% indigo carmine. Polyp 
location, size (as compared to open biopsy forceps or snare) and morphology258 was 
noted. A prediction of polyp histology (Neoplastic vs Non-neoplastic) was first made by 
the endoscopist following HDWL assessment and again following assessment with i-Scan 
modes and finally following chromoendoscopy. The endoscopist also indicated whether 
the overall in vivo assessment was made with high or low confidence. Predicted histology 
was subsequently compared to the final histopathological diagnosis, as reported by a 
Bowel Cancer Screening Programme accredited histopathologist who was not aware of 
the results of the in vivo assessment. 
Patients were excluded from the study for the following reasons; poor bowel preparation, 
polyposis syndrome and inflammatory bowel disease. Polyps were not included in the 
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study if they were ≥10 mm in diameter, or if polyp tissue was not retrieved for histological 
analysis. 
 
5.4 Results 
5.4.1 Study population  
A total of 107 patients were screened for inclusion in the study of which 23 were 
excluded (19 no polyps found, 2 inflammatory bowel disease, 2 stricturing colorectal 
cancer). The remaining 84 patients were included, of which 29 were female and 55 male.  
 
5.4.2 Polyp size, morphology, location and histology 
A total of 271 colonic polyps were found, of which 62 were excluded from the main 
analysis (≥10 mm in size = 32, low confidence assessment = 29, lost specimen = 1). 
Therefore 209 polyps ≤10 mm in size were included in the main analysis. Mean polyp size 
was 4.3 mm, median 4 mm and standard deviation 2.2 mm.  
Only 7 of the 209 polyps were pedunculated (Ip) with the remainder being sessile (Is, 
n=90) or flat-raised (IIa, n=112) according to the Paris classification of gastrointestinal 
lesion morphology258. Of the 209 polyps, 75 (35.9%) were non-neoplastic and 134 (64.1%) 
neoplastic. Of the polyps included, 43% were found in the right colon (transverse, 
ascending and caecum) – see table 30. 
Table 30- Polyp location and histology. SSP – sessile serrated polyp. 
Location Caecum/ 
Ascending colon 
Transverse 
colon 
Descending 
colon 
Sigmoid/Rectum Total 
Histology 
Adenomatous 36 39 16 41 132 
Hyperplastic 3 5 6 48 62 
Normal mucosa 1 4 2 2 9 
Inflammatory 1 0 1 2 4 
SSP 0 0 0 2 2 
Total 41 48 25 95 209 
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5.4.3 In-vivo characterisation results – all polyps 
Overall diagnostic accuracy for high confidence in-vivo assessments of SCPs using HDWL 
was 93.3%, compared to 94.7% with i-Scan and 95.4% with chromoendoscopy, with no 
significant difference between the three modes of assessment – see table 31. Similarly 
there was no significant difference between HDWL, i-Scan and chromoendoscopy in 
sensitivity and specificity for adenomatous histology. Only 7 polyp diagnostic assessments 
were changed between HDWL and i-Scan imaging and 3 changed between i-Scan and 
chromoendoscopy assessments. 
Table 31 - Results of in-vivo characterisation with HDWL, i-Scan and chromoendoscopy for all polyps, n=209. 
 HDWL 
Correct/Total 
% & 95% CI 
i-Scan 
Correct/Total 
% & 95% CI 
Chromoendoscopy 
Correct/Total 
% & 95% CI 
P value 
HDWL vs 
i-Scan 
P value 
HDWL vs 
Chromo 
P value        
i-Scan vs 
Chromo 
Accuracy 195/209 
93.3% 
(88.5-96.3%) 
198/209 
94.7% 
(90.3-97.2%) 
199/209 
95.2%  
(90.9-97.6%) 
1.000 1.000 1.000 
Sensitivity 128/134 
95.5% 
(91.8-97.8%) 
130/134 
97.0% 
(93.6-98.9%) 
130/134 
97.0%  
(93.6-98.9%) 
0.500 0.625 1.000 
Specificity 67/75 
89.3% 
(82.7-93.5%) 
68/75 
90.7% 
(84.5-94.0%) 
69/75 
92.0%  
(85.9-95.3%) 
1.000 0.625 1.000 
 
 
5.4.4 In-vivo characterisation results – diminutive polyps 
A sub-analysis of the results for high confidence assessments of diminutive polyps 
(≤5 mm, n=172) revealed overall diagnostic accuracy of 92.4% with HDWL, 94.2% with i-
Scan and 94.2% with chromoendoscopy - see table 32. Again there was no significant 
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difference between HDWL, i-Scan and chromoendoscopy in accuracy, sensitivity or 
specificity. 
Table 32 - Results of in-vivo characterisation with HDWL, i-Scan and chromoendoscopy for polyps ≤5mm, n=172. 
 HDWL 
Correct/Total 
% & 95% CI 
i-Scan 
Correct/Total 
% & 95% CI 
Chromoendoscopy 
Correct/Total 
% & 95% CI 
P value 
HDWL vs 
i-Scan 
P value 
HDWL vs 
Chromo 
P value        
i-Scan vs 
Chromo 
Accuracy 159/172 
92.4% 
(86.9-95.8%) 
162/172 
94.2% 
(92.8-99.2%) 
162/172 
94.2% 
(92.8-99.2%) 
1.000 1.000 0.500 
Sensitivity 98/103 
95.1% 
(90.5-97.9%) 
100/103 
97.1% 
(92.8-99.2%) 
99/103 
96.1% 
(91.8%-98.5%) 
0.500 1.000 1.000 
Specificity 61/69 
88.4% 
(81.5-92.6%) 
62/69 
89.9% 
(83.5-93.0%) 
63/69 
91.3% 
(84.8-94.9%) 
1.000 0.625 1.000 
Negative 
Predictive 
Value 
(Rectosigmoid 
polyps only) 
46/46 
100% 
(92.8-100%) 
48/48 
100% 
(93.4-100%) 
48/48 
100% 
(93.4-100%) 
   
 
The negative predictive value for adenomatous histology of diminutive rectosigmoid 
polyps was 100% with all 3 modalities.  
 
5.4.5 Results of low confidence assessments 
A total of 29 low confidence polyp assessments were made. The actual histological 
diagnosis of these polyps is shown in table 33. Mean polyp size was 3.1 mm with a 
standard deviation of 1.7 mm. This was significantly lower than the mean size of polyps 
with a high confidence assessment when compared using an unpaired t-test (P=0.005). 15 
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of the 29 polyps with low confidence assessments were located in the right colon 
(Caecum/ascending/transverse) and 14 in the left colon (descending/sigmoid/rectum). 
When compared using Fisher’s exact test the proportion of polyps with low confidence 
assessments in the right colon (15/29) did not differ from that in polyps with high 
confidence assessments (89/209), (P=0.425). 
Table 33 - Final histology of 29 polyps with low confidence in-vivo assessments. 
Hyperplastic 13 
Normal mucosa 2 
Adenoma 12 
Lymphoid aggregate 1 
Pseudolipomatosis 1 
Total 29 
 
5.4.6 Surveillance intervals 
Polyp surveillance intervals were calculated based on the British Society of 
Gastroenterology (BSG) and American Gastroenterological Association (AGA) guidelines 
for adenoma surveillance following colonoscopy43, 252. One case was excluded from this 
analysis as a single polyp was not retrieved for histological analysis. Intervals were 
calculated based on the in-vivo assessments for all DCPs combined with histopathology 
results for all polyps >5 mm in size, as set out in the ASGE PIVI document251. Predicted 
intervals with in vivo assessment were compared to those made with standard 
histopathology of all polyps. Surveillance intervals were in agreement in 78 of 83 cases 
with HDWL (93.9%), 80 of 83 cases with i-Scan (96.4%) and 80 of 83 cases (96.4%) with 
chromoendoscopy using the BSG guidelines. With HDWL assessment 4 patients would 
return for surveillance colonoscopy earlier than the interval determined by standard 
histopathology, and a single patient would return at 5 years rather than 3 years. With i-
Scan assessment 2 patients would return earlier, and a single patient would have been 
brought back at 5 years rather than 3 years. The outcomes with chromoendoscopy were 
identical to those with i-Scan – see table 34. 
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Table 34 - Patients in whom surveillance interval using optical diagnosis of DCPs with high confidence assessments 
differed from that determined by histopathology as per BSG guidelines 
Patient Histopathology HDWL i-Scan Chromoendoscopy 
1 No surveillance 5 years 5 years 5 years 
2 5 years 3 years 3 years 3 years 
3 5 years 3 years 5 years 5 years 
4 No surveillance 5 years No surveillance No surveillance 
5 3 years 5 years 5 years 5 years 
 
5.5 Discussion 
The results of this study demonstrate that the use of HDWL with i-Scan image 
enhancement can enable an endoscopist to make a highly accurate distinction between 
neoplastic and non-neoplastic SCPs. They fulfil the criteria set out in the ASGE PIVI 
statement with a 97.2% accuracy in predicting polyp surveillance intervals, the target PIVI 
threshold for a ‘Resect and Discard’ policy being 90%, and a negative predictive value for 
adenomatous histology of rectosigmoid DCPs of 100%, the target PIVI threshold for a ‘Do 
not Resect’ policy being 90%. 
The results with i-Scan assessment are in keeping with those from other similar studies 
using i-Scan158, 161, 216 and those utilising similar technologies such as NBI160, 161, 187, 215, 217 
and FICE155, 217. They add to the growing body of evidence for the use of advanced 
endoscopic imaging for the assessment of DCPs. No significant improvement in in-vivo 
diagnostic performance was achieved with the use of chromoendoscopy following 
HDWL/i-Scan assessments. Although the study was not powered to show a difference 
between i-Scan and chromoendoscopy it is unlikely that any clinically significant 
difference would have been demonstrated, even in a much larger study, given that the 
results obtained with the two modalities were nearly identical. 
Where the results of this study differ from those of previous similar work is in the high 
level of accuracy achieved with high definition white light endoscopy. The accuracy level 
achieved with HDWL did not differ significantly from that with an advanced imaging 
technique (i-Scan), or chromoendoscopy. The vast majority of studies that have compared 
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white light endoscopy with advanced imaging/chromoendoscopy have found a significant 
difference between the two. A few other studies have found no significant difference 
between white light endoscopy and another technique. Apel et al compared standard 
definition white light endoscopy and non-magnifying chromoendoscopy for assessment of 
diminutive rectosigmoid polyps and found no significant difference in accuracy between 
the two techniques (81% vs 83%, P=0.686)198. Vu et al studied in-vivo characterisation by 
community and academic endoscopists using HDWL +/- NBI where required226. Accuracy 
of in-vivo assessments was 82.5% with HDWL compared to 73.9% with NBI (P=0.02). 
However NBI may have been used predominately for more difficult to assess polyps 
which could not be easily classified with HDWL. 
The question of whether neoplastic and non-neoplastic colonic polyps can be 
distinguished by making an ‘optical diagnosis’ has been posed by endoscopists since the 
1980s. Studies using fibreoptic colonoscopes, or early video colonoscopes, achieved 
diagnostic accuracy rates of 75-83% 183-185, although these were limited to sigmoidoscopy 
rather than full colonoscopy. Somewhat surprisingly, the diagnostic accuracy of white 
light endoscopy for the same aim has changed little over the intervening decades. Despite 
the advances in endoscopic and imaging technology, similar accuracy rates of 61-84% 
have been reported in more recent studies 152, 155, 160, 184, 187, 258. Table 35 lists the results 
of studies which have reported outcomes with white light endoscopic assessment. 
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Table 35 - Studies of white light endoscopy for the in-vivo characterisation of colonic polyps. Modality SD = standard 
definition endoscopy, HD = high definition endoscopy, Mag = optical magnification, RT = real-time, P = picture, ** - 
rectosigmoid polyps only 
Author Year Country 
Real-tim
e/ 
Picture study 
Size 
Modality 
(SD/HD/ 
Mag) 
N
eoplastic lesions 
N
on-neoplastic lesions 
Sensitivity. 
%
 
Specificity 
%
 
Accuracy 
%
 
Chapuis 1982 Australia RT 80% 
≤10mm 
Fiberoptic 84 36 84.5 77.8 82.5 
Neale 1987 USA RT NR Fiberoptic 26 55 69.2 85.5 80.2 
Norfleet 1988 USA RT 94% 
≤10mm  
Fiberoptic 289 322 80.0 71.1 75.3 
Fu187 2004 Japan RT Max 10mm SD 160 46 88.8 67.4 84.0 
Machida 2004 Japan RT Max 25mm, 
mean 
7.5mm 
Mag  34 9 85.3 44.4 79.1 
Lawrance 2006 Australia RT NR NR 1988 total 87.4 65.0 73.4 
Su 2006 Taiwan P NR SD & HD 70 40 82.9 80.0 81.8 
Apel198 2006 Germany RT Max 5mm SD 48** 225** 60.4 93.7 87.9 
De Palma 2006 Italy RT Max 5mm, 
mean 
3.6mm 
SD 82 158 91.5 68.4 76.3 
Chiu191 2007 Taiwan P Max 20mm 
Mean 
5.3mm 
SD 141 39 63.6 79.9 67.7 
Tischendorf 2007 Germany 
P – pit 
pattern Mean 
9.9mm 
Mag 
123 77 
63.4 51.9 59 
P –Vasc. 
patterns 
Mag 47.2 97.4 66.5 
Pohl193 2008 Germany P 
Max 20mm 
Mean 
7.7mm 
HD  
89 61 
76.4 65.6 72.0 
Mag 84.3 64.0 76.0 
Sikka 2008 USA P Max 10mm, 
mean 
5.1mm 
HD 49 31 59.0 76.0 66.0 
Rogart 2008 USA RT NR HD 131 134 69.0 86.0 77.0 
Rastogi 2008 USA RT Mean 
4.9mm 
HD 143 93 38.0 97.0 61.0 
Chang 2009 Taiwan P Max 10mm, 
mean 
5.2mm 
HD 82 81 89.6 59.3 74.5 
van den Broek 2009 Netherla-
nds 
P – 
experts 
Mean 
5.5mm 
HD 22 28 56.9 63.0 60.4 
Togashi 2009 Japan RT Max 5mm, Mag 80 27 71.3 81.5 73.8 
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mean 
3.3mm 
Parra-
Blanco195 
2009 Spain P Max 5mm HD 14 5   56.8 
Tischendorf 2010 Germany P Max 20mm, 
mean 7mm 
HD 58 42 43.1 97.6 66.0 
Rastogi 2011 USA 
RT Mean 
5.9mm 
SD 
993 total 
51.7 90.8 68.5 
HD 66.8 85.3 73.2 
Lee 2011 USA 
RT 
Max 5mm 
HD (Olym) 80 76 68.8 90.8 79.4 
HD 
(Pentax) 
74 66 74.3 87.9 80.7 
Kim 2011 Korea RT Max 10mm, 
mean 
4.5mm 
HD 315 210 63.2 83.8 71.4 
Ignjatovic 2011 UK P 
Max 10mm, 
mean 
4.5mm 
HD – 
experts 
40 40 
69.0 60.0 64.0 
HD – Non-
experts 
52.0 29.0 40.0 
Sato 2011 Japan P 6-7mm 
mean 
HD 339 85   69.1 
Kuiper 2012 Netherla
nds 
RT Max 9mm, 
median 
4mm 
HD – all 141 140 72.5 79.7 76.1 
HD – high 
confidence 
178 total 
79.0 84.5 82.0 
Longcroft-
Wheaton 
2012 UK RT Max 10mm, 
mean 
4.7mm 
SD 96 54 76.0 59.0 70.0 
HD 95 48 76.0 67.0 73.0 
Yoshida202 2012 Japan P Max 20mm HD 95 56 74.7 73.2 74.1 
Hong 2012 Korea RT NR HD 62 36 72.6 80.6 75.5 
Chan 2012 USA RT Max 9mm, 
mean 
3.7mm 
HD 54 49 74.1 69.4 71.8 
 
One explanation may be that with the use of video-endoscopy and higher definition 
endoscopes, endoscopists are detecting greater numbers of diminutive sessile and flat 
polyps as discussed in chapter 3.  Due to their size and morphology diminutive polyps 
have more subtle surface and vascular patterns which are more difficult to assess than 
larger lesions. This has been confirmed in studies showing lower sensitivity rates of in-
vivo assessment of smaller polyps152, 160. Another potential confounding factor could be 
bias in favour of any new optical enhancement technology being evaluated over white 
light endoscopy, or publication bias in favour of ‘positive studies’ that reject the null 
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hypothesis and therefore demonstrate an advantage of a new technique over white light 
endoscopy. 
In contrast, this is the first study to demonstrate a diagnostic accuracy in excess of 90% 
for the in-vivo characterisation of SCPs using white light endoscopy.  This study used 
endoscopes with a 1.2 megapixel charge-coupled device and the definition achieved may 
be sufficient to make a highly accurate diagnosis. Adenomatous and hyperplastic polyps 
are distinguished on the basis of vascular and surface patterns and these results suggest 
that these are potentially visible with HDWL endoscopy, thus allowing the endoscopist to 
make an accurate assessment. This contrasts conventional thinking regarding white light 
endoscopy. As these results have not been reproduced in other studies using lower 
definition endoscopes, this may be dependent on using a very high-definition endoscope 
(e.g. above 1 megapixel) plus an extended period of training.  
However these results with HDWL differ somewhat from previous studies of small and 
diminutive colonic polyps using identical processors and 1.2 megapixel endoscopes. Lee 
et al155 reported an overall accuracy using HDWL of 80.7% in distinguishing diminutive 
adenomas from hyperplastic polyps, compared to an accuracy of 92.4% in this study. 
Results from the study by Hong et al160 report that in the analysis of polyps <10 mm the 
overall accuracy rate with HDWL was 72.2%.  
There are several potential explanations for these results. Firstly the experience of the 
endoscopist, and in particular previous experience in vivo diagnostic techniques, is likely 
to heavily influence the performance of any new in vivo diagnostic technology. Prior to 
commencement of this study an extended period of familiarisation plus development and 
validation of a classification system to assess SCPs with i-Scan was carried out. Therefore 
when the study was commenced the endoscopist was very familiar with the technology 
and was likely to have risen up any learning curve involved. The assessments in this study 
were made by a single experienced endoscopist with extensive prior experience in the 
field of in vivo characterisation156, 157. The study by Lee et al was performed by a single 
experienced endoscopist and the study by Hong et al by 3 experienced endoscopists, 
although prior experience of in vivo diagnostic techniques is not reported. Secondly, this 
study followed a strict protocol of cleaning all polyps with a fluid flush of water, 
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simethicone and n-acetylcysteine prior to assessment. The use of this solution, to remove 
mucus and bubbles, may have improved the HDWL assessment by allowing better 
visualisation of surface patterns and vasculature. A third factor which may account for 
some of the difference in observed results is that the three studies were carried out in 
different populations and therefore the morphology and ease of in vivo assessment of 
any polyps encountered may have differed somewhat.  
The results reported by Lee et al differ from this study in that they include both high and 
low confidence assessments. Again, the study from Hong et al did not restrict the results 
to high confidence assessments. In the present study 88% of assessments of SCPs were 
made with high confidence. When both high and low confidence assessments of SCPs are 
combined, overall accuracy with i-Scan falls from 94.7% to 86.9%, more in keeping with 
the result from Lee et al. This would support the ASGE PIVI guidelines that advise that 
only polyps for which a high confidence assessment can be made should be managed 
based on their optical diagnosis.  
This study has limitations; it was carried out in a single centre by a single expert 
endoscopist with extensive previous experience of in-vivo diagnosis, and therefore the 
study needs to be repeated in other centres and by multiple users with different levels of 
experience. As has been discussed in chapter 3, previous studies of in vivo 
characterisation techniques in community settings performed by endoscopists who are 
not enthusiasts in this field have failed to reproduce the results found in academic 
centres219, 221, 226, 235, 254. The HDWL, i-Scan and chromoendoscopy assessments were not 
fully independent, as i-Scan and chromoendoscopy assessments were made with prior 
knowledge of HDWL and HDWL/i-Scan appearances respectively. However this is more 
reflective of a real life situation where polyps are first encountered during white light 
endoscopy before additional techniques are used to characterise them further. The study 
therefore addresses what additional benefit i-Scan adds to a HDWL assessment and what 
benefit chromoendoscopy adds to a combined HDWL/i-Scan assessment. 
It can be argued that in vivo assessment may increase the cost and duration of 
colonoscopy if endoscopy units were to upgrade equipment from SD to HD. However as 
most new endoscope processors are HD quality, and have advanced imaging features, 
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these are likely to become the standard over the next few years. A recent study suggests 
that the additional time taken for in vivo assessments is minimal224. Although time for 
in vivo assessment was not formally measured in this study, the overall experience was 
that the in vivo assessment was performed in the time between finding a polyp and 
preparing for polypectomy and did not cause significant delay. If i-Scan were used for 
optical diagnosis in daily practice, according to the ASGE PIVI criteria, then the additional 
time taken for in vivo assessment may be offset by time saved by avoiding unnecessary 
polypectomy of rectosigmoid hyperplastic polyps. 
This study was performed with optimised conditions for in vivo assessment; 1) An 
extensive period of development and validation of polyp assessment criteria, thus 
allowing the endoscopist to ascend the learning curve involved with a new technology 2) 
Meticulous cleansing of the polyp surface prior to assessment 3) HD capable endoscope, 
processor, connection and monitor 4) An endoscopist experienced in in vivo assessment. 
If any of these factors were not present, then such a high level of accuracy may not have 
been possible. 
The results showed no significant difference in overall accuracy, sensitivity or specificity 
between HDWL, i-Scan and chromoendoscopy. This lack of difference could be in part due 
to a ceiling effect, given the high performance achieved with HDWL. The confidence 
assessment assigned to each polyp was based on the overall assessment made with 
HDWL followed by i-Scan and chromoendoscopy and therefore it is possible that fewer 
high confidence assessments might be made using HDWL alone. This may also be heavily 
influenced by the experience of the endoscopist. In different settings use of i-Scan may 
show significant improvement in accuracy over HDWL alone. Therefore, whether in vivo 
characterisation with HDWL alone is applicable to the wider endoscopy community 
remains to be seen and should be the focus of further studies. 
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Chapter 6 - Comparison between standard definition and 
high definition endoscopy for the detection of colonic 
polyps in the UK Bowel Cancer Screening Programme 
 
6.1 Introduction 
As set out in chapter 2 one of the key quality indicators of colonoscopy is the adenoma 
detection rate. An individual endoscopist’s ADR correlates with risk of interval colorectal 
cancer (CRC) for patients in whom they perform colonoscopy40, 82.  Patients who undergo 
a colonoscopy performed by an endoscopist with a high ADR have a significantly lower 
risk of interval CRC than those whose procedure is performed by an endoscopist with low 
ADR40, 82. The same is true of advanced CRC and CRC-related death82. 
Thus many studies have examined various methods for improving ADR including bowel 
preparation quality85-88, withdrawal time91-94, position changes100-102, 
chromoendoscopy126-130, advanced imaging148, 161 and use of antispasmodics95, 96. 
Steady improvements in the definition or pixel density of endoscopes have taken place in 
recent years. The majority of modern endoscopes now produce a high definition (HD) 
output and are supplied with HD quality monitors. Older standard definition (SD) 
endoscopes have been defined as those with fewer than 650 vertical pixels and high 
definition as greater than 650 vertical pixels259. This improvement in endoscope definition 
has been proposed as a possible method of improving adenoma detection rates. 
Several studies have compared the ADR in colonoscopy performed with standard 
definition endoscopes compared to that using HD endoscopes218, 260-265 – see table 36. Of 
7 studies, 6 have shown no significant difference in ADR between SD and HD endoscopes, 
although the majority have shown a trend towards higher ADR using HD endoscopes. The 
largest study to date by Buchner et al involving 2430 patients did show a significantly 
higher ADR in the HD cohort262. A meta-analysis examining 5 of these 7 studies did find a 
significantly higher ADR with HD endoscopy compared to SD endoscopy266. The pooled 
incremental yield with HD endoscopes was 3.5%, with a number need to treat to detect 
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one additional patient with an adenomatous polyp of 28. Based on this data the benefit 
of HD endoscopy over SD endoscopy appears to be small. 
Table 36 - Studies comparing the adenoma detection rate (ADR) using standard definition endoscopes (SD) and high 
definition endoscopes (HD). 
Study Year Study Type Patients SD ADR HD ADR P value for 
comparison 
East260 2008 Prospective 130 60.0% 71.0% 0.20 
Pellise261 2008 Prospective 620 25.0% 26.0% 0.85 
Buchner262 2010 Retrospective 2430 24.3% 28.8% 0.012 
Burke263 2010 Retrospective 852 21.9% 24.7% 0.36 
Tribonias264 2010 Prospective 390 50.0% 58.0% 0.16 
Erim265 2011 Retrospective 900 24.9% 24.2% 0.82 
Rastogi218 2011 Prospective 420 38.6% 45.7% 0.16 
 
The same 7 studies also examined the mean number of adenomas per patient (MAP) in 
SD and HD groups – see table 37. MAP is considered to possibly represent a better marker 
of clearance of colonic adenomas, and hence the quality of colonoscopy, than ADR181, 267. 
Two of the 7 studies found a significantly greater MAP with HD endoscopes compared to 
SD218, 262. The previously mentioned meta-analysis found a pooled mean gain of 0.098 
adenomas per patient with HD compared to SD colonoscopy266.  
Table 37 - Studies comparing the mean adenomas per patient (MAP) using standard definition endoscopes (SD) and 
high definition endoscopes (HD). 
Study Year Study Type Patients SD MAP HD MAP P value for 
comparison 
East260 2008 Prospective 130 1.22 1.60 0.12 
Pellise261 2008 Prospective 620 0.45 0.43 0.87 
Buchner262 2010 Retrospective 2430 0.44 0.51 0.013 
Burke263 2010 Retrospective 852 0.39 0.31 0.13 
Tribonias264 2010 Prospective 390 1.10 1.38 0.10 
Erim265 2011 Retrospective 900 0.42 0.41 0.88 
Rastogi218 2011 Prospective 420 0.69 1.12 0.016 
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The UK BCSP aims to screen the entire population aged 60-75 years with biennial faecal 
occult blood testing, with colonoscopy offered to those participants with a strongly 
positive FOBt. As this is an enriched population there is a high prevalence of colonic 
neoplasia in participants who proceed to colonoscopy. To date no studies have addressed 
whether the use of high definition endoscopy in the UK BCSP population improves ADR or 
MAP. 
 
6.2 Aims 
The aim of this study was to compare the number of polyps found in patients who 
underwent colonoscopy using standard definition colonoscopes and high definition 
colonoscopes in the UK BCSP. 
 
6.3 Outcome Measures 
The primary outcome measures were adenoma detection rate and mean number of 
adenomas per patient. 
Secondary outcome measures were polyp detection rate, mean number of polyps per 
patient, diminutive adenoma and polyp detection rates, proximal colon adenoma 
detection rate, proximal colon serrated polyp detection rate and advanced adenoma 
detection rate. 
Diminutive polyps/adenomas and lesions found in the proximal colon were chosen in 
particular as these lesions are often more subtle, and hence may in theory be missed 
during standard definition endoscopy.  
 
6.4 Power calculations 
Overall ADR was assumed to be 46% based on the national average in the UK BCSP. To 
detect a relative increase in ADR of 15% (absolute increase 6.9%) between SD and HD 
groups with a significance level of 5% and power (1-β) of 80% would require 1642 
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patients in total (821 per group). Sample size was increased by 5% to allow for exclusions 
resulting in a final sample size of 1724. 
 
6.5 Definitions 
Adenoma detection rate (ADR) was defined at the percentage of patients with one or 
more adenomatous polyps detected.  
Polyp detection rate (PDR) was defined as the percentage of patients with one or more 
polyps detected. 
The proximal colon was defined as that proximal to the splenic flexure. 
Diminutive adenomas/polyps were defined as those ≤5mm in size. 
Advanced adenomas were defined as those ≥10mm in size and/or containing high grade 
dysplasia or cancer. 
There is no universal definition of what constitutes an SD or HD endoscope. For the 
purposes of this study, SD endoscopes were defined as those with up to 500,000 pixels 
and HD endoscopes were defined as those with >500,000 pixels. This is in line with a 
recent technology status evaluation report on HD endoscopes published by the ASGE259. 
Standard definition endoscope models used:- 
• Olympus CFQ260DL 
• Fujinon EC530WL 
High definition endoscope models used:- 
• Fujinon EC530FL 
• Fujinon EC530ZW 
• Pentax EC-3890Li 
• Pentax i90 
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6.6 Exclusion criteria 
Cases were excluded for the following reasons:- 
• The definition of endoscope used was not recorded or could not be reliably 
determined 
• Two different endoscopes were used to complete the procedure (eg scope failure 
mid-procedure) 
• Inflammatory bowel disease 
• Polyposis syndrome 
• Incomplete colonoscopy (failure to achieve caecal intubation) 
• Previous colonic surgery 
 
 
6.7 Ethical considerations 
This project was deemed to be a retrospective service evaluation and hence formal ethics 
committee approval was not sought. All patient data was anonymised with no patient 
identifiable information was collected. Data was kept in a secure password protected 
electronic database. 
 
6.8 Methods 
Consecutive BSCP colonoscopy cases performed at Portsmouth Hospitals NHS Trust were 
identified from the local BCSP online database. A total of 1724 consecutive cases were 
identified for the period February 2009 – December 2012. Data on patient age, gender, 
bowel preparation quality, polyp size, location and histology and endoscopist was 
extracted from the database.  
All procedures were performed by 3 experienced BCS colonoscopists who had undergone 
an accreditation process including a formal assessment of knowledge and competence in 
colonoscopy and polypectomy technique. Each had experience of over 5000 
colonoscopies.  
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All endoscopes used within the endoscopy department are marked with a unique 
reference number. This reference number can be used to identify the make and model of 
endoscope. When a BCSP colonoscopy is performed, the endoscope reference number is 
recorded in both the BCSP online database and a separate logbook in each endoscopy 
suite. Both the BCSP database and suite logbooks were checked to establish the model of 
endoscope used for each procedure. Any cases where the endoscope reference numbers 
did not match or were not recorded in either location were excluded (unknown definition 
of endoscope). 
 
Of the initial 1724 cases identified, 92 cases were excluded for the following reasons; two 
different endoscopes used during procedure (n=40), unknown definition of endoscope 
(n=23), incomplete procedure (n=15), diagnosis of colitis (n=13) and previous colonic 
surgery (n=1). This left 1632 cases for the main analysis. 
 
 
6.9 Statistics 
Baseline characteristics of the SD and HD groups were compared using the independent 
samples t-test for continuous variables and Fisher’s exact test or Pearson’s Chi-squared 
test for categorical variables. 
Differences in categorical outcomes (ADR, PDR, Diminutive adenoma detection rate 
(DimADR), proximal adenoma detection rate (ProxADR), proximal serrated polyp 
detection rate (ProxSerrDR) and advanced adenoma detection rate (AdvADR)) were 
examined using the Fisher’s exact test or Pearson’s Chi-squared test for categorical 
predictor variables (gender, age, endoscopist, bowel preparation quality, endoscope 
definition). Patient age was divided into 4 equal quartiles to aid calculation of results.  
Differences in the mean number of adenomas per patient according to independent 
variables were calculated using the Mann-Whitney U test or Kruskal-Wallis test for 
152 
 
categorical independent variables (gender, endoscopist, bowel preparation quality and 
endoscope definition) and using Pearson’s correlation for subject age. 
To minimise confounding variables stepwise binary logistic regression was performed 
using the following factors – gender, age quartile, endoscopist, bowel preparation quality 
and endoscope definition. Six different models of different binary dependent variables 
were created (≥1 adenoma, ≥1 polyp, ≥1 diminutive adenoma, ≥1 proximal colonic 
adenoma, ≥1 proximal serrated polyp and ≥1 advanced adenoma). Odds ratios were 
calculated with 95% confidence intervals. Bowel preparation quality was excluded as an 
independent variable from the model for proximal serrated polyp detection as no 
proximal serrated polyps were found in the ‘inadequate’ prep group. 
A p value of <0.05 was considered statistically significant for all calculations. All reported 
p values are 2-sided. 
 
6.10 Results 
6.10.1 Baseline demographics 
787 cases were included in the SD group and 845 in the HD group. 
Table 38 shows the main characteristics of the two groups. No significant differences 
were found between the SD and HD groups in terms of age, gender or bowel preparation 
quality. However there was a significant difference in the proportion of procedures 
performed using SD/HD endoscopes between endoscopists. Endoscopist C performed a 
greater proportion of their procedures using HD endoscopes than endoscopists A or B. 
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Table 38 - Baseline demographics of SD and HD groups. 
Variable SD (n = 787) HD (n = 845) P value 
Age, years (range) 67.0 +/- 4.5  67.2 +/- 4.5 0.448 
Male gender 448 (56.9%) 510 (60.4%) 0.174 
Endoscopist   0.000 
     A 492 (62.5%) 391 (46.3%)  
     B 149 (18.9%) 126 (14.9%)  
     C 146 (18.6%) 328 (38.8%)  
Bowel Preparation   0.832 
     Poor 11 (1.4%) 9 (1.1%)  
     Adequate 289 (36.7%) 310 (36.8%)  
     Good 487 (61.9%) 524 (62.2%)  
 
Colonoscopy withdrawal time for cases without polyps did not differ significantly 
between the 3 endoscopists when analysed by one-way ANOVA (P=0.955) – see table 39. 
Table 39 - Mean withdrawal time for negative colonoscopies. 
Endoscopist Mean withdrawal time (95% CI), min 
A 10.79 (10.41-11.18) 
B 10.92 (9.92-11.92) 
C 10.76 (9.86-11.65) 
 
6.10.2 Adenoma detection rate 
Differences in ADR, according to gender, age, endoscopist, bowel preparation quality and 
endoscope definition, were examined in univariate analysis. 
ADR for male subjects was 63.7% compared to 46.6% for female subjects (p value <0.001 
for comparison) – see table 40. 
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There was no significant difference in ADR according to subject age (by quartile). ADR did 
differ significantly between endoscopists, ranging from 50.9% for endoscopist B to 61.2% 
for endoscopist C (p = 0.020). 
There were also significant differences in ADR according to bowel preparation quality (p = 
0.026) with a lower ADR in subjects with inadequate bowel preparation quality  
No significant difference in ADR was found between subjects who underwent 
colonoscopy with an SD endoscope compared to those who’s procedure was performed 
using an HD endoscope (p = 0.764) 
Table 40 - Univariate analysis of factors associated with ADR 
Independent variable Subjects  
n=1632 (% of total) 
Subjects with ≥1 
adenoma n=924 (%) 
P value 
Gender 
    Male 
    Female 
 
958 (58.7) 
674 (41.3) 
 
610 (63.7) 
314 (46.6) 
<0.001 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
411 (25.2) 
408 (25.0) 
405 (24.8) 
408 (25.0) 
 
234 (56.9) 
235 (57.6) 
220 (54.3) 
235 (57.6) 
0.752 
Endoscopist 
    A 
    B 
    C 
 
883 (54.1) 
275 (16.9) 
474 (29.0) 
 
494 (53.5) 
140 (50.9) 
290 (61.2) 
0.020 
Bowel Prep 
    Inadequate 
    Adequate 
    Good 
 
20 (1.2) 
599 (36.7) 
1011 (62.0) 
 
7 (35.0) 
359 (59.9) 
558 (55.2) 
0.026 
Endoscope Definition 
    Standard definition 
    High definition 
 
787 (48.2) 
845 (51.8) 
 
449 (57.1) 
475 (56.2) 
0.764 
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6.10.3 Mean Adenomas per patient (MAP) 
A significant correlation was found between subject age and MAP (r = 0.059, p = 0.017). 
Significant differences in MAP were also found when subjects were divided by gender, 
endoscopist and bowel preparation quality – see table 41. Male subjects had a MAP of 
1.47 compared to 0.94 for female subjects. Between the 3 endoscopists in the study MAP 
ranged from 1.00 (endoscopist B) to 1.45 (endoscopist C). Subjects with inadequate bowel 
preparation quality had a MAP of 1.10 compared to 1.35 with adequate preparation and 
1.20 with good preparation. 
No significant difference in MAP was found when subjects were divided according to 
definition of endoscope used (p = 0.810). 
Table 41 - Univariate analysis of factors associated with MAP 
Independent variable Subjects  
n=1632 (% of total) 
Mean Adenomas per subject  
(95% confidence interval) 
P value 
Gender 
    Male 
    Female 
 
958 (58.7) 
674 (41.3) 
 
1.47 (1.36 – 1.59) 
0.94 (0.82 – 1.07) 
<0.001 
Endoscopist 
    A 
    B 
    C 
 
883 (54.1) 
275 (16.9) 
474 (29.0) 
 
1.23 (1.11 – 1.35) 
1.00 (0.84 – 1.15) 
1.45 (1.28 – 1.62) 
0.004 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
20 (1.2) 
599 (36.7) 
1011 (62.0) 
 
1.10 (-0.08 – 2.28) 
1.35 (1.21 – 1.49) 
1.20 (1.10 – 1.31) 
0.037 
Endoscope Definition 
    Standard definition 
    High definition 
 
787 (48.2) 
845 (51.8) 
 
1.20 (1.09 – 1.31) 
1.31 (1.18 – 1.44) 
0.810 
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6.10.4 Polyp Detection Rate (PDR) 
Analysis by PDR showed very similar results to ADR, with significant differences in PDR 
found when subjects were classified according to gender, endoscopist or bowel 
preparation quality – see table 42. No significant differences in PDR were found when 
subjects were classified by age or by definition of endoscope used. 
Table 42 - Univariate analysis of factors associated with PDR 
Independent variable Subjects (n=1632),  
n (% of total) 
Subjects with ≥1 polyp 
(n=1017), n (%) 
P value 
Gender 
    Male 
    Female 
 
958 (58.7) 
674 (41.3) 
 
659 (68.8) 
358 (53.1) 
<0.001 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
411 (25.2) 
408 (25.0) 
405 (24.8) 
408 (25.0) 
 
257 (62.5) 
262 (64.2) 
250 (61.7) 
248 (60.8) 
0.777 
Endoscopist 
    A 
    B 
    C 
 
883 (54.1) 
275 (16.9) 
474 (29.0) 
 
537 (60.8) 
155 (56.4) 
325 (68.6) 
0.002 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
20 (1.2) 
599 (36.7) 
1011 (62.0) 
 
8 (40.0) 
389 (64.9) 
619 (61.2) 
0.039 
Endoscope Definition 
    Standard definition 
    High definition 
 
787 (48.2) 
845 (51.8) 
 
481 (61.1) 
536 (63.4) 
0.358 
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6.10.5 Mean Polyps per patient (MPP) 
Similar to the results for MAP a significant correlation was found between MPP and age (r 
= 0.070, p = 0.004). 
Significant differences in MPP were also found when subjects were divided by gender, 
endoscopist and bowel preparation quality. Male subjects had a MPP of 1.91 compared to 
1.18 for female subjects. MPP ranged from 1.35 (endoscopist B) to 2.00 (endoscopist C) 
when assessed by endoscopist. Subjects with inadequate bowel preparation had a MPP of 
1.15 compared to 1.72 with adequate preparation and 1.56 with good preparation. 
No significant difference in MPP was found when subjects were divided according to 
definition of endoscope used, although there was a trend towards higher MPP in the HD 
group (p = 0.088). 
Table 43 - Univariate analysis of factors associated with MPP 
Independent variable Subjects  
(n=1632), n (% of 
total) 
Mean polyps per subject  
(95% confidence interval) 
P value 
Gender 
    Male 
    Female 
 
958 (58.7) 
674 (41.3) 
 
1.91 (1.77 – 2.06) 
1.18 (1.05 – 1.32) 
<0.001 
Endoscopist 
    A 
    B 
    C 
 
883 (54.1) 
275 (16.9) 
474 (29.0) 
 
1.49 (1.35 – 1.63) 
1.35 (1.12 – 1.59) 
2.00 (1.79 – 2.25) 
<0.001 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
20 (1.2) 
599 (36.7) 
1011 (62.0) 
 
1.15 (-0.02 – 2.32) 
1.72 (1.55 – 1.90) 
1.56 (1.43 – 1.69) 
0.031 
Endoscope Definition 
    Standard definition 
    High definition 
 
787 (48.2) 
845 (51.8) 
 
1.48 (1.35 – 1.61) 
1.74 (1.58 – 1.90) 
0.088 
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6.10.6 Diminutive adenoma detection rate and proximal colon adenoma detection rate 
A significantly greater proportion of male subjects had diminutive adenomas, and right 
sided adenomas, than female subjects on univariate analysis – see table 44. 
Diminutive adenoma detection rate (DimADR - percentage of subjects with ≥1 diminutive 
adenoma) and proximal colon adenoma detection rate (ProxADR – percentage of subjects 
with ≥1 adenoma in theproximal colon) did not differ significantly between age quartiles. 
However both DimADR and ProxADR did differ significantly between subjects according to 
endoscopist. ProxADR differed significantly according to bowel preparation quality. There 
were no significant differences in either DimADR or ProxADR when subjects were grouped 
by endoscope definition. 
Table 44 - Univariate analysis of factors associated with DimADR and ProxADR 
Independent variable Subjects  
n=1632 (% 
of total) 
Subjects with ≥1 
diminutive 
adenoma 
(n = 655), n (%) 
P value Subjects with ≥1 
proximal colon 
adenoma 
(n=492), n (%) 
P value 
Gender 
    Male 
    Female 
 
958 (58.7) 
674 (41.3) 
 
452 (47.2) 
203 (30.1) 
<0.001  
337 (35.2) 
155 (23.0) 
<0.001 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
411 (25.2) 
408 (25.0) 
405 (24.8) 
408 (25.0) 
 
151 (36.7) 
171 (41.9) 
163 (40.2) 
170 (41.7) 
0.406  
119 (29.0) 
110 (27.0) 
122 (30.1) 
141 (34.6) 
0.111 
Endoscopist 
    A 
    B 
    C 
 
883 (54.1) 
275 (16.9) 
474 (29.0) 
 
364 (41.2) 
92 (33.5) 
199 (42.0) 
0.045  
263 (29.8) 
63 (22.9) 
166 (35.0) 
0.002 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
20 (1.2) 
599 (36.7) 
1011 (62.0) 
 
5 (25.0) 
257 (42.9) 
393 (38.9) 
0.106  
3 (15.0) 
201 (33.6) 
288 (28.5) 
0.033 
Endoscope Definition 
    Standard definition 
    High definition 
 
787 (48.2) 
845 (51.8) 
 
308 (39.1) 
347 (41.1) 
0.449  
228 (29.0) 
264 (31.2) 
0.331 
159 
 
6.10.7 Proximal colon serrated polyps and advanced adenomas 
The only significant predictor of proximal serrated polyp detection rate was endoscopist, 
with a rate of 3.2% for endoscopist A, 5.5% for endoscopist B and 5.9% for endoscopist C. 
All other independent variables (gender, age, bowel preparation quality and endoscope 
definition) were not significant predictors of proximal serrated polyp detection rate on 
univariate analysis – see table 45. Advanced adenoma detection rate was significantly 
greater in male subjects compared to female subjects (27.2% vs 21.1%, p = 0.005). There 
was also a significant difference when subjects were grouped according to endoscopist. 
Age, bowel preparation quality and endoscope definition did not predict advanced 
adenoma detection rate on univariate analysis. 
Table 45 - Univariate analysis of factors associated with proximal serrated polyp detection rate and advanced adenoma 
detection rate 
Independent variable Subjects  
n=1632 (% 
of total) 
Subjects with ≥1 
proximal serrated 
polyp (n = 71), n (%) 
P value Subjects with ≥1 
advanced adenoma 
(n = 402), n (%) 
P value 
Gender 
    Male 
    Female 
 
958 (58.7) 
674 (41.3) 
 
37 (3.9) 
34 (5.0) 
0.268  
260 (27.2) 
142 (21.1) 
0.005 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
411 (25.2) 
408 (25.0) 
405 (24.8) 
408 (25.0) 
 
14 (3.4) 
23 (5.6) 
18 (4.4) 
16 (3.9) 
0.441  
112 (27.3) 
93 (22.8) 
97 (24.0) 
100 (24.5) 
0.504 
Endoscopist 
    A 
    B 
    C 
 
883 (54.1) 
275 (16.9) 
474 (29.0) 
 
28 (3.2) 
15 (5.5) 
28 (5.9) 
0.038  
198 (22.4) 
67 (24.4) 
137 (28.9) 
0.031 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
20 (1.2) 
599 (36.7) 
1011 
(62.0) 
 
0 (0.0) 
22 (3.7) 
49 (4.8) 
0.339 
 
 
4 (20.0) 
153 (25.6) 
245 (24.2) 
0.738 
Endoscope Definition 
    Standard definition 
    High definition 
 
787 (48.2) 
845 (51.8) 
 
27 (3.4) 
44 (5.2) 
0.089  
197 (25.1) 
205 (24.3) 
0.730 
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6.10.8 Logistic Regression – ADR & PDR 
Gender, endoscopist and bowel preparation quality were found to be independent 
predictors of both ADR and PDR. In multivariate analysis male gender was a strong 
predictor of polyp or adenoma detection – see table 46.   
After adjustment male gender was associated with a doubling of the odds of ≥1 adenoma 
being detected during BCSP colonoscopy, and a 92% increase in the odds of ≥1 polyp 
being detected.  
Cases performed by endoscopist C were associated with a 27% increase in the odds of ≥1 
adenoma being detected and a 40% increase in the odds of ≥1 polyp being detected in 
comparison to cases performed by endoscopist A.  
Good or adequate bowel preparation were significant predictors of polyp detection in 
comparison to the reference group of inadequate bowel preparation. Adequate bowel 
preparation was associated with a 3-fold increase in the odds of detection of ≥1 adenoma 
or polyp compared inadequate bowel preparation. Good bowel preparation was 
associated with a 2.5-fold increase in the odds of ≥1 adenoma or polyp being detected in 
comparison to those with inadequate preparation, although this difference in odds did 
not reach statistical significance for adenoma detection.  
Endoscope definition was not found to be a significant predictor of adenoma or polyp 
detection on multivariant analysis. 
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Table 46 - Multivariant analysis of independent variables associated with ADR and PDR. 
Independent variable Adjusted Odds Ratio 
≥1 adenoma (95% 
confidence interval) 
P value Adjusted Odds Ratio 
≥1 polyp (95% 
confidence interval) 
P value 
Gender 
    Female 
    Male 
 
1.00 
2.00 (1.64-2.45) 
 
 
<0.001 
 
1.00 
1.92 (1.57-2.36) 
 
 
<0.001 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
1.00 
0.97 (0.73-1.29) 
0.91 (0.68-1.20) 
1.06 (0.80-1.410 
 
 
0.854 
0.502 
0.693 
 
1.00 
1.01 (0.75-1.35) 
0.97 (0.73-1.30) 
0.95 (0.72-1.27) 
 
 
0.963 
0.840 
0.750 
Endoscopist 
    A 
    B 
    C 
 
1.00 
0.85 (0.64-1.12) 
1.27 (1.00-1.61) 
 
 
0.237 
0.050 
 
1.00 
0.86 (0.65-1.14) 
1.40 (1.10-1.79) 
 
 
0.294 
0.007 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
1.00 
2.86 (1.11-7.39) 
2.52 (0.98-6.47) 
 
 
0.030 
0.056 
 
1.00 
2.76 (1.09-6.97) 
2.53 (1.01-6.36) 
 
 
0.032 
0.048 
Endoscope Definition 
    Standard definition 
    High definition 
 
1.00 
0.90 (0.73-1.10) 
 
 
0.302 
 
1.00 
1.01 (0.82-1.24) 
 
 
0.950 
 
6.10.9 Logisitic Regression – DimADR & ProxADR 
Significant predictors of diminutive adenoma detection were male sex, and endoscopist – 
see table 47. Male gender was associated with double the odds of detecting at least one 
diminutive adenoma. Cases performed by endoscopist B were associated with a 27% 
decrease in the odds of diminutive adenoma detection in comparison to cases performed 
by endoscopist A. 
Age, bowel preparation quality and endoscope definition were not found to be significant 
predictors of detection of ≥1  diminutive adenoma.  
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Gender, Age and endoscopist were found to be significant predictors of detection of ≥1 
proximal colon adenoma.  
Male gender was associated with an 80% increase in the odds of detecting at least one 
proximal colon adenoma. Cases in the highest age quartile were associated with a 36% in 
the odds of detecting ≥1 proximal adenoma in comparison to the lowest quartile. Cases 
performed by endoscopist B were associated with a 28% decrease in the odds of proximal 
adenoma detection in comparison to cases performed by endoscopist A. 
Table 47 - Multivariant analysis of independent variables associated with DimADR and ProxADR. 
Independent variable Adjusted Odds Ratio 
≥1 diminutive 
adenoma (95% 
confidence interval) 
P value Adjusted Odds Ratio 
≥1 proximal colon 
adenoma (95% 
confidence interval) 
P value 
Gender 
    Female 
    Male 
 
1.00 
2.06 (1.67-2.54) 
 
 
<0.001 
 
1.00 
1.82 (1.45-2.28) 
 
 
<0.001 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
1.00 
1.19 (0.89-1.58) 
1.17 (0.88-1.57) 
1.26 (0.94-1.68) 
 
 
0.240 
0.278 
0.116 
 
1.00 
0.86 (0.63-1.17) 
1.07 (0.79-1.46) 
1.36 (1.00-1.83) 
 
 
0.334 
0.657 
0.048 
Endoscopist 
    A 
    B 
    C 
 
1.00 
0.73 (0.59-0.98) 
1.02 (0.80-1.29) 
 
 
0.038 
0.887 
 
1.00 
0.72 (0.52-0.99) 
1.28 (1.00-1.64) 
 
 
0.045 
0.051 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
 
1.00 
2.20 (0.78-6.23) 
1.99 (0.70-5.61) 
 
 
0.138 
0.194 
 
1.00 
2.95 (0.84-10.32) 
2.48 (0.71-8.65) 
 
 
0.091 
0.154 
Endoscope Definition 
    Standard definition 
    High definition 
 
1.00 
1.04 (0.85-1.28) 
 
 
0.706 
 
1.00 
1.03 (0.82-1.28) 
 
 
0.829 
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6.10.10 Logistic Regression – Proximal Serrated polyp detection and advanced adenoma 
detection 
The only significant predictor of proximal serrated polyp detection was endoscopist – see 
table 48. Cases performed by endoscopist C were associated with a 76% increase in the 
odds of proximal serrated polyp detection in comparison to cases performed by 
endoscopist A. Endoscope definition was not associated with proximal serrated polyp 
detection. 
Significant predictors or advanced adenoma detection were male gender and 
endoscopist. Male gender was associated with a 41% increase in the odds of ≥1 advanced 
adenoma being detected. Cases performed by endoscopist C were associated with a 44% 
increase in the odds of advanced adenoma detection in comparison to cases performed 
by endoscopist A. Advanced adenoma detection was not associated with endoscope 
definition. 
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Table 48 - Multivariant analysis of independent variables associated with proximal serrated polyp detection rate and 
advanced adenoma detection rate. 
Independent variable Adjusted Odds Ratio 
≥1 proximal serrated 
polyp (95% 
confidence interval) 
P value Adjusted Odds Ratio 
≥1 advanced 
adenoma (95% 
confidence interval) 
P value 
Gender 
    Female 
    Male 
 
1.00 
0.74 (0.47-1.19) 
 
 
0.213 
 
1.00 
1.41 (1.11-1.78) 
 
 
0.005 
Age (quartiles) 
    60.1 – 63.4 
    63.41 – 67.31 
    67.32 – 70.18 
    70.19 – 85.24 
 
1.00 
1.69 (0.86-3.34) 
1.29 (0.63-2.64) 
1.16 (0.56-2.42) 
 
 
0.131 
0.485 
0.693 
 
1.00 
0.77 (0.56-1.06) 
0.86 (0.63-1.18) 
0.89 (0.65-1.23) 
 
 
0.114 
0.347 
0.485 
Endoscopist 
    A 
    B 
    C 
 
1.00 
1.74 (0.92-3.32) 
1.76 (1.01-3.05) 
 
 
0.091 
0.044 
 
1.00 
1.13 (0.82-1.57) 
1.44 (1.11-1.88) 
 
 
0.445 
0.006 
Bowel Preparation 
    Inadequate 
    Adequate 
    Good 
   
1.00 
1.42 (0.46-4.34) 
1.35 (0.44-4.10) 
 
 
0.541 
0.599 
Endoscope Definition 
    Standard definition 
    High definition 
 
1.00 
1.42 (0.86-2.34) 
 
 
0.177 
 
1.00 
0.89 (0.70-1.12) 
 
 
0.311 
 
6.11 Discussion 
This was a large retrospective analysis of factors influencing ADR, MAP and other 
outcome measures in UK BCSP patients undergoing screening colonoscopy. Endoscope 
definition was not found to be significantly associated with either ADR or MAP on 
univariate or multivariate analysis. Endoscope definition was also found not to be 
significantly associated with detection of all polyps, diminutive adenomas, proximal 
adenomas, proximal serrated lesions or advanced adenomas. 
165 
 
In multivariate analysis the factors associated with increased ADR and PDR were gender, 
endoscopist and quality of bowel preparation. Gender and endoscopist were found to be 
associated with significant differences in diminutive adenomas detection and proximal 
adenoma detection. The highest age quartile was also found to be associated with a 
significant increase in the odds of proximal adenoma detection. Detection of proximal 
serrated lesions was only significantly influenced by endoscopist, and advanced adenoma 
detection by gender and endoscopist. 
Patients who undergo colonoscopy within the UK BCSP are by definition an enriched 
population with positive FOBt. BCS accredited endoscopists undergo a rigorous 
accreditation process with frequent review of their performance and thus are a high-
performing set of colonoscopists. The mean ADR in nationwide analysis of BCSP data is 
46.5%181. In this cohort the mean ADR was 56.6%, indicating that the 3 endoscopists who 
performed the procedures in this cohort were performing above the national average. In 
comparison the ADR in the Buchner study, which showed a positive effect of HD 
endoscopy on ADR, was much lower at 26.5%262. Thus there may be a ceiling effect in 
very high performing endoscopist where there is minimal scope for improvement in 
performance by using HD endoscopes, rather than SD endoscopes. 
The endoscopes used in this analysis ranged from 410,000 pixels to 1.2 megapixels. A cut 
off value of 500,000 pixels was used to define what constituted SD and HD endoscopes. 
This is line with the ASGE technology evaluation on HD endoscopy259. It may be the case 
that the main gain in terms of higher endoscope definition improving ADR occurs at lower 
pixel densities than those evaluated in this study. For example there may be significant 
gains when switching from a 100,000 pixel endoscope to one with 400,000 pixels. 
Although endoscope definition did not influence any of the primary or secondary 
outcome measures, several factors were found to be significantly associated with 
increased adenoma/polyp detection, or subsets of these. Male gender is a well-
established risk factor for adenomatous polyps and CRC and this was confirmed in these 
results42, 91. Surprisingly, increasing age was not found to be significantly associated with 
ADR, but there was some effect on proximal colon ADR. Age is also a well-established risk 
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factor for CRC and adenomatous polyps. This has been confirmed in larger analyses of 
BCS data and hence this may represent a type 2 error in this analysis. 
Quality of bowel preparation has been confirmed in many studies to be an important 
determinant of ADR and this was confirmed in our results85-88. In this study there was a 
trend towards a significant influence on diminutive and proximal adenoma detection, 
which did not reach significance. This may be explained by the very low number of cases 
with inadequate bowel preparation (20). BCS patients receive a pre-procedure 
appointment and pre-assessment with a BCS specialist nurse. This involves in-depth 
explanation of the importance of achieving good bowel preparation for the procedure, 
with detailed and clear instructions to the patient. Thus the percentage of cases with 
inadequate bowel preparation is generally lower than that found in non-BCS colonoscopy 
patients.  
The consistent factor found to be significantly associated with all outcome measures was 
the individual endoscopist. Although all 3 endoscopists in this study performed above the 
national average in terms of ADR, significant differences were found between them. 
Many studies have now demonstrated wide variability in ADR and MAP between 
endoscopists. The seminal Barclay et al paper found a 3-fold difference in ADR between 
the lowest and highest performing endoscopists and a 10-fold difference in MAP92. Corley 
et al found a 7-fold difference in ADR between the lowest and highest performing 
endoscopists82.  
We found that there were differences between the 3 endoscopists in several outcome 
measures – ADR, PDR, DimADR, ProxADR, AdvancedADR and ProxSerrDR.  
Differences between endoscopists may be influenced by several factors. Withdrawal time 
is closely associated with ADR91, 92, but in this study did not differ significantly between 
the three endoscopists. Withdrawal technique is also likely to influence differences in 
ADR and other outcome measures between colonoscopists; flushing to cleanse the 
mucosal surface, careful inspection of the whole colonic mucosal surface including behind 
folds and use of position changes to allow maximum distension are all likely to be 
important factors. Recognition of small, subtle flat or sessile lesions will be influenced by 
training and education. Proximal serrated polyps (PSP) in particular can be subtle flat 
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lesions which are easily missed and are not familiar to many endoscopists – “the eye only 
sees what the mind is prepared to comprehend”. This is evidenced in studies that show 
variability between individual endoscopists and hospital in the rate of PSP detection268, 
269. 
This study had some limitations: cases were not equally divided amongst endoscopists 
and neither was the division between use of SD and HD endoscopes for an individual 
endoscopist. By performing a regression analysis we hoped to control for these factors. 
Very few cases had inadequate bowel preparation which may have led to an 
underestimation of the influence of bowel preparation quality on some of the outcome 
measures (for instance no cases with inadequate prep had proximal serrated polyps 
detected). 
Whilst this was not a randomised trial, it does reflect real-world data relating to the 
impact of endoscope definition in BCS colonoscopy and is not subject to the potential bias 
that could exist in a trial (it would be very difficult to blind an endoscopist to endoscope 
resolution). The strengths of this study include a highly standardised cohort of patients, 
competent and accredited endoscopists, a large cohort and prospective data recording in 
a comprehensive database. The key findings are that the main factors associated with 
increased ADR and other outcome measures are gender (which cannot be manipulated), 
bowel preparation and endoscopist (which can). Endoscope definition was not 
significantly associated with any primary or secondary outcome measure. Proximal 
serrated polyps are difficult to detect and are potentially of high risk of malignant 
transformation270. This may explain the failure of colonoscopy in some studies to protect 
against proximal colon cancer. It is notable that in this study detection of proximal 
serrated polyps was not associated with endoscope definition but did differ significantly 
between endoscopists. Endoscopist C who had the highest proximal serrated polyp 
detection rate also had the highest ADR and DimADR. This suggests that the technique of 
mucosal evaluation and skills in recognition of subtle and diminutive lesions is associated 
with detection of both diminutive adenomas, and proximal serrated lesions. Hence efforts 
to improve outcomes in BCS colonoscopy should be directed at endoscopist factors such 
as withdrawal technique and lesion recognition and improving the quality of bowel 
preparation.  
168 
 
Chapter 7 - A randomised controlled trial of simeticone 
and n-acetylcysteine as a pre-procedure drink to improve 
mucosal visibility during diagnostic gastroscopy – the 
NICEVIS Study 
 
 
7.1 Introduction 
Survival from upper gastrointestinal cancer is largely determined by stage at diagnosis, 
with very good outcomes for patients diagnosed with early stage disease but a dismal 
prognosis for the majority diagnosed with more advanced lesions. For example stage I 
gastric cancer has a 5-year survival rate of 80%, compared to <5% for stage IV gastric 
cancer. Thus early diagnosis is key in improving outcomes from upper gastrointestinal 
cancer. There is a well-documented miss rate for oesophageal and gastric cancer at upper 
GI endoscopy with studies reporting miss rates of 4-13% at index endoscopy for cancers 
diagnosed on subsequent investigations including repeat endoscopy72, 73, 271-274. 
Recent years we have seen a rapid growth in advanced endoscopic techniques, including 
endoscopic resection (ER) of dysplasia and early cancer in the upper gastrointestinal tract. 
ER can offer complete cure, and avoid major surgery35, 275, however ER can only be 
considered if early lesions can be detected and characterized. By their nature early 
dysplastic lesions are smaller and more subtle than more advanced cancer and are 
therefore more easily overlooked.  
It is common to find views in the upper gastrointestinal tract impaired by mucus and 
bubbles. This can hamper the identification of subtle abnormalities, such as dysplasia 
within Barrett’s oesophagus or early gastric cancer. 
If views of the mucosa are found to be inadequate during endoscopy it is standard 
practice to use fluid flushes/lavage of 20-50ml aliquots of a solution containing a bubble-
breaker +/- mucolytic to cleanse the mucosal surface. These are delivered from a syringe 
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via one of the endoscope channels. In some cases multiple flushes, eg 200ml, may be 
required to achieve adequate views. 
In Japan, where ER has been common place for many years, it has become standard 
practice to use the mucosal toileting drink Gascon (Dimethylpolysiloxane, DMPS) with 
Pronase prior to gastroscopy. Patients are given a 30-100 ml drink 5-10 minutes prior to 
gastroscopy. Gascon acts as a defoaming agent, thereby dispersing foam and bubbles. 
Pronase is a mucolytic which breaks down mucus, improving the view of the mucosal 
surface 
However, Pronase is not licensed for use in the United Kingdom. Because of this 
endoscopists in the UK have started using alternative pre-endoscopy preparatory drinks. 
The combination of simeticone and n-acetylcysteine (NAC) is used in many UK endoscopy 
units.  
Several previous studies have examined the effect on mucosal visibility of a pre-
procedure drink of a defoaming agent (such as DMPS or simethicone) either alone or in 
combination with a mucolytic such as Pronase or NAC. The main outcomes of previous 
studies are summarised in table 49. In early studies McDonald and Bertoni demonstrated 
that simeticone and water alone improved mucosal visibility during gastroscopy in 
comparison to no preparation. In addition, fewer flushes were required to achieve 
adequate views and procedure times were reduced276, 277. 
Fujii et al found that the combination of water, DMPS, sodium bicarbonate and pronase 
produced the best mucosal visibility, significantly better than the same combination 
without pronase278. In a similar study Kuo et al found that the same combination, albeit in 
different quantities, produced the best results279. 
Chang compared solutions containing two different mucolytics – pronase and NAC. No 
significant difference in mucosal visibility was found between subjects given a solution 
containing DMPS, sodium bicarbonate and pronase and those given one containing DMPS 
and NAC280.  
In contrasting results Asl et al found no significant differences in mucosal visibility 
between subjects given a solution containing water, DMPS and NAC and those given one 
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containing just water and DMPS281. The authors therefore questioned whether a 
mucolytic adds any additional benefit to a solution containing just a defoaming agent and 
water. In a study published in 2014 Chang et al reported similar results, with no 
significant difference in mucosal visibility between subjects given a 
water/simeticone/NAC solution compared to those given water/simeticone, although the 
dose of NAC used in this study (200mg) was lower than that used in other studies282. 
Thus several studies have demonstrated that a pre-endoscopy drink of a defoaming agent 
improves mucosal visibility but there are conflicting results between studies which have 
examined whether the addition of a mucolytic offers any further benefit. 
The majority of studies to date have been carried out in Asian populations. To date the 
only study in a western population of a pre-endoscopy drink containing a defoaming 
agent and mucolytic was performed by Neale et al in the UK283. In a pragmatic design with 
two control arms they compared no preparation with water alone, or a solution of 
water/simethicone/NAC. The mean volume of procedural flush required and proportion 
of patients requiring use of flush was significantly lower in the group which received the 
active solution. 
Table 49 - Previous studies of pre-endoscopy preparatory drinks. DMPS = Dimethylpolysiloxane, NAC = n-acetylcysteine, 
TMVS = total mucosal visibility score 
Study #Pts Groups Results 
McDonald et al, 
Gastrointestinal 
Endoscopy 
1978277 
111 • A - Placebo 
• B - 30ml water & 40mg Simethicone 
• C - 30ml water  & 80mg Simeticone 
• Significantly better visibility scores for 
both Simeticone groups vs placebo. 
• Scores ranged from 0 (best) to 4 
(worst) 
• Mean values A – 3.71, B – 0.73, C – 
0.76 (A vs B and A vs C p <0.001) (B vs 
C p= ns) 
• Additional Simeticone flushes 
required in 15/41 placebo patients 
but 0 of 70 Simeticone patients 
(p<0.001) 
Bertoni et al, 
Endoscopy, 
1992276 
330 • A - 90ml Water & 65mg Simeticone  
• B - 30ml Water & 65mg Simeticone 
• C - Placebo 
• D - 90ml Water & 195mg Simeticone 
 
• Groups A, B & D had significantly 
better visibility scores than C 
(placebo) (P<0.001 for each but exact 
values not reported) 
• Group C (placebo) had required 
significantly longer procedure time 
(119sec C vs mean 91.9sec A/B/D, 
p<0.001) 
• 62.5% of pts in group C required 
additional lavage vs 9.9% in A/B/D 
combined (p<0.001) 
171 
 
Fujii et al, 
Gastrointestinal 
Endoscopy 
1998278 
100 • A – 100ml water & 80 DMPS 
(Dimethylpolysiloxane - Gascon) 
• B – 100ml water, 80mg DMPS, 1g 
sodium bicarbonate 
• C – 100ml water, 80mg DMPS, 1g 
sodium bicarbonate, 20,000u 
Pronase 
• Visibility scores significantly better in 
group C vs A (65% pts with no mucus 
vs 0% pts with no mucus, p<0.01) 
• Significantly shorter procedure time in 
group C vs A (21.4min vs 17.3min, 
P<0.001) 
Kuo et al, 
Endoscopy, 
2002279 
160 • A – 100mg DMPS 
• B – 100ml water, 100mg DMPS 
• C – 100ml water, 2000u Pronase 
• D – 100ml water, 2000u Pronase, 
1.2g Sodium bicarbonate 
• E – 100ml water, 2000u Pronase, 
1.2g Sodium bicarbonate, 100mg 
DMPS 
• Group E had significantly better 
overall visibility scores than groups A-
D, range 4 (best) to 16 (worst) 
• A 5.19, B 5.27, C 8.23, D 7.68, E 4.42  
• E vs A (p<0.05), E vs B (p<0.05) 
• E vs C (p<0.01), E vs D (p<0.01) 
Chang, World 
Journal of 
Gastroenterology, 
2007280 
146 • A – 100mg DMPS 
• B – 100mg DMPS & 100ml water 
• C – 100mg DMPS, 2000u Pronase, 
1.2g sodium bicarbonate, 100ml 
water 
• D – 400mg NAC, 100mg DMPS, 
100ml water 
• Overall visibility score significantly 
better in group C than groups A/B, 
range 4 (best) to 16 (worst) 
•  Overall visibility score significantly 
better in group D than group A (6.5 vs 
8.2, p<0.01) 
• No significant difference in score 
between groups C and D (5.8 vs 6.5, 
p=0.39) 
 
Bhandari et al, 
Scandinavian 
Journal of 
Gastroenterology, 
2010284 
112 • A – 100ml water, 2ml DMPS & 
20000u Pronase pre-endoscopy 
• B – same solution as flushes 
• C – flushes with DMPS flushes alone 
• Significantly better visibility in group A 
vs B/C 
• Fewer flushes required in group A vs 
B/C 
• Figures not given in paper 
Ahsan et al, 
Diagnostic & 
Therapeutic 
Endoscopy, 
2011285 
173 • A – 30mg simethicone chewable 
tablet & 30ml water 
• B – 30ml water 
• Significantly better views in stomach 
in group A (P=0.002) 
• No sig difference in duodenum 
(P=0.422) 
• Procedure duration A – 308s vs B -
376s, P<0.001) 
• No difference in patient satisfaction 
Asl et al, World 
Journal of 
Gastroenterology, 
2011281 
148 • A – 100ml water 
• B – 100mg DMPS & 100ml water 
• C – 600mg NAC & 100ml water 
• D – 600mg NAC, 100mg DMPS & 
100ml water 
• TMVS 4 (best) to 16 (worst) 
• A – 9.50, B – 5.11, C – 8.41, D – 5.39 
• Group B TMVS significantly better 
than A and C 
• Group D TMVS significantly better 
than A and C 
• No significant difference in TMVS 
between groups B and D 
Neale et al, 
European Journal 
of 
Gastroenterology 
& Hepatology, 
2013283 
75 • A – no preparation 
• B – 100ml water 
• C – 100ml water, 100mg 
simethicone & 600mg NAC 
• Significantly less flush required in 
group C (A – 54.2ml, B – 61ml, C – 
12.1ml). A vs C P<0.01, B vs C P<0.01. 
• Significantly less flush required in 
group C at 3 gastric locations and 1st 
part of the duodenum. No significant 
difference at the gastro-oesophageal 
junction. 
• No additional flush required in 61% in 
group C vs 13% in group A and 9% in 
group B. 
• No significant difference in procedure 
time between groups but Group C 
time significantly shorter when 
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Barrett’s cases excluded. 
Chen et al, 
Scandinavian 
Journal of 
Gastroenterology, 
2013286 
177 • A – 100mg DMPS & 100ml water 
• B – 100mg DMPS, 300mg NAC & 
100ml water 
• Lower median flush volume in group B 
(40ml vs 50ml, P=0.0095) 
Chang et al, 
Journal of 
Gastroenterology 
& Hepatology, 
2014282 
1859 • A - 100mg Simeticone & 5ml water 
• B – 100mg Simeticone & 100ml 
water 
• C – 100mg Simeticone, 200mg NAC 
& 100ml water 
• TMVS based on 7 locations (7 – best 
to 21 – worst) 
• TMVS significantly lower in groups B/C 
compared to group A (A – 8.34, B -
7.67, C – 7.52) 
• Number of patients requiring flushing 
significantly lower in group C 
compared to groups A/B (A – 6.7%, B 
– 4.1%, C – 1.2%) 
 
7.2 Investigational Medicinal Products 
Simeticone is an anti-foaming agent made of polydimethylsiloxane and hydrated silica gel, 
similar in properties to Gascon (Dimethylpolysiloxane).  It’s most common use in UK is in 
the preparation Infacol used to treat colic in infants. It has shown to be safe and is not 
absorbed from the gastrointestinal tract. 
 
N-acetylcysteine is used for a number of indications. It is the main treatment for 
paracetamol overdose, maintaining and restoring glutathione levels in the liver. N-
acetylcysteine is also given as a nephroprotective agent either orally or intravenously to 
prevent contrast-induced nephropathy. It also acts as a mucolytic and is used in a variety 
of respiratory conditions such as idiopathic pulmonary fibrosis, cystic fibrosis and 
respiratory infections in children. N-acetylcysteine is unlicensed as a mucolytic for 
respiratory conditions in the UK and therefore the drug is supplied from outside the UK 
and used ‘off–license’. Side effects in previous clinical trials are uncommon and usually 
mild. 
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7.3 Trial Objectives 
• To investigate whether water plus Simeticone and n-acetylcysteine, given as a pre-
endoscopic drink, provides better mucosal visualisation than an unprepared upper 
gastrointestinal tract or one prepared with water alone.  
• To investigate whether fewer fluid flushes are required to achieve adequate mucosal 
views if water plus simeticone and n-acetylcysteine is given as a pre-endoscopy drink, 
compared to no preparation or preparation with water alone. 
• To investigate whether total procedure time is shorter if water plus simeticone and n-
acetylcysteine is given as a pre-endoscopy drink, compared to no preparation or 
preparation with water alone. 
 
7.4 Primary endpoints 
Mean total mucosal visibility score at 4 pre-defined locations rated by four blinded 
assessors 
 
7.5 Secondary endpoints 
1) The volume of fluid flushes required to achieve adequate mucosal views 
2) Total procedure time from intubation of the oesophagus to extubation of the 
oesophagus 
 
7.6 Trial Design  
This study was a randomised controlled clinical trial. The trial was registered with the 
European Clinical Trials agency (EudraCT 2013-001097-24), and approved by the local 
research ethics committee (13/SC/0248) and Portsmouth Hospitals NHS trust research 
quality committee (PHT/2013/01). We aimed to recruit 126 patients attending 
Portsmouth Hospitals NHS Trust for upper gastrointestinal endoscopy.  
Baseline patient data on age, gender, medication usage (particularly gastrointestinal 
medications) were recorded.  
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Patients who consented to take part in the study were randomised to three groups:- 
• Group A - Simeticone/n-acetylcysteine pre-endoscopy drink (50 ml water, 
1000 mg  n-acetylcysteine, 60 mg simeticone) 
• Group B – 50 ml water pre-endoscopy drink  
• Group C – no pre-endoscopy drink (current standard practice) 
 
Randomisation was performed by random sequence generation in permuted blocks of 
varying sizes by an independent statistician. Allocations were placed in sealed envelopes 
to be opened by the nurse preparing the pre-endoscopy drink.  
Pre-endoscopy drink was given 5-10 minutes before the procedure and subjects were 
asked to roll onto their left and right hands sides briefly to aid coverage of the gastric 
mucosa. 
 
The endoscopist was blinded to the preparation used. Each patient was allocated a 
unique trial reference number. Following intubation of the endoscope excess fluid in the 
stomach was removed via the endoscope suction channel. Electronic photographs were 
taken at 4 pre-defined locations (Lower oesophagus/Upper body greater 
curve/Antrum/Fundus) during the procedure prior to any mucosal flushing. These images 
were digitally stored for mucosal visibility scoring.   
Fluid flushes of the simeticone/n-acetylcysteine solution were then be used to remove 
residual mucus/foam to achieve adequate mucosal views (this was already routine 
practice within the unit). The volume of flushes required and the total procedure duration 
were recorded. Further photographs of any abnormalities were then taken as felt 
indicated by the endoscopist. 
 
Photographs were rated for mucosal visibility by four experienced endoscopists (scorers). 
Visibility scores were rated on a four point scale (see figures 51/52) :- 
• 1 = no adherent mucus and clear views of the mucosa  
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• 2 = a thin coating of mucus but not obscuring views of the mucosa  
• 3 = some mucus/bubbles partially obscuring views of the mucosa (a small mucosal 
lesion might be missed without flushing).  
• 4 = heavy mucus/bubbles obscuring views of the mucosa (a small mucosal lesion 
could easily be missed without flushing)  
 
 
Figure 51 - Left image – fundus view Score 1, right image – fundus view score 2 
  
Figure 52 - Left image – fundus view Score 3, right image – antrum view score 4 
Therefore total score based on 4 photographs ranges from 4 (best) to 16 (worst). The 
scorers were trained in the use of the visibility score with photographic examples prior to 
scoring the study photographs. A pre-study test was performed to check that there was 
sufficient inter-observer agreement before the study photographs were scored with a 
pre-specified kappa value of >0.4 required before the study images could be rated. The 
scorers were blinded to the pre-endoscopy preparation relating to each photograph. The 
mean visibility scores for the 3 groups were compared.  
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7.7 Inclusion Criteria  
Patients referred for routine or CWT pathway outpatient upper gastrointestinal endoscopy at 
Queen Alexandra Hospital, Cosham. 
1. Minimum Age 18. No maximum age. 
 
7.8 Exclusion Criteria  
1. Cases with severe oesophagitis  
2. Emergency cases (eg gastrointestinal bleeding) 
3. Patients who would already receive NAC/Simeticone pre-endoscopy as part of 
their standard care 
4. Patients with a known stricture or stenosis (narrowing) 
5. Pregnant or breastfeeding women 
6. Patients with a known upper gastrointestinal malignancy 
7. Patients with a previous CVA resulting in pharyngeal weakness or paralysis 
8. Patients with bulbar or pseudobulbar palsy 
9. Patients with a history of previous oesophageal or gastric surgery 
10. Patients who are currently in another clinical trial 
11. Patients with a known allergy to NAC or Simeticone 
 
7.9 Safety Monitoring/Adverse events 
All procedural adverse events were recorded. Participants were provided with a card 
detailing the nature of the study medication to be shown to healthcare providers should 
they have experienced any adverse events after leaving hospital. Participants were then 
contacted by telephone 2-7 days after endoscopy to check for any possible delayed 
adverse events. Only events occurring in the first 48 hours following the study endoscopy 
were considered to be adverse events. It was anticipated that any possible adverse events 
were likely to occur during the procedure, in the period immediately after the procedure, 
or possibly in the 24 hours following the procedure, given that Simeticone is not absorbed 
from the gastrointestinal tract and that the half-life of n-acetylcysteine is estimated to be 
3.5-6.25 hours287, 288. 
177 
 
Procedures for 24 hour emergency unblinding of study group allocation were put in place 
but this was not required during the study. 
  
 
7.10 Selection of Participants 
Patients referred to PHT for outpatient (day case) upper gastrointestinal endoscopy were 
identified as possible study participants if felt eligible and meeting the inclusion criteria by 
the clinician processing their referral. 
  
 
7.11 Statistics & Sample size calculation 
 
Visibility scores of 1-4 were rated for 4 locations (1 best, 4 worst) giving a total score 
range 4-16. Based on the results of previous similar studies we predicted the mean score 
in groups B&C to be 8.2 with a standard deviation of 2.7. The standard deviation of group 
A was expected to be 1.2. 
  
We aimed to be able to detect a 20% improvement in overall visibility score which would 
be considered clinically significant based on clinical experience. 
 
Based on a significance level of 0.017 to allow for multiple comparisons between the 3 
groups and a power of 80%, a sample size of 40 patients in each group (120 in total) was 
required. To allow for missing or spurious data occurring in 5% of cases the sample size 
was increased to 126 (42 patients per group). 
 
Inter-observer agreement was calculated using mean weighted Fleiss’s kappa. 
 
Mean total mucosal visibility scores between groups were compared using one-way 
analysis of variance with Tukey’s test to detect between group differences. In post-hoc 
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testing the Kruskall-Wallis test was used to compare the distribution of scores between 
groups. 
 
Procedure duration and mean flush volume were compared using one-way analysis of 
variance with Tukey’s test to detect differences between groups. 
 
 
 
7.12 Results 
7.12.1 Enrolment & Exclusions 
A total of 126 patients were recruited to take part in the study and randomised to the 3 
study groups. Three patients were excluded as their procedure could not be completed 
and 1 was excluded as severe oesophagitis was found (a pre-defined exclusion criteria) – 
see flow chart figure 53. 
In two further patients 1 of the 4 study photographs was not captured due to technical 
reasons. The remaining 3 study photographs for each of these participants were included 
for analysis. 
One further patient was excluded from the analysis for procedure duration and flush 
volume as they were found during the procedure to have an actively bleeding 
angiodysplasia requiring endoscopic intervention. 
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Figure 53 - Study enrolement and exclusions flow chart 
 
7.12.2 Baseline group demographics 
The 3 study groups were well matched in terms of baseline demographics and indications 
for endoscopy - see table 50. There was a significant difference found between groups in 
the number of patients referred for investigation of dysphagia (P = 0.04), but not for any 
other indications for gastroscopy. 
 
 
 
Randomised Group A   
n =42  
 
Randomised Group B  
n = 42 
 
Randomised Group C  
n = 42 
 
126 patients enrolled 
 
Excluded Group A   
n = 1 (incomplete 
procedure) 
  
Excluded Group B   
n = 2 (incomplete 
procedure) 
Excluded Group C   
n = 1 (severe 
oesophagitis)  
 
Analysed Group A   
n = 41 
  
Analysed Group B  
n = 40 
 
Analysed Group C   
n = 41  
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Table 50 - Baseline demographics, indications for endoscopy, significant regular medications, relevant comorbidities 
and procedural medications.PPI = proton pump inhibitor, H2RA = histamine 2 receptor antagonist 
Study Group A (Water/NAC/ 
Simeticone) 
B (Water) C (No prep.) P value 
Male Gender 
    n (%) 
 
22 (53.7) 
 
20 (50.0) 
 
20 (48.8) 
 
0.90 
Age (Years) 
   mean (SD) 
 
63.8 (15.8) 
 
62.3 (15.4) 
 
61.9 (16.2) 
 
0.84 
Indication – n  
   Dyspepsia/Heartburn 
   Dysphagia 
   Anaemia 
   Barrett’s surveillance 
   Weight loss 
   Duodenal biopsies (+ve TTG) 
   Abnormal radiology 
   Ulcer healing check 
   Other 
 
21 
4 
6 
7 
2 
1 
1 
1 
5 
 
22 
7 
4 
6 
4 
1 
0 
0 
9 
 
13 
13 
5 
8 
2 
1 
0 
4 
4 
 
0.10 
0.04 
0.80 
0.84 
0.59 
1.00 
0.37 
0.07 
0.26 
Regular Medication - n 
   PPI/H2RA 
   Prokinetic 
   Calcium channel antagonist 
 
31 
5 
9 
 
27 
2 
6 
 
30 
4 
6 
 
0.61 
0.50 
0.60 
Comorbidities - n 
    Type 1 Diabetes 
    Type 2 Diabetes 
    Gastroparesis 
 
2 
5 
0 
 
0 
5 
0 
 
0 
6 
1 
 
0.13 
0.93 
0.37 
Procedural medication – n 
   Throat spray 
   Sedation 
 
33 
19 
 
30 
23 
 
29 
26 
 
0.59 
0.31 
 
Use of medications which may affect gastric fluid secretion or gastric emptying (PPI, 
H2RA, prokinetics and calcium-channel antagonists) did not differ significantly between 
the three groups. There were also no significant differences in the prevalence of 
conditions which may affect gastric emptying (diabetes mellitus, gastroparesis). 
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7.12.3 Inter observer agreement prior to rating study images 
80 non-study images were used to ensure adequate inter-observer agreement when 
using the 4-point mucosal visibility rating scale prior to rating of the study images. The 
mean weighted kappa value between the 4 assessors was 0.583. 
 
7.12.4 Primary outcome measure – mucosal visibility scores 
Analysis of the primary outcome measure of mean total mucosal visibility score (TMVS) 
showed significant differences between groups. Mucosal visibility was significantly better 
in group A compared to groups B or C (P<0.001 for both comparisons). No significant 
difference in mean TMVS was found between groups B and C (P=0.541) – see table 51 
Table 51 - Mucosal visibility scores 
Study Group → A (Water/NAC/ 
Simeticone) 
B (Water) C (No prep.) P value 
A vs B 
P value 
A vs C 
P value 
B vs C Location Score  
(mean, 95%CI) 
Lower 
Oesophagus 
1.18 (1.09-1.28) 1.69 (1.48-
1.89) 
1.93 (1.66-
2.21) 
0.002 <0.001 0.210 
Upper Body 1.58 (1.39-1.77) 2.34 (2.11-
2.57) 
2.36 (2.10-
2.62) 
<0.001 <0.001 0.992 
Antrum 1.20 (1.09-1.30) 2.31 (2.02–
2.60) 
2.40 (2.08-
2.71) 
<0.001 <0.001 0.869 
Fundus 1.45 (1.27-1.63) 2.10 (1.90-
2.30) 
2.16 (1.92-
2.40) 
<0.001 <0.001 0.914 
Total 5.40 (5.02-5.80) 8.44 (7.91-
8.97) 
8.85 (8.17-
9.53) 
<0.001 <0.001 0.541 
 
Sub-analysis of the results for each of the 4 pre-defined locations showed very similar 
results with significantly better mean visibility score in group A compared to groups B/C 
and no significant difference in mean score between groups B and C. 
Post-hoc testing was carried out to assess the distribution of mucosal visibility scores 
between groups. Results are shown below in table 52 and figure 54. 
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Table 52 - Distribution of mucosal visibility scores. 
Group A (Water/NAC/ 
Simeticone) 
B (Water) C (No prep.) P value 
Score - n (%) 
    1 
    2 
    3 
    4 
 
459 (70.4%) 
167 (25.6%) 
16 (2.5%) 
10 (1.5%) 
 
176 (27.7%) 
258 (40.6%) 
160 (25.2%) 
42 (6.6%) 
 
162 (24.7%) 
286 (43.6%) 
115 (17.5%) 
93 (14.2%) 
 
<0.001 
Images rated as 
inadequate prep 
(3/4) – n (%) 
26 (4.0%) 202 (31.8%) 208 (31.7%)  
Total - n 652 636 656  
 
 
 
 
Figure 54- Distribution of mucosal visibility scores. 
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 There were significant differences between the 3 groups in the distribution of mucosal 
visibility scores when compared using the Kruskal-Wallis test (P<0.001). 96% of images in 
group A were rated as not requiring additional use of flushing to achieve adequate views, 
compared to 68.2% in group B and 68.3% in group C.  
The mean weighted kappa for the study images was 0.605, indicating good interobserver 
agreement289. 
 
7.12.5 Secondary outcomes – procedure duration and volume of flush used 
No significant differences in mean procedure duration were found between the 3 groups 
– see table 53.  There was a trend towards shorter procedure duration in group A but this 
did not reach statistical significance. 
Mean flush volume required to achieve mucosal views during gastroscopy was 2ml for 
group A compared to 31.5ml for group B and 39.2ml for group C. The difference in mean 
volume between groups A and B and also groups A and C were highly statistically 
significant – see table 53. No significant difference in flush volume was found between 
groups B and C. 
Table 53- Procedure duration and volume of intraprocedural flush required 
Group A (Water/NAC/ 
Simeticone) 
B (Water) C (No prep.) P value 
A vs B 
P value  
A vs C 
P value 
B vs C 
Procedure 
duration, mean 
(+/-SD) - 
seconds 
309 (+/- 129) 352 (+/- 216) 334 (+/- 118) 0.438 0.758 0.863 
Flush volume, 
mean (+/-SD) - 
ml 
2.0 (+/- 9.3) 31.5 (+/- 38.3) 39.2 (+/- 45.4) 0.001 <0.001 0.583 
 
184 
 
7.13 Adverse events 
One serious adverse event occurred during the study. A participant developed 
laryngospasm shortly after intubation of the oesophagus during gastroscopy. The 
procedure was abandoned and the participant recovered quickly with no long-term 
sequelae. The participant had been randomised to group B and had received water pre-
procedure. Laryngospasm is a recognised rare complication of gastroscopy and 
independent review deemed that this was not related to the administration of water. 
One other participant had a minor adverse event recorded (self-limiting abdominal 
cramps and one episode of diarrhoea the day after gastroscopy). They had been 
randomised to study group C and received no pre-gastroscopy preparation. 
 
7.14 Discussion 
This randomised controlled trial examined the impact of a pre-gastroscopy drink 
containing the mucolytic agent n-acetylcysteine and defoaming agent simeticone, on 
mucosal visibility during routine outpatient gastroscopy. Two control groups were used, 
one receiving water, and the other no preparation. The endoscopists performing study 
procedures and the 4 separate endoscopists who assessed the study images were all 
blinded to group allocation. The active study medication was well tolerated by all 
participants and did not result in any adverse events or reactions. 
Analysis of the primary outcome showed significant improvements in mucosal visibility in 
the group receiving the active study medication compared to both control groups. Thus 
this study is in keeping with the findings of several previous studies in demonstrating 
improvements in gastric mucosal visibility with a pre-gastroscopy drink containing a 
mucolytic and a defoaming agent 278, 279, 283. This is only the second study to examine the 
specific combination of simeticone and NAC in a Western population and the first to 
specifically assess mucosal visibility in this group. In a post-hoc analysis only 4% of images 
in the group receiving the active study medication were deemed inadequate compared to 
32% in the water and no preparation groups.  
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Secondary outcome measures demonstrated a marked reduction in the volume of flush 
required in group A compared to groups B/C to achieve adequate mucosal views. We 
hypothesised that reduced need for flushes may reduce procedure time but although 
there was a trend towards reduced time in group A this did not reach significance. This 
may be due to confounding factors such as indication for endoscopy and findings during 
the procedure. Barrett’s surveillance cases tend to result in a longer procedure time due 
to the need to carefully assess the Barrett’s mucosa and take multiple biopsies, however 
the proportion of Barrett’s cases was similar in the three study groups. A larger study may 
have sufficient statistical power to show a significant difference in procedure time 
between the groups. Whilst no significant difference in procedure time was 
demonstrated it can be argued that for subjects in group A more time could be spent 
carefully assessing a mucosal surface that was free of mucus and bubbles. In contrast in 
groups B & C some of the procedure time would be spent flushing the mucosal surface 
before adequate views could be achieved, thus reducing the amount of procedure time 
utilised for careful mucosal inspection. 
The importance of adequate bowel cleansing preparation prior to colonoscopy is well 
understood and numerous studies, including the data presented in chapter 6, have 
demonstrated the importance of good bowel preparation to improve adenoma 
detection85-88. In contrast, at least in the West, the concept of giving preparation prior to 
gastroscopy is not familiar to most endoscopists and preparation is not routinely used. In 
a nationwide survey, no UK endoscopy units were routinely using a mucolytic drink prior 
to gastroscopy290. Adequate preparation prior to gastroscopy is now of even greater 
importance than in previous years; with improved endoscopic technology, enhacement 
techniques and training endoscopist can detect and remove subtle precancerous lesions 
and early cancer. However for this to be possible requires good views of the mucosal 
surface. 
Quality of gastroscopy is currently high on the agenda for national societies such as the 
British Society of Gastroenterology291. This has been driven by the recognised miss rate 
for oesophageal and gastric cancers at index endoscopy and the need to detect early 
neoplasia to improve outcomes. Clearly, achieving adequate views of the mucosa is a key 
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component of performing a high quality gastroscopy, although at present this not a 
quality assurance standard in the UK292.  
Whereas previous studies of pre-endoscopy preparatory drinks have demonstrated 
improvements in gastric mucosal visibility, this is the first study to demonstrate improved 
mucosal visibility in the lower oesophagus. This is a vital area for careful inspection during 
gastroscopy, particularly as the incidence of oesophageal adenocarcinoma and gastro-
oesophageal junction adenocarcinoma has risen rapidly in the UK in recent years. Early 
dysplastic lesions arising in Barrett’s oesophagus, the precursor of oesophageal 
adenocarcinoma, can be subtle and easily missed hence clear views of this area of the 
upper GI tract are vital.  
The use of mucosal visibility as the primary outcome measure of this study is of course a 
surrogate marker for detection of upper gastrointestinal neoplasia. Hence the results of 
this study do not prove that use of a pre-endoscopy drink containing NAC and simeticone 
would improve detection of neoplasia. Due to the high prevalence of upper 
gastrointestinal symptoms in the general population, most of whom have normal findings 
or benign disease at endoscopy, the incidence of neoplasia in patients referred for 
gastroscopy is low. Hence to conduct a study powered to detect an increase in the 
diagnosis of neoplasia would require tens of thousands of patients.  
There are of course downsides of giving a pre-gastroscopy drink: time to prepare the 
drink lengthens the overall time to complete the procedure and may reduce the number 
of cases that can be performed on an endoscopy list. In practice it takes 2-3 minutes for a 
nurse to prepare and administer the drink. In this study the drink was given 5-10 minutes 
prior to the procedure which led to a further delay whilst waiting for the drink to take 
effect. However with careful planning patients could be administered the drink in 
advance of entering the endoscopy suite. There are also cost implications. At current 
prices the drink costs £1.21 per patient. A busy endoscopy unit such as Portsmouth 
Hospitals NHS Trust performs around 6,000 gastroscopies per annum so this would result 
in additional annual costs of around £7,000. The majority of the cost results from the use 
of NAC, with simeticone costing only 8.2 pence per patient, hence the cost-effectiveness 
of a solution containing just simeticone may be greater. The main concerns regarding 
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safety of administering a drink prior to endoscopy are those of potential aspiration of 
fluid. In this study no adverse events related to study medication occurred. Similarly none 
have been reported in other similar studies. It is not uncommon to find small to moderate 
amounts of gastric fluid residue when performing gastroscopy and hence we do not feel 
that the small volume of fluid used in this study significantly increase risk of aspiration.  
In summary this study confirms that a pre-gastroscopy drink containing simeticone and 
NAC significantly improves mucosal visibility in the lower oesophagus and stomach and 
reduces the need for procedural flushing. This has the potential to become part of 
standard pre-gastroscopy preparation to improve the detection of upper gastrointestinal 
neoplasia and improve overall outcomes from upper gastrointestinal cancer. 
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Chapter 8 - Colonic lesion assessment skills amongst UK 
endoscopists  
 
8.1 Introduction 
Accurate assessment of colonic lesions is required for their optimum management during 
colonoscopy. Benign adenomatous polyps should be endoscopically resected, but lesions 
demonstrating endoscopic features suggestive of submucosal invasion should be 
tattooed, biopsied and referred for surgical resection. Hyperplastic polyps located in the 
recto-sigmoid colon have negligible malignant potential and therefore can in theory be 
safely left in situ. However the practice of most colonoscopists at present is to remove all 
polyps. 
Data from the UK national colonoscopy audit suggest that approximately half a million 
colonoscopies are performed in the UK each year81. During the course of their career 
most endoscopists who perform regular colonoscopy will perform several thousand 
colonoscopies, and therefore encounter and manage several thousand colonic lesions.  
In the United Kingdom completion rates, sedation levels and safety are assessed as a 
routine part of colonoscopy training293, monitored and enforced by the Joint advisory 
Group (JAG) for gastrointestinal endoscopy.  More recently the DOPyS (Direct 
Observation of Polypectomy Skills) assessment 294 has been introduced. Currently neither 
the JAG assessment process, nor the 2010 gastroenterology higher specialist training 
curriculum include any formal training in the skills of colonic lesion assessment295. 
This study aimed to assess the competence of UK gastroenterology trainees' and 
established consultants' in the skills of in vivo diagnosis of colonic lesions, plus the impact 
of a dedicated colonic lesion assessment training intervention. 
 
8.2 Methods  
An existing image library of 37 colonic lesions developed as part of a previous study296 
was used. The 37 lesions consisted of 13 hyperplastic polyps, 15 adenomatous polyps and 
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9 submucosally invasive cancers. High quality images of each lesion viewed in 3 modalities 
were used: white light (WL), 0.2% indigo carmine chromoendoscopy (IC) and 0.2% indigo 
carmine chromoendoscopy with magnification (MIC), giving 111 images in total. Images 
were incorporated into a Powerpoint presentation (Microsoft, UK) displaying one image 
per screen with the 3 images of each lesion presented sequentially (WL-IC-MIC) see figure 
55. 
 
 
Figure 55 - Example images from image library of colonic lesions viewed with white light, chromoendoscopy and 
magnifying chromoendoscopy. A – hyperplastic polyp, WL; B – adenoma, WL; C – invasive cancer, WL; D – hyperplastic 
polyp, IC, E – adenoma, IC; F – invasive cancer, IC, G – hyperplastic polyp, MIC; H – adenoma, MIC; I – invasive cancer, 
MIC 
Participants were divided in to 4 groups :-  
• 5 general consultant gastroenterologists without any special interest in in-vivo 
diagnosis (Consultants, range 1500-5000 colonoscopies performed)  
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• 5 gastroenterology trainees (Trainees, range 5-1000 colonoscopies performed)  
• 5 bowel cancer screening programme specialist nurses (Nurses, not performing 
endoscopy) 
• 2 Experts - a UK based and Japanese expert endoscopists both using in-vivo 
diagnostic techniques including indigo carmine on a regular basis in their daily 
practice (Experts). 
Participants were asked to classify the lesion displayed in each image as either a 
hyperplastic polyp, adenomatous polyp or invasive cancer. No feedback was given and 
participants were unaware of the number of each type of lesion used in the study. 
Following this first testing phase all participants in the Trainee, Consultant and Nurse 
groups participated in a 20 minute computer based training module using Microsoft 
Powerpoint – see figure 56. This included information on the principles of in-vivo 
assessment using white light, chromoendoscopy and magnification chromoendoscopy, 
lesion morphology using the Paris classification258, and Kudo’s pit patterns123-125. The 
module was delivered by the researcher and participants were encouraged to clarify 
learning points, ask questions and return to earlier part of the module to reinforce 
learning if required. Participants then repeated the testing phase in an identical manner. 
  
Figure 56 - Example slides from the in-vivo diagnosis training module. 
 
8.3 Statistics 
Participant classification of each lesion was compared to the formal histopathological 
diagnosis as established by an experienced Japanese specialist gastrointestinal 
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histopathologist . Mean accuracy rates, sensitivity and specificity for neoplasia for each 
group of participants were calculated, with 95% confidence intervals. For comparison of 
accuracy between groups, before and after training, one-way analysis of variance with 
post-hoc Tukey’s test was used. For comparison of each group’s accuracy, sensitivity and 
specificity before and after training the McNemar’s test was used. The results of this 
study are considered experimental hypothesis-generating data and hence no correction 
for multiple comparisons was made. A P value of <0.05 was considered statistically 
significant. 
 
8.4 Results 
8.4.1 Overall accuracy pre and post training 
Prior to undergoing the training module the mean overall accuracy was 61.1% for the 
Trainee group, compared to 67.6% for the Consultant group, and 60.0% for the Nurse 
group. The mean score for the 2 experts was 89.6%. Mean scores following the training 
module were 71.2% for the Trainee group, 72.6% for the Consultant group and 67.2% for 
the Nurse group – see table 54. 
Comparison between groups prior to training showed accuracy of lesion assessment did 
not differ significantly between the Consultant, Trainee and Nurse groups. The two 
experts performed significantly better than each of the other 3 groups (p<0.001 for all 3 
comparisons). 
Following the training module there was a significant improvement in the mean accuracy 
for all 15 participants from 62.9% to 70.3% (p<0.001, McNemar’s test). Subgroup analysis 
showed that significant improvement occurred in all 3 groups. The trainee group 
improved from an accuracy of 61.1% to 71.2% (P<0.001), the Consultant  from 67.6% to 
72.6%, (p=0.037) and the Nurse groups from 60.0% to 67.0% (p=0.005). The performance 
of the two experts remained significantly better than all 3 groups post-training (p<0.02 for 
all 3 comparisons). Changes in accuracy pre and post-training for individual participants 
are shown in figure 57. 
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Table 54 - Overall accuracy pre- and post-training* Consultant vs Trainee comparison, ** Trainee vs Nurses, *** 
Consultant vs Nurse, ****Expert vs all 3 groups 
 Accuracy pre-training  
Correct/Total, 
% (95% CI) 
P value Accuracy post-training  
Correct/Total, 
% (95% CI) 
P value 
Consultant 375/555 
68% (61-74%) 
0.170* 403/555 
73% (67-79%) 
0.920* 
Trainee 339/555 
61% (54-68%) 
0.982** 395/555 
71% (68-74%) 
0.519** 
Nurses 333/555 
60% (56-64%) 
0.092*** 372/555 
67% (56-78%) 
0.320*** 
     
Experts 199/222 
90% (85-93%) 
<0.001****   
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 Figure 57- Overall score (max 111) pre and post training. Individual subjects represented by each line and colour-coded 
by group. 
 
8.4.2 Sensitivity pre- and post-training 
Mean sensitivity for neoplastic histology for the 15 participants improved from 68.3% to 
73.2%, a significant increase – see table 55. When analysed by participant group, the 
increase in mean sensitivity post-training was limited to the nurse group, not reaching 
statistical significance for the consultant or trainee groups. 
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Table 55 - Sensitivity for neoplasia pre- and post-training. P values comparing pre- and post-training performance using 
McNemar’s test  
 Sensitivity  
pre-training  
Correct/Total, 
% (95% CI) 
Sensitivity  
post-training  
Correct/Total, 
% (95% CI) 
P value 
All subjects 738/1080 
68% (63-73%) 
791/1080 
73% (70-76%) 
0.002 
    
Consultant 257/360 
71% (59-84%) 
271/360 
75% (66-85%) 
0.151 
Trainee 245/360 
68% (57-79%) 
262/360 
73% (68-78%) 
0.100 
Nurses 236/360 
66% (54-77%) 
258/360 
72% (66-77%) 
0.047 
 
8.4.3 Specificity pre- and post-training 
Mean specificity for all participants increased significantly from 52.8% to 64.7% - see table 56. 
Analysis by group showed increased mean specificity in all 3 groups post-training, but the increase 
only reached statistical significance in the trainee group.  
Table 56 - Specificity pre- and post-training. P values comparing pre- and post-training performance using 
McNemar’s test  
 Specificity  
pre-training  
Correct/Total, 
% (95% CI) 
Specificity 
post-training  
Correct/Total, 
% (95% CI) 
P value 
All subjects 309/585 
53% (42-63%) 
379/585 
65% (55-74%) 
<0.001 
    
Consultant 118/195 
61% (34-87%) 
132/195 
68% (54-82%) 
0.161 
Trainee 94/195 
48% (23-73%) 
133/195 
68% (58-78%) 
<0.001 
Nurses 97/195 
50% (28-71%) 
114/195 
58% (23-94%) 
0.064 
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 8.4.4 Interobserver agreement 
Prior to training mean kappa values for interobserver agreement were ‘poor’ for the 
Trainee (0.35) and Nurse (0.39) groups and ‘fair’ for the Consultant group (0.43). Mean 
kappa values significantly increased following training for the Consultant and Trainee 
groups but not for the Nurse group – see table 57. Post-training levels of agreement were 
‘fair’ for the Nurse group (0.46) and Consultant group (0.55) and ‘good’ for the Trainee 
group (0.60). 
Table 57 - Interobserver agreement pre- and post-training 
 Mean Pre-training 
kappa (95% CI) 
Mean Post-training 
kappa (95% CI) 
Pre vs Post kappa 
change, p value 
Consultants 0.43 (0.38-0.48) 0.55 (0.48-0.62) 0.002 
Trainees 0.35 (0.28-0.41) 0.60 (0.55-0.64) 0.027 
Nurses 0.39 (0.31-0.46) 0.46 (0.37-0.55) 0.193 
 
8.4.5 Performance by modality 
Performance was also analysed by modality pre-and post-training. For consultants and 
trainees there was no significant differences in overall accuracy between WL, IC and MIC 
assessments either pre- or post-training – see table 58. In the nurse group pre-training 
accuracy was significantly higher for IC assessments compared to WL (P = 0.021) and for 
MIC assessments compared to WL (P=0.016). There was no significant difference in 
accuracy between IC and MIC assessments pre-training. In the nurse group post-training 
there were no significant differences between assessments made with the three 
modalities. 
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Table 58 - Overall accuracy analysed by modality by group and pre-/post-training. 
  Accuracy Pre-training  
Correct/Total, 
% (95% CI) 
P value 
(ANOVA) 
Accuracy Post-training   
Correct/Total 
% (95% CI) 
P value 
(ANOVA) 
Consultants 
    WL 
    IC 
    MIC 
 
125/185, 68% (61-74%) 
125/185, 68% (57-78%) 
125/185, 68% (64-71%) 
1.000  
131/185, 71% (66-75%) 
139/185, 75% (66-85%) 
133/185, 72% (62-82%) 
0.579 
Trainees 
    WL 
    IC 
    MIC 
 
120/185, 65% (57-73%) 
117/185, 63% (53-74%) 
102/185, 55% (44-66%) 
0.160  
136/185, 74% (71-76%) 
131/185, 71% (67-75%) 
128/185, 69% (65-73%) 
0.084 
Nurses 
    WL 
    IC 
    MIC 
 
98/185, 53% (48-58%) 
117/185, 63% (57-69%) 
118/185, 64% (56-72%) 
0.010  
126/185, 68% (64-73%) 
123/185, 67% (55-78%) 
122/185, 66% (48-84%) 
0.939 
 
 
8.5 Conclusions 
Colonoscopy is one of the main weapons in the battle to reduce death from colorectal 
cancer. High quality colonoscopy with removal of precursor lesions and detection of early 
stage cancers has been shown to reduce colorectal cancer death rates40, 297, 298. In recent 
years there has been a drive to improve the quality of colonoscopy in the UK, both in 
terms of the quality of patient experience but also the main outcome measures such as 
caecal intubation and adenoma detection81, 181. Improved caecal intubation rates, bowel 
preparation and withdrawal techniques improve colonic lesion detection92, 93, 299. What is 
not known is the quality of colonic lesion interpretation and subsequent management of 
those lesions. Potential precursors of cancer such as adenomatous polyps and proximal 
serrated polyps should be removed. Distal hyperplastic polyps have negligible malignant 
potential and a future paradigm may be that these can be left in situ if identified with 
high confidence251. 
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Interpretation of larger colonic lesions can be difficult: Benign laterally spreading tumours 
(LST) are amenable to endoscopic resection (ER). However over-enthusiastic biopsy of 
these lesions has been shown to lead to submucosal fibrosis, hampering subsequent 
attempts at ER300. Conversely, for lesions which have areas showing features of 
submucosal invasion such as irregular Kudo pit pattern124, 125 or depressed areas258 ER 
should generally not be attempted and referral for surgery should be made following 
biopsy and tattooing. LSTs cannot be assessed by biopsy alone and in-vivo diagnostic skills 
are vital for appropriate management to be instituted. 
This picture based study examined colonic lesion assessment skills in 3 groups of 
endoscopists (trainees, consultants and experts) plus UK Bowel Cancer screening nurses 
who do not perform any endoscopic procedures. The results would suggest that lesion 
assessment skills are not simply obtained through routine colonoscopy experience. They 
are specific skills which can be learnt through focused education and training.  
The results of this study demonstrate that the baseline level of lesion assessment skills is 
limited for gastroenterology consultants and trainees. Overall accuracy improved 
significantly for all 3 groups after a brief intervention but the magnitude of the increase in 
accuracy was small. However this does demonstrate that even a brief intervention can 
improve diagnostic accuracy. When sensitivity and specificity for neoplasia were assessed 
there was significant improvement for the 15 subjects analysed as a whole. However, 
when analysed by group, the improvement in sensitivity was only significant in the Nurse 
group and improvement in specificity was only significant in the Trainee group. Specificity 
for the Trainee and Nurse groups was lower pre-training than the consultant group which 
may be explained by these groups being more risk-averse and concerned about under-
calling a potential neoplastic lesion. Consultants, by the nature of their job, are key 
decision makers and are more used to making risk-assessments on a regular basis. It is 
also notable that post-training confidence intervals were much narrower for sensitivity 
than for specificity, indicating greater variability between subjects in their ability to 
identify non-neoplastic lesions. 
The 2 expert endoscopists who used in vivo diagnostic techniques such as indigo carmine 
chromoendoscopy frequently in their usual practice showed significantly higher accuracy 
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levels than each of the other 3 groups. This is unsurprising and simply validates the 
assessment tool. Prior to the training intervention there were no significant differences in 
accuracy between Consultant, Trainee and Nurse groups. Post-training again there was no 
difference in overall accuracy between the three non-expert groups.  This is despite the 
consultant group having many years and several thousand procedures greater experience 
in colonoscopy and in vivo interpretation of hundreds-thousands of colonic lesions in real-
life clinical practice. The results of this study suggest that there is room for improvement 
in lesion assessment amongst both trainees and experienced consultants with neither 
group performing any better than non-endoscopist nurses. 
Following the brief training intervention delivered to the 3 non-Expert groups the mean 
accuracy of the 15 subjects combined improved significantly. Subgroup analysis showed 
that a significant gain in mean accuracy was seen in all three groups, when the 
performance of the 5 participants in each groups was analysed together. However, as can 
be seen in figure 57, improvement was not seen for every individual participant.  
Significant improvement in inter-observer agreement was also seen in the Consultant and 
Registrar groups following the training intervention. 
Overall the gains in accuracy seen following training were modest (from a mean of 63% to 
70% for the 15 subjects overall). Previous similar studies have shown greater 
improvements in accuracy using a similar brief training intervention. Raghavendra et al., 
demonstrated an improvement in accuracy from 47.6% to 90.8% in distinguishing 
hyperplastic and adenomatous polyps viewed with narrow-band imaging (NBI) following a 
20 minute training session301. Ignjatovic et al., performed a similar computer-based 
training study and showed improvement in differentiation between hyperplastic and 
adenomatous polyps viewed with NBI302. A similar study to ours using the same image 
library as our study showed limited improvements with training in interpreting white light 
and chromoendoscopy images of hyperplastic and adenomatous polyps296. However 
improvements in accuracy in interpreting NBI images were greater. Our study does differ 
from those described above in that three categories of colonic lesions were included 
(hyperplastic polyps, adenomatous polyps and early invasive cancers), rather than two 
(hyperplastic and adenomatous polyps) and hence the chances of a correct result from a 
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‘guess’ would be lower. The difference in results may indicate that it may be easier to 
learn interpretation of NBI rather than traditional chromoendoscopy.  
Apart from in the Nurse group pre-training, no significant differences in accuracy were 
found when assessments made with different modalities (WL/IC/MIC) were compared, so 
the potential advantage of IC chromoendoscopy for in vivo characterisation 
demonstrated in many previous studies is likely to require a longer dedicated period of 
experience and training. Trainees actually performed best with WL (although not 
statistically different to IC/MIC) and therefore, at least initially they may find IC/MIC 
images difficult to interpret despite brief training. 
Whereas other studies focussed mainly on interpretation of vascular and surface 
patterns, our training module also included information on overall lesion morphology 
according to the Paris classification258. The amount of information included may have 
been too much for the participants to acquire within a 20 minute training session. 
Following training, the overall accuracy of the 3 non-expert groups fell well short of that 
achieved by experts. It is likely that to become highly proficient in in-vivo assessment 
requires not only learning through studying images but incorporation of advanced 
imaging and chromoendoscopy techniques into an endoscopists regular daily practice 
over a prolonged period of time. Mentoring and teaching during real life cases is also 
likely to be an important part of the learning process. 
If in-vivo diagnosis is to become a part of routine clinical care then training programmes 
will need to be developed and robust methods for assessing competence established. 
This study would suggest that training is more complex than a simple brief intervention, 
and does not support the findings of earlier studies suggesting that in-vivo diagnosis can 
be learnt in as little as 20 minutes301, 302. This would be in keeping with the results seen in 
community-based in-vivo diagnosis studies where the results were sub optimal219, 226, 235, 
254. 
This study had some limitations: picture based studies do not always reflect real-life in-
vivo interpretation of lesions. The spectrum of lesions included a far higher proportion of 
early cancers than would be encountered in everyday practice. 
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In summary our study showed gains in diagnostic accuracy of lesions viewed following a 
brief training intervention. Before and after training there was no difference in mean 
accuracy between consultants, registrars and nurses, however two expert endoscopists 
had significantly greater accuracy in lesion characterisation. 
At present, even basic in-vivo diagnostic skills and lesion assessment do not feature in the 
curriculum for higher specialist trainees in gastroenterology in the UK. Given the advances 
in this field over the past few years there is a strong case for lesion assessment to become 
a standard part of training in colonoscopy, which should be learnt alongside technical 
skills for endoscope handing and therapeutic procedures.  
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Chapter 9 - Endoscopic characterisation of small colonic 
polyps – comparison between medical students, registrars 
and consultants and the impact of a novel web-based 
training intervention 
 
9.1 Introduction 
Small colonic polyp characterisation has been identified as a key goal for novel 
endoscopic advanced imaging techniques and is an area of much research activity251. As 
described in previous chapters, whilst experts and those with an interest in-vivo 
diagnostic techniques can obtain high levels of accuracy, this level of performance has not 
generally been seen in studies of non-expert endoscopists who have no particular 
experience or expertise in this area. 
Hence the issue of training in advanced diagnostic imaging techniques is of paramount 
importance if use of these techniques is to become part of everyday practice in the 
endoscopy community as a whole. 
Several studies have examined the impact of brief training interventions on small colonic 
polyp characterisation. The previously described studies performed by Ignjatovic and 
Raghavendra both showed significant improvements in NBI characterisation in picture-
based studies following a training session lasting only 15-20 minutes301, 302. In a similar 
study by Neumann et al., 4 subjects underwent a one hour i-Scan training session 
followed by interpretation of 110 polyp images in batches of 22233. Feedback was given 
after each image and mean accuracy improved from 73.9% in the first set to 94.3% in the 
final set. Thus there appears to be a learning effect of feedback. Patel et al., 
demonstrated similar high accuracy rates following a video-based NBI training 
programme with feedback after each of 80 polyp videos303. Coe et al., examined the 
impact of two one-hour training sessions on the use of NBI for SCP characterisation. They 
assessed real-time in-vivo characterisation accuracy of 15 endoscopists who were split 
into those receiving training, and a control group, who did not receive training304. No 
202 
 
significant improvement in prediction of polyp histology or surveillance intervals occurred 
following the training sessions.  
Our previous in-vivo characterisation study described in chapter 5 demonstrated that in 
the hands of an expert endoscopist there was no significant difference in accuracy 
between HDWL imaging and i-Scan image enhancement. Whether this would be the case 
for less experienced endoscopists has not been addressed by previous in-vivo 
characterisation training studies, which have all only assessed an advanced imaging 
technique (NBI/i-Scan) but not white-light imaging. Our study described in chapter 8 
demonstrated no significant difference in accuracy post-training between white light, 
chromoendoscopy and magnified chromoendoscopy. However it is widely accepted that 
chromoendoscopy has a significant learning curve and hence improvements over and 
above white light accuracy may require a prolonged period of training. 
 
9.2 Aims 
This study aimed to examine the effect of a web-based training module on the accuracy 
in-vivo characterisation of diminutive (<5mm) colonic polyps using white light, i-Scan and 
Indigo carmine. Differences between groups with varying degrees of endoscopic 
experience were also assessed.  
 
9.3 Methods 
This work was formally assessed and deemed to be an evaluation of an educational tool 
and therefore did not require formal research ethics committee approval.  
Images obtained during the study described in chapter 5 were used for this study. 
Informed consent was obtained from all patients for the use of anonymised images of 
polyps for future teaching and training purposes. High quality images of diminutive polyps 
viewed with HDWL, i-Scan 3 (SE+3, CE+2, TE colon) and 0.2% indigo carmine 
chromoendoscopy were selected with 3 images of each polyp used (one with each 
modality). 30 polyps were included in this study, 15 adenomatous and 15 hyperplastic, 
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which corresponds to the approximate proportions of each histological type found in 
DCPs in situ. Therefore in total there were 90 study images of the 30 polyps. 
Histopathological diagnosis as determined by a BCSP accredited histopathologist was 
used as the reference standard for all optical assessments. 
Images were randomised using an online randomisation tool (Graphpad) and 
incorporated into a web-based testing and training module hosted on the University of 
Portsmouth virtual learning platform (Moodle). Participants viewed each image in turn 
and were asked to predict polyp histology (adenomatous vs hyperplastic) and to also 
report their confidence level for each assessment based on the following confidence 
levels :- 
• <70% certain = low confidence 
• 70-90% certain = medium confidence 
• >90% certain = high confidence 
All questions had to be answered to complete the training module. To avoid influence of 
other participants all tests and training were undertaken individually. 
Following the initial ‘pre-training’ testing phase, subjects completed a novel web-based 
training tool on small colonic polyp characterisation. The training module was developed 
using Prezi – a cloud-based presentation software programme, and was designed to take 
15-20 minutes to complete. 
The training module covered several key areas :- 
• Outlining the two main types of SCPs (hyperplastic & adenomatous) 
• Modes of assessing polyps in-vivo – HDWL, i-Scan and indigo carmine 
chromoendoscopy 
• Key features used for SCP characterisation (vascularity, vascular patterns and 
surface patterns) and which features were suggestive of each histological type as 
described in chapter 4. 
• Several image examples of all key features  
• An interactive ‘test’ section where subjects were asked to predict histology, 
followed by feedback on key features visible and the histopathological diagnosis 
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To avoid subject bias the training module did not refer to which key features were visible 
with each imaging modality, nor whether any modality was likely to lead to a more 
accurate prediction of histology. 
Screenshot images from the training module are shown in figures 58-61 below:- 
 
Figure 58 - Screenshot image from the Prezi web-based training module 
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 Figure 59 - Screenshot image from the Prezi web-based training module 
 
Figure 60 - Screenshot image from the Prezi web-based training module 
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Figure 61 - Screenshot image from the Prezi web-based training module 
 
Following completion of the training module subjects underwent a second test module 
using the same 90 polyp images but presented in a different randomised order. 
Subjects were divided into 3 groups:- 
• 3rd year Medical students (n=7) 
o First clinical year students. Limited experience of endoscopy with all having 
attended 0-2 endoscopy lists in total. No previous training on SCP 
characterisation. 
• Gastroenterology Registrars (n=7) 
o Higher specialist gastroenterology trainees. All currently training in 
colonoscopy and polypectomy.  
o No previous formal training in in-vivo diagnostic techniques 
o Median lifetime colonoscopy cases performed 120 (range 30-450) 
• Gastroenterology Consultants (n=7) 
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o No previous formal training in in-vivo diagnostic techniques 
o Median lifetime colonoscopy cases performed 3000 (range 1000-5000) 
o Non-BCSP endoscopists  
 
2 expert endoscopists with extensive experience in in-vivo diagnostic techniques also 
undertook the test module to validate the image library. 
 
9.4 Statistics 
The pre-training test was expected to demonstrate a difference in overall accuracy 
between the 3 subject groups. Based on similar pilot studies the predicted overall 
accuracy on each modality for each group was:- 
• Medical students 60% 
• Registrar 70% 
• Consultant 75% 
Power calculations showed that 7 subjects per group would be required to provide 80% 
power to demonstrate these differences with a significance level of 5%. 
Overall accuracy was expected to be similar in all 3 groups after training 296, 301, 305. It was 
anticipated that following training there will be a small difference in accuracy between 
white light (80%) and iScan/Indigo carmine (85%). 
Comparisons between groups for mean accuracy, sensitivity, specificity and NPV were 
performed by one-way ANOVA. In those comparisons where a significant difference was 
detected using ANOVA, post-hoc testing was performed to detect significant differences 
between pairs of groups using Hochberg’s GT2 test (when sample sizes differed) or 
Tukey’s test. Comparisons of mean accuracy by modality were also performed using one-
way ANOVA and post-hoc Tukey’s test. Differences in performance pre- and post-training 
were compared using McNemar’s test. Differences in confidence levels between groups 
and modality were compared using the Pearson’s chi-squared test. Odds ratios were 
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calculated for two level confidence results (low/medium vs high) if a significant chi-
squared statistic was detected. 
Mean kappa values within groups pre- and post-training were also calculated and 
accuracy of high confidence predictions was also assessed. 
 
9.5 Results 
9.5.1 Overall Accuracy 
Mean overall accuracy results in the pre-training test are shown in table 59 below. No 
significant differences were found between the 3 study groups. The mean accuracy of the 
two experts was significantly higher than the three study groups. 
Table 59- Pre-training accuracy by group with comparisons between groups 
 Accuracy pre-training  
Correct/Total, 
% (95% CI) 
Comparison vs 
Students, P value 
Comparison vs 
Registrars, P value 
Comparison vs 
Consultants, P 
value 
Students 372/630,   
59.1% (50.6-67.5%) 
   
Registrars 414/630,   
65.7% (60.8-70.7%) 
0.530   
Consultants 393/630,   
62.4% (54.0-70.7%) 
0.959 0.959  
Experts 156/180,   
86.7% (58.4-100%) 
0.002 0.020 0.006 
 
In the post-training test mean overall accuracy was higher for all three groups compared 
to pre-training – see table 60. Again there were no significant differences between the 
three study groups but mean accuracy remained significantly higher for the two experts. 
Mean pre- and post-training accuracy results by group and by individual participant are 
displayed in figures 62 & 63. Comparison of mean accuracy pre- and post-training showed 
significant improvement in accuracy post-training for each of the three groups (P<0.001 
for all 3 comparisons) 
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Table 60 - Post-training accuracy by group with comparisons between groups 
 Accuracy post-training  
Correct/Total, 
% (95% CI) 
Comparison vs 
Students P value 
Comparison vs 
Registrars P value 
Comparison vs 
Consultants P 
value 
Students 436/630,   
69.2% (66.1-72.3%) 
   
Registrars 448/630, 
71.1% (67.4-74.9%) 
0.977   
Consultants 449/630, 
71.3% (64.7-77.9%) 
0.966 1.000  
Experts 156/180,   
86.7% (58.4-100%) 
0.002 0.006 0.007 
 
 
 
Figure 62 – Pre and Post-training accuracy by group with comparisons between groups, n=7 for Student, Registrar and 
Consultant groups and n=2 for the Expert group. 
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 Figure 63 - Individual participant accuracy scores pre- and post-training 
 
9.5.2 Sensitivity, Specificity & Negative Predictive Value 
In analysis of sensitivity, specificity and NPV for adenomatous histology, no significant differences 
were found between the 3 groups either pre- or post-training – see tables 61, 62 & 63 
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Table 61 - Pre-training and post-training sensitivity by group with comparisons between groups 
 Sensitivity  
pre-training  
Correct/Total,  
% (95% CI) 
P value for 
comparison 
between groups 
 
Sensitivity      post-
training  
Correct/Total,    % 
(95% CI) 
P value for 
comparison 
between 
groups 
 
Students 175/315, 
55.6% (36.8-74.3%) 
0.285 223/315, 
70.8% (63.1-78.5%) 
0.520 
Registrars 218/315, 
69.2% (59.8-78.7%) 
222/315, 
70.5% (65.6-75.3%) 
Consultants 203/315, 
64.4% (50.3-78.6%) 
234/315 
74.3% (68.4-80.2%) 
 
Table 62 - Pre-training and post-training specificity by group with comparisons between groups 
 Specificity              
pre-training  
Correct/Total,           
% (95% CI) 
P value for 
comparison 
between groups 
 
Specificity         
post-training  
Correct/Total,       
% (95% CI) 
P value for 
comparison 
between 
groups 
 
Students 197/315, 
62.5% (49.6-75.5%) 
0.973 213/315, 
67.6% (55.9-79.4%) 
0.825 
Registrars 195/315, 
61.9% (49.8-74.0%) 
226/315, 
71.7% (64.7-78.8%) 
Consultants 190/315, 
60.3% (37.0-83.6%) 
214/315 
67.9% (50.6-85.2%) 
 
Table 63 - Pre-training and post-training negative predictive value by group with comparisons between groups 
 NPV pre-training  
Mean % (95% CI) 
P value for 
comparison 
between groups 
NPV post-training  
Mean % (95% CI) 
P value for 
comparison 
between 
groups 
Students 59.8% (51.7-67.9%) 0.220 70.2% (67.4-73.1%) 0.523 
Registrars 67.2% (61.4-73.0%) 70.9% (67.4-74.4%) 
Consultants 62.7% (55.4-70.0%) 72.3% (69.2-75.4%) 
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9.5.3 Interobserver agreement 
Mean kappa values for each group pre- and post-training were calculated – see table 64. 
Agreement pre-training in the student group was slight and fair in the registrar and 
consultant groups. There was a significant improvement in mean kappa for all three 
groups post-training. Post training mean kappa was fair for the consultant group and 
moderate for the student and registrar groups. 
 
Table 64 - Mean kappa values by group pre- and post-training 
 Mean Pre-training 
kappa (95% CI) 
Mean Post-training 
kappa (95% CI) 
Pre vs Post kappa 
change, p value 
Students 0.106 (-0.009 – 0.222) 0.472 (0.417 – 0.528) <0.001 
Registrars 0.298 (0.239 - 0.258) 0.541 (0.502 – 0.581) <0.001 
Consultants 0.216 (0.128 – 0.304) 0.371 (0.321 – 0.422) 0.004 
 
9.5.4 Performance by modality 
Accuracy rates achieved when assessing images with each of the three modalities (WL/i-Scan/IC) 
were compared pre-and post-training – see tables 65 & 66 and figure 64.  No significant difference 
in mean accuracy between the three modalities was found pre-training. Post-training mean 
accuracy for WL and IC images was significantly higher than for i-Scan images.  
Following training accuracy for WL and IC images improved significantly (P=0.002 and P<0.001 
respectively) compared to pre-training. However accuracy with i-Scan images did not improve 
significantly post-training (P=0.074). 
Table 65 - Mean accuracy pre-training by modality 
 Accuracy pre-training  
Correct/Total, % (95% CI) 
P value  
 
WL 408/630, 64.8% (59.1-70.4%) 0.317 
i-Scan 378/630, 60.0% (56.1-63.9%) 
IC 392/630, 62.2% (58.2-66.2%) 
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Table 66 - Mean accuracy post-training by modality. WL = white light 
 Accuracy post-training  
Correct/Total, 
% (95% CI) 
Comparison vs WL P 
value 
Comparison vs        
i-Scan P value 
WL 459/630, 72.9% (70.2-75.5%)   
i-Scan 410/630, 65.1% (61.3-68.8%) 0.002  
IC 464/630, 73.7% (70.7-76.6%) 0.927 <0.001 
 
 
 
Figure 64- Pre- and Post-training mean accuracy by modality. WL = white light, IC = indigo carmine 
 
 
 
 
214 
 
9.5.5 Confidence ratings by subject group 
There were significant differences between the three groups pre-training in the spread of 
confidence ratings. As might be expected, students rated few of their predictions as high 
confidence (only 3.7% overall). Registrars and consultants were far more likely to make a 
high confidence prediction, although the majority of their predictions were still rated as 
low or medium confidence – see tables 67 & 68 
 
Table 67 - Prediction confidence ratings pre-training 
 Confidence in predictions Pre-training P value 
 Low Medium High 
Students 428 (67.9%) 179 (28.4%) 23 (3.7%) <0.001 
Registrars 214 (34.0%) 221 (35.1%) 195 (31.0%) 
Consultants 187 (29.7%) 176 (27.9%) 267 (42.4%) 
All Subjects 829 (43.9%) 576 (30.5%) 485 (25.7%)   
     
Experts 19 (10.6%) 36 (20.0%) 125 (69.4%)  
 
Table 68 - Odds ratio of high confidence prediction pre-training - comparison between groups 
 Low/Medium High Odds Ratio High  Confidence Prediction 
(95% confidence interval) 
Prediction confidence pre-training 
Students 
Registrars 
Consultants 
   
607 23 1.0 
435 195 11.8 (7.5-18.5) 
363 267 19.4 (12.4-30.3) 
 
Post-training there remained a significant difference between the three groups in 
confidence levels – see table 69. However the proportion of predictions made with high 
confidence by students had risen from 3.7% to 30.5%, and with medium confidence from 
28.4% to 39.2%. The proportion of high confidence predictions also increased significantly 
for the registrar and consultant groups but to a lesser degree – see table 71. Registars and 
consultants remained more likely to make a high confidence prediction than students but 
the difference was much less marked than seen pre-training– see table 70. 
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Table 69 - Prediction confidence ratings post-training 
 Confidence in predictions Post-training P value 
 Low Medium High 
Students 191 (30.3%) 247 (39.2%) 192 (30.5%) <0.001 
Registrars 139 (22.1%) 207 (32.9%) 284 (45.1%) 
Consultants 145 (23.0%0 176 (27.9%) 309 (49.0%) 
All Subjects 475 (25.1%) 630 (33.3%) 785 (41.5%)  
 
 
Table 70 - Odds ratio of high confidence prediction post-training – comparison between groups 
 Low/Medium High Odds Ratio High  Confidence Prediction 
(95% confidence interval) 
Prediction confidence post-training 
Students 
Registrars 
Consultants 
   
438 192 1.0 
346 284 1.87 (1.49-2.60) 
321 309 2.20 (1.74-2.77) 
 
 
Table 71 - Odds ratio of high confidence prediction pre vs post-training 
 Low/Medium High Odds Ratio High  Confidence Prediction 
(95% confidence interval) 
Prediction confidence - Students 
Pre-training 
Post-Training 
Prediction confidence - Registrars 
Pre-training 
Post-Training 
Prediction confidence - Consultants 
Pre-training 
Post-Training 
   
607 23 1.0 
438 192 11.57 (7.38-18.14) 
 
435 
346 
 
363 
321 
 
195 
284 
 
267 
309 
 
1.0 
1.83 (1.45-2.31) 
 
1.0 
1.31 (1.05-1.63) 
 
 
 
216 
 
9.5.6 Confidence rating by modality 
No significant differences in confidence ratings between modalities were found pre-
training – see table 72. Post-training, subjects were significantly less likely to make a high 
confidence prediction on IC images than WL or i-Scan images -  see tables 73 & 74. 
Table 72 - Confidence ratings by modality pre-training 
 Confidence in predictions Pre-training P value 
 Low Medium High 
WL 280 (44.4%) 190 (30.2%) 160 (25.4%) 0.959 
i-Scan 271 (43.0%) 191 (30.3%) 168 (26.7%) 
IC 278 (44.1%) 195 (31.0%) 157 (24.9%) 
 
Table 73 - Confidence ratings by modality post-training 
 Confidence in predictions Post-training P value 
 Low Medium High 
WL 133 (21.1%) 227 (36.0%) 270 (42.9%) 0.001 
i-Scan 168 (26.7%) 179 (28.4%) 283 (44.9%) 
IC 174 (27.6%) 224 (35.6%) 232 (36.8%) 
 
Table 74 - Odds ratio of high confidence prediction by modality post-training 
 Low/Medium High Odds Ratio High  Confidence Prediction 
(95% confidence interval) 
Prediction confidence post-training 
WL 
i-Scan 
IC 
   
360 270 1.0 
347 283 1.09 (0.87-1.36) 
398 232 0.78 (0.62-0.97) 
 
 
9.5.7 Accuracy of high confidence predictions 
When only high confidence predictions in the post-training test were analysed mean accuracy was 
significantly higher for all three study groups (p<0.01 for all 3)– see table 75 . There was no 
difference in the mean accuracy of high confidence predictions between the three study groups. 
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Accuracy of high confidence predictions by the two experts was higher (93.6% vs 86.7%) but this 
did not quite reach statistical significance (P=0.052). 
Table 75 - Mean accuracy of high confidence predictions. 
 High confidence accuracy post-
training  % (95% CI) 
P value  
 
Students 82.4% (74.3-90.5%) 0.785 
Registrars 79.8% (76.2-83.5%) 
Consultants 82.9% (72.2-93.5%) 
Experts 93.6% (53.6-100%)  
 
9.6 Conclusions 
This large study examined the baseline in-vivo characterisation skills for assessing SCPs 
amongst three groups with widely varying experience of endoscopy and polypectomy, 
plus the impact of a novel web-based training module. Differences between 3 endoscopic 
modalities, HDWL, i-Scan and indigo carmine chromoendoscopy were also examined. 
Perhaps the most striking results are the pre-training accuracy rates which showed no 
significant difference in accuracy between the three participant groups. Accuracy 
amongst medical students, who had observed at most a handful of colonoscopies, did not 
differ from that of experienced endoscopists. One would logically assume that experience 
of performing several thousand colonoscopies, and hundreds/thousands of 
polypectomies during those procedures, would lead to the acquisition of some in-vivo 
diagnostic skills amongst consultants, but these results suggest this is not the case. 
Following the training module, performance improved significantly for all groups, as did 
agreement between subjects and confidence in predictions. However accuracy remained 
significantly below that of expert endoscopists. Although they were not specifically 
addressed by this study the ASGE PIVI criteria for optical diagnosis of DCPs are unlikely to 
have been met by any of the groups following training. To reach the levels of accuracy 
shown by experts is likely to require an ongoing period of practising optical diagnostic 
skills in vivo with regular review and feedback of performance. The studies by 
Neumann233 and Patel303 suggest that feedback on performance is a key component of 
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learning optical diagnosis skills. Both these studies gave feedback after each question in 
their test modules and hence ongoing learning occurred through the testing phase. 
Feedback was not given in this study, and if included, may have improved performance.  
Studies of brief training interventions show varying results in the accuracy achieved by 
participants post-training. In this study, post-training accuracy was around 70% for all 3 
groups, which may suggest that training endoscopists to achieve high accuracy rates is 
more difficult than suggested in other studies. In another study using i-Scan, participants 
achieved 94% accuracy for the final set of study images233. Most other training studies 
have used NBI and reported post-training accuracy levels vary from 80%304, 306 to around 
90%301-303. Several factors could influence post-training accuracy – ability of participants 
to acquire new skills, effectiveness of the training module, imaging modality used and 
difficulty of the test module.  
As demonstrated in figure 64 there was notable variability between participants in the 
improvement in accuracy following training. Of the 21 participants, 17 improved their 
scores following training, 3 remained the same and one actually scored lower post-
training. This variability may be explained by differences between subjects in ability and 
motivation to acquire new skills.  
The training module devised for this study covered several factors used for optical 
diagnosis – vascularity, surface patterns and vascular patterns. NBI training modules are 
likely to just cover vascularity and vascular patterns and hence may be simpler and less 
likely to confuse participants unfamiliar with advanced imaging techniques. The training 
module in this study also covered three modalities – HDWL, i-Scan and indigo carmine 
chromoendoscopy which may have added complexity and the potential to overload 
participants with information.  
The test module used in this study may have been more challenging than those used in 
other studies. In the similar study performed by Ignjatovic et al., an expert group (one of 
whom also participated in this study) achieved 95% accuracy302, compared to 86.7% in 
this study. We selected high quality images for this study but did not restrict selection to 
polyps which showed very obvious and typical features of either hyperplastic or 
adenomatous DCPs, and hence some of the polyps included may have proven to be more 
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‘difficult’ than others. There may be a propensity in studies of this type for researchers to 
select images which demonstrate very apparent features of adenomatous and 
hyperplastic polyps, which may not represent the full spectrum of DCPs found in clinical 
practice. This study used still images for the test module whereas other studies have used 
short videos306, 307 which may enable a more accurate assessment to be made. 
Whereas most other studies have only assessed training in just one endoscopic modality, 
this study compared three different endoscopic modalities, and participants’ ability to 
acquire optical diagnosis assessment skills with each of them. As has been discussed in 
chapter 5, most published studies suggest that advanced imaging techniques or 
chromoendoscopy are superior to white light endoscopy in the assessment of SCPs/DCPs. 
However our in-vivo study reported in chapter 5 found that in the hands of an expert 
endoscopist there was no significant difference between HDWL, i-Scan and 
chromoendoscopy. The results of the study reported in this chapter suggest that this may 
also be the case with non-expert endoscopists and novices (medical students). Following 
the training module, accuracy with HDWL was not significantly different to that with 
chromoendoscopy and was actually significantly higher than accuracy with i-Scan. This 
may suggest that optical diagnosis skills with HDWL are easier to acquire than with i-Scan. 
Endoscopists may have also been unfamiliar with the i-Scan image, and despite 
undergoing the training module, found it more difficult to interpret than a white light 
image that they would be used to seeing in everyday practice. Further studies are 
required comparing advanced imaging techniques with HDWL imaging to explore whether 
HDWL is a viable alternative to NBI/FICE/i-Scan for optical diagnosis. Ongoing research is 
also required to determine what further training is needed for a non-expert endoscopist 
to achieved optical diagnostic accuracy that can meet the ASGE PIVI criteria. This will 
undoubtedly require a period of monitored in vivo training and feedback over a period of 
time, in addition to computer/web based initial training. National and international 
endoscopy societies will need to set out a clear training and certification process for 
optical diagnosis for this to become widespread practice. At present optical diagnosis 
skills do not form part of the curriculum for higher gastroenterology trainees in the UK295. 
Clearly it would make sense to teach these skills alongside technical skills in endoscopy so 
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that newly qualified consultants have acquired them before entering independent 
practice.  
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Chapter 10 – Summary of work and suggestions for future 
research 
 
Endoscopic technology has advanced dramatically in the past few decades. 
 
Figure 65 - Image capture with an early endoscope using a polaroid camera directed at the monitor. 
 
The findings described in this thesis hopefully enhance our knowledge of how advanced 
endoscopic imaging techniques can be best used to identify and characterise early 
gastrointestinal neoplasia with the end result of reducing mortality due to gastrointestinal 
cancers. 
This has been an area of considerable research activity over the past few decades, gaining 
pace with the constant development of new technologies. Endoscopists require robust 
evidence of what difference new technologies can make to patient outcomes – there is 
risk that without this, technologies may be viewed only as a gimmick. 
Survival from gastrointestinal cancer is closely related to stage at diagnosis, or better still 
prevention of the development of cancer by the removal of precursor lesions. Advances 
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in endoscopic technology have enhanced our recognition and understanding of subtle 
precancerous lesions such as flat high-grade dysplasia within Barrett’s oesophagus or flat 
adenomatous or serrated polyps in the colon. Once identified, accurate lesion 
characterisation is crucial to inform decision making regarding appropriate management 
– leave in situ, endoscopic resection or biopsy and refer for radical surgery. 
The development of a novel classification system for i-Scan demonstrates that the 
features of neoplastic and non-neoplastic polyps visible with i-Scan are, in broad terms, 
very similar to those found with NBI and FICE. The key features that appear to be 
highlighted with these 3 related advanced imaging techniques are vascularity, vascular 
patterns and surface patterns. Our results suggest that the main gain when assessing 
diminutive polyps is in improved sensitivity for adenomatous polyps. Endoscopists may be 
limited to using one particular advanced imaging system by the availability of endoscopic 
equipment within their unit. Hence, to aid adoption of optical diagnosis techniques, it 
may be beneficial to develop a universal optical diagnosis characterisation system for use 
with all 3 technologies (NBI, FICE and i-Scan). Before a universal system could be adopted 
it would require validation in large studies in multiple centres with a variety of 
endoscopists of varying degrees of experience.  
The HiSCOPE study described in chapter 5 broke new ground in the field of endoscopic 
characterisation of diminutive colonic polyps – HDWL endoscopy was found to be as 
accurate as both i-Scan and chromoendoscopy assessment and met both PIVI criteria set 
by the ASGE. This is the first time this standard has been reached using HDWL and 
demonstrates that this is possible with appropriate training. Further studies of in-vivo 
characterisation using HDWL in endoscopists of varying degrees of experience, are much 
needed with assessment of the learning curve involved and comparison with the 
performance achieved with enhancement techniques such as i-Scan. It may be the case 
that in the hands of less experienced endoscopists, an image enhancement technique 
improves optical assessment over HDWL. Indeed, as shown in chapter 4, i-Scan tone 
enhancement was significantly more accurate than surface/contrast enhancement. It may 
also be the case that use of an advanced imaging technique helps highlight vascular and 
surface patterns, thus helping an endoscopist to recognise and learn these features, 
which with experience are then identifiable (but more subtle) when viewed with HDWL. 
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The HiSCOPE study contrasts other colonic optical characterisation studies which 
generally show inferior performance of white light assessment in comparison to image 
enhancement. Indeed, despite advances in endoscope resolution, accuracy of white light 
assessment does not appear to have progressed. One potential contributing factor is that 
increasing endoscope resolution is leading to the detection of smaller and more subtle 
lesions which pose a greater challenge when attempting to make an optical diagnosis. 
This in itself is a driver for the ASGE PIVI on diminutive colonic polyps – with increasing 
resolution of endoscopes, endoscopists are identifying more tiny lesions, potentially 
leading to spiralling costs from endoscopic consumables and histopathology. 
However the study in chapter 6 demonstrates that for high-performing BCSP 
endoscopists the use of HD endoscopy does not improve adenoma detection (or several 
other outcome measures) compared to SD endoscopy. Significant differences between 
individual endoscopists were found, suggesting that training and technique factors may 
play an important role. Good quality bowel preparation was also found to be crucial to 
optimise lesion detection. The endoscopists in this study already had very high ADRs and 
hence there may be a ceiling effect, with limited scope for improvement in ADR. These 
results suggest that in a BCSP population, use of HD endoscopes should not be 
mandatory. Overall the literature examining ADR in relation to endoscope definition 
suggests that any benefit is modest. 
The NICEVIS study shows that pre-procedure preparation not only applies to colonoscopy, 
but is also of great importance prior to gastroscopy. Mucosal visibility was significantly 
improved in patients attending for routine upper GI endoscopy by use of a simeticone/n-
acetyl cysteine drink. In the control groups there was an 8-fold increase in the number of 
areas with inadequate views of the mucosa. It is worthy of note that this was the first 
study of it’s kind to demonstrate a significant benefit in the oesophagus as well as the 
stomach, which may have important implications for Barrett’s surveillance procedures. 
Secondary outcomes showed markedly reduced need for fluid flushes during the 
procedure. Although overall procedure time was not significantly reduced in the group 
receiving the active drink it can be argued that in this group more of that time was spent 
inspecting clear mucosa, rather than flushing to obtain clear mucosal views. The NICEVIS 
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study should lead on to a larger multi-centre study of a pre-gastroscopy drink examining 
the endpoint of lesion or dysplasia detection. 
Perhaps the most surprising results from this current study are those set out in chapters 8 
& 9 – two studies examining in-vivo characterisation skills amongst endoscopists of 
varying experience versus complete novices. The first study included a variety of colonic 
lesions, including early invasive cancer, whereas the second study only included 
diminutive colonic polyps. Both studies demonstrated that the performance of 
experienced endoscopists was not significantly different to inexperienced endoscopists 
and novices – a finding that was unexpected. This suggests that volume of endoscopic 
experience does not necessarily lead to acquisition of in-vivo characterisation skills. These 
results contrast those of previous studies suggesting that a brief training intervention can 
enable endoscopists to achieve very high levels of accuracy (>90%). However many 
studies of community based endoscopists which have included an initial training module, 
followed by picture-based test have shown significantly inferior performance when those 
endoscopists have embarked on polyp characterisation in vivo. This suggests that the 
spectrum of polyps used in test modules in these studies do not represent those found in 
clinical practice, where a greater proportion of ‘difficult’ polyps are encountered. Our 
results suggest that the spectrum of polyps used in the study described in chapter 9 was 
more representative of that found in clinical practice. 
The results of these 2 studies suggest that specific training in in vivo characterisation is 
required and needs to be incorporated into the training of all endoscopists – endoscopy 
training should not focus solely on being able to pass the endoscope to the desired point, 
but must also equip endoscopists with the skills to make an accurate and informed 
assessment of any lesions they encounter. Both chapters demonstrate that a brief 
training module can go some way to improving lesion characterisation skills, but this will 
require an ongoing programme of using these skills in-vivo with feedback and reference 
to histopathology. The on-line training module developed for the study in chapter 9 was 
effective at improving in vivo characterisation and has the advantage that it is accessible 
to endoscopists remotely, in their own time and can be revisited for clarification and 
revision. This may form an important first step in teaching endoscopic characterisation 
techniques, but would need expansion to include training on NBI and FICE.  However in 
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addition there needs to be an ongoing culture change within UK endoscopy for this to 
become a standard part of training and practice. Further studies are required to 
determine the optimal methods for teaching endoscopists in vivo characterisation skills, 
both in terms of training modules and also during endoscopy training lists. In time, it may 
be appropriate for an examination in lesion assessment skills to become part of the 
certification process for endoscopy in the UK.  
It would seem logical for novice endoscopists to begin to learn the skills of in-vivo 
characterisation soon after they begin training in endoscopy. This could be initially learnt 
through on-line resources and image libraries. These skills and knowledge could then be 
applied to real-life endoscopy whilst they are still in the training phase, so that careful 
lesion assessment becomes part of usual endoscopic practice and not just a concept that 
is introduced once an endoscopist has become independent in the technical aspects of 
the procedure. Alongside characterisation of lesions, identification of subtle neoplastic 
lesions such as dysplasia within Barrett’s oesophagus, early gastric cancer, flat 
adenomatous polyps, sessile serrated lesions and dysplasia within a colitic bowel should 
also be taught as part of routine endoscopic training. In this day and age it is not 
acceptable to train endoscopists simply to advance the scope to the desired point – they 
should be trained to identify and interpret important abnormalities along the way. 
Further studies are required to establish the optimal methods for teaching the required 
skills and knowledge and this should be the focus of future endoscopy-based research. 
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